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SUMMARY 
Autosomal dominant optic atrophy (ADOA) is an inherited optic neuropathy due 
to mutation in the OPA1 gene. Patients present with bilateral optic nerve head 
pallor and loss of visual function. Patients also show a reduction in the P50:N95 
ratio of the pattern electroretinogram (PERG) and thinning of the retinal nerve 
fibre layer (RNFL) and macula. 
 
In a mouse model of ADOA, previously generated in this laboratory, the defect 
first manifested as a dendritic pruning of RGCs, which appeared to be ON-
centre specific. Electrophysiological evidence in both humans and the mutant 
mice showed a reduction in the photopic negative component (PhNR) of the 
brief flash electroretinogram (ERG). The separation of the photopic ERG into 
ON- and OFF-pathway components using long-duration monochromatic (red) 
flash on a rod suppressing blue background, provided an opportunity to assess 
ON- and OFF-RGC function in ADOA, which had not been previously 
investigated in humans. This study therefore aimed to assess the effect of 
ADOA on the red-on blue PhNR-ON and PhNR-OFF components to determine 
whether the PhNR-ON was a selective marker for ADOA. 
 
In this thesis, a protocol was developed for recording long duration red-on-blue 
PhNRs from the macula (focal) and entire retina (full-field). A comparison of the 
retinotopic characteristics of the PhNRs (brief and long-duration) with the N95 of 
the PERG and the distribution of RGCs in the retina showed that the PhNR was 
capable of assessing RGC function. Retinal function was then probed in twelve 
participants with ADOA and sixteen controls using focal and full-field long 
duration ERG, full-field brief flash ERG and PERG. Retinal structure was also 
assessed using optical coherence tomography.  
 
In conclusion, this thesis found that the PhNR-ON and PhNR-OFF amplitudes 
were equally affected with no evidence of a preferential ON-pathway loss.  
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 CHAPTER ONE – INTRODUCTION 
 
 
1.1 Introduction to the Thesis 
This thesis describes a series of studies using electrophysiology to explore 
retinal function in healthy participants and participants with autosomal dominant 
optic atrophy (ADOA), an inherited optic neuropathy caused by mutations in the 
OPA1 gene leading ultimately to retinal ganglion cell (RGC) dysfunction or loss. 
Currently, there is no treatment for this blinding condition however, ongoing 
research is aimed at establishing early biomarkers for the disease so that 
treatment options can be introduced in early stages of the disease where the 
changes can be stopped or potentially reversed.  
 
This thesis is composed of eight chapters. Chapter 1 presents the relevant 
background information on the healthy eye, ADOA and ocular electrophysiology 
as well as the main hypotheses, aims and relevance of the PhD. Chapter 2 
describes the general methods used in this study, including equipment and the 
selection of control participants. It also presents a series of studies to develop a 
suitable protocol for recording the long duration ERG in healthy controls. In 
Chapter 3, the retinotopic characteristics of the focal long duration ERG 
developed in chapter 2 are compared to the pattern ERG, a standardised test 
for RGC function. In Chapter 4, the density profiles of the long duration and brief 
flash photopic negative response (PhNR) are compared to the published 
distribution of RGCs in the human retina. Chapters 5 to 7 constitute the main 
study of this thesis in which twelve participants with ADOA and sixteen age 
matched controls were recruited. Chapter 5 focuses on the baseline tests 
(visual acuity, contrast sensitivity, visual fields, colour vision and optical 
coherence tomography) used to assess the participants. Chapter 6 details their 
electrophysiological assessment findings while chapter 7 explores the 
relationship between findings of the baseline and electrophysiological tests. 
Finally, the general discussion of the thesis, limitations of the study, conclusions 
and future work are presented in chapter 8.  
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1.2 Overview of the Retinal Architecture 
The human retina is the photosensitive part of the eye (Figure 1.1). It lines the 
back of the eye and  extends from the circular edge of the optic disc to the ora 
serrata where it is continuous with the epithelial layers of the ciliary body 
(Remington, 2005; Kolb, 2011). A circular field of approximately 6 mm (~20o) 
around the fovea is considered the central retina, or macula, while the area 
beyond this is considered as the peripheral retina (Figure 1.1A)  (Kolb, 2011). 
Anatomically, the macula is defined as the area of the retina where the retinal 
ganglion cell (RGC) layer is more than one cell thick (Guedes et al., 2003). The 
fovea is the area of depression in the centre of the macula where cone density 
is highest. The fovea is about 1.5 mm (5o) in diameter and is used for sharpest 
acuity and colour vision (Remington, 2005; Kolb, 2011). In the centre of the 
fovea is the foveal pit, or foveola. It is an area about 0.35 mm (~1o) in diameter 
containing only cones and no rods (Remington, 2005; Kolb, 2011).  
 
The retina is approximately 0.5 mm thick. A radial section of the human retina 
reveals that the photoreceptors (rods and cones) lie outermost, against the 
retinal pigment epithelium and choroid while the RGCs, which are the output 
neurons of the retina, lie innermost in the retina, closest to vitreous chamber 
(Figure 1.1B). Light must therefore traverse the thickness of the retina before 
activating the photoreceptors (Remington, 2005). Typically, the inner or 
proximal retina refers to the vitreous side of the outer plexiform layer (OPL) 
while the outer or distal retina refers to the choroidal side of the OPL. 
 
The photoreceptors and RGCs are connected vertically by the bipolar cells, 
providing a three-step vertical pathway for light signalling through the retina. 
The horizontal cells, amacrine and interplexiform cells create intra-retinal cross-
connections (lateral and vertical), provide feedback information and integrate 
retinal function. In addition, the retinal architecture is supported by the Müller 
cells, glial cells which span between the inner limiting membrane and the outer 
limiting membrane. The outer limiting membrane of the retina is formed from 
adherens junctions between Müller cells and photoreceptor cell inner segments. 
The inner limiting membrane of the retina is likewise composed of laterally 
contacting Müller cell end feet and associated basement membrane 
constituents. 
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Figure 1.1. (A) A fundus photograph of the retina a study participant. It shows the fovea, 
macula and optic disc as well as blood vessels coursing from the optic disc. The central 
retina refers to the macula (outer circular ring) where the retinal ganglion cell layer is 
more than one cell thick and has a diameter 6 mm (~ 20o). The diameter of the fovea 
(inner circular ring) is about 1.5 mm (5o).  (B) A radial slice through the retina showing the 
various layers and cells of the retina (Remington, 2005). Typically, inner and outer retina 
refer to the vitreous and choroidal sides of the outer plexiform layer respectively. 
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1.2.1 The Photoreceptors 
The human retina is made up of rods and three types of cones (Kolb, 2003; 
Kolb, 2011). There are about 90 - 100 million rods and 4 - 6 million cones 
(Osterberg, 1935; Curcio et al., 1990). There are no rods in the foveolar, i.e. the 
central 0.35 mm (1o) area of the fovea (Remington, 2005). Rod density peaks at 
about 4 - 5 mm (~15 - 18o) from the foveal centre where it is over 150,000 
rods/mm2 and declines to about 40,000 rods/mm2 towards the periphery. Cone 
density on the other hand is at its peak of about 200,000 cones/mm2 at the 
foveal centre, declines rapidly to about 20,000 cones/mm2 at 1mm eccentricity 
and levels off to about 5,000 cones/mm2 towards the periphery (Osterberg, 
1935; Curcio et al., 1990).  
 
 
Figure 1.2. Spectral sensitivity curves of the four photoreceptors of the human retina. 
(Source: 
https://commons.wikimedia.org/wiki/File:1416_Color_Sensitivity.jpg#/media/File:1416_Co
lor_Sensitivity.jpg) 
 
The rods are highly sensitive to low levels of light and are used for vision under 
scotopic conditions. They contain the visual pigment rhodopsin (consisting of a 
protein, opsin, and chromophore, retinal) and are sensitive to blue-green light 
with peak sensitivity to a wavelength of around 500 nm (Bowmaker and 
Dartnall, 1980; Bowmaker et al., 1980). The cones are less sensitive to light and 
are used for vision under photopic conditions. Cone visual pigments contain a 
different type of opsin to the rod visual pigment, which results in a different 
spectral sensitivity. The three types of cones are named depending on their 
sensitivity to different wavelengths; L-cones are maximally sensitive to long 
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wavelengths of light (peak sensitivity 564nm), M-cones to medium wavelengths 
of light (peak sensitivity 534nm) and S-cones to short wavelengths (peak 
sensitivity 420nm) (Figure 2) (Bowmaker and Dartnall, 1980; Bowmaker et al., 
1980). The ratio of responses of the three cone types with their overlapping 
spectral sensitivity curves, and the consequent pathways of connectivity to the 
brain form the basis of colour perception (Remington, 2005). 
 
1.2.2 The Bipolar Cells 
The bipolar cells are the second order neurons in the vertical pathway, 
transmitting signals from photoreceptors to RGCs. Bipolar cell bodies reside in 
the inner nuclear layer; their dendrites synapse with photoreceptors in the outer 
plexiform layer (OPL) and their axon terminals with dendrites of RGCs and 
amacrine cells in the inner plexiform layer (IPL) (Figure 1.1).  
 
In the human retina, eleven types of bipolar cells have been identified using 
Golgi staining (Figure 1.3) (Boycott and Wassle, 1991; Kolb, 2003; Wassle, 
2004). Only one type of bipolar cell is known to synapse with rods, while the 
remaining types synapse with cones. Based on their response to light, the 
bipolar cells are further divided into two groups, depolarising and 
hyperpolarising bipolar cells. This division gives rise to the ON and OFF parallel 
pathways in the visual system which are further discussed in section 1.2.4.  
 
Figure 1.3. Bipolar cell types in the primate retina shown schematically in vertical view. 
Their axons terminate at different levels in the inner plexiform layer (IPL); OFF cone 
bipolar cells terminate in the outer half, while ON bipolar cells terminate in the inner half. 
DB – Diffuse bipolar cells; FMB – flat bipolar cells; IMB – invaginating bipolar cells; BB – 
blue bipolar cells; RB – rod bipolar cells; OPL – outer plexiform layer; INL – inner nuclear 
layer; IPL – inner plexiform layer; GCL – ganglion cell layer. (Wassle, 2004) 
 
1.2.3 The Retinal Ganglion Cells 
The RGCs are the third order neurons. Their cell bodies are located in the 
ganglion cell layer (GCL) and receive direct input from the bipolar cells and 
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amacrine cells (Wassle, 2004). There are approximately 1.2 million RGCs in the 
human retina (Quigley et al., 1982; Curcio and Allen, 1990). About 50% of the 
population of RGC bodies are found in the  macula (Curcio and Allen, 1990). 
There are no RGCs in the fovea; their cell bodies are laterally displaced away 
from the cones they connect to (Curcio and Allen, 1990; Drasdo et al., 2007). 
The peak density of 32,000 – 38,000 cells/mm2 therefore occurs in a 
horizontally oriented elliptical ring about 1 – 2 mm (3 - 5o) eccentric to the foveal 
centre (Figure 1.4). Curcio and Allen (1990) report that RGC density is about 
15% higher in the nasal retina than at equivalent eccentricities in the temporal 
retina from 0.4 to 2.0 mm, but from 2 – 4 mm, the nasal and temporal retina 
have approximately equal densities. Densities along the vertical meridian are 
equal in the superior and inferior retina from 0.4 – 2.0mm, but from 4 mm 
eccentricity, the superior retina has 65% higher RGC density than inferior retina.  
 
 
Figure 1.4. Average density of RGC bodies as a function of eccentricity along the 
horizontal (A, C) and vertical (B, D)  meridians of the composite retina. A and B show the 
central and C, D show peripheral ganglion cell density at appropriate scales. The gap in 
the nasal curve at 4 mm represent the site of the optic disc. RGC bodies were counted in 
unstained whole mount retinas of six young normal adults post-mortem (Curcio and 
Allen, 1990). 
 
Each ganglion cell has a single axon, which emerges from the cell body and 
turns to run parallel to the inner surface of the retina thus forming the retinal 
nerve fibre layer (RNFL) (Figure 1.1). The axons take a more or less arcuate 
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path towards the optic disc where they leave the eye as the optic nerve (Figure 
1.5). Axons from the fovea take a direct route towards the temporal rim of the 
optic disc and form the papillomacular bundle. Approximately 90% of all axons 
leaving the optic disc eventually terminate in the lateral geniculate body (Figure 
1.5); others project to subthalamic areas involved in processes such as the 
pupillary reflexes and the circadian rhythm (Remington, 2005).  
 
 
Figure 1.5. The visual pathway.  Objects in the nasal field are projected onto the temporal 
retina and vice versa. The nerve fibres from the nasal retina cross over to join the 
temporal fibres of the contralateral eye at the chiasm. Approximately 90% of all the nerve 
fibres in the optic nerve terminate at various layers of the lateral geniculate body. The 
remaining 10% project to the subthalamic areas of the superior colliculus and pretectal 
area. The geniculo-calcarine tract is made up of optic radiations projecting from the 
lateral geniculate body to the cortex in the occipital lobe. (Source: 
http://www.oculist.net/others/ebook/generalophthal/vaughan/public/co_figures/ch014/ch1
4fg2.jpg)  
 
There are many types of RGCs in the vertebrate retina with at least 10 – 15 
morphological types found in any mammalian retina (Wassle, 2004). Polyak in 
1941 identified six types of ganglion cells in primates according to cell body and 
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dendritic field size, naming them midget, parasol, shrub, small diffuse, garland 
and giant ganglion cells (Polyak, 1941; Rodieck et al., 1985). Of these six types, 
the midget and parasol ganglion cells have received the most attention mainly 
because they together constitute up to 80% of the entire population of RGCs 
(Rodieck et al., 1985; Watanabe and Rodieck, 1989; Dacey and Petersen, 
1992; Dacey, 1993b). Indeed many more RGC types have been identified more 
recently however, they exist at low densities, ranging from less than 1% to 5% 
of the total and much of their physiology is yet to be elucidated (Dacey, 2004).  
 
The midget RGCs are also referred to as P-cells and parasol RGCs as M-cells 
to denote their central projection respectively to the parvocellular and 
magnocellular layers of the LGN (Leventhal et al., 1981; Perry and Cowey, 
1981; Perry and Cowey, 1984; Perry et al., 1984; Rodieck et al., 1985; Dacey et 
al., 2003; Dacey, 2004). There also exists a third pathway involving the 
koniocellular (K) layers of the LGN which receives input from the small 
bistratified RGCs (Hendry and Reid, 2000; Xu et al., 2002; Casagrande et al., 
2007). Midget RGCs are identified by their small, dense and monostratified 
dendritic arbours. They are the most numerous RGC type in the retina 
constituting about 65-80% of the total number of RGCs in the central retina and 
about 40-50% in the periphery (Polyak, 1941; Rodieck et al., 1985; Watanabe 
and Rodieck, 1989; Dacey and Petersen, 1992; Dacey, 1993b). The parasol 
cells have more extensive dendritic arbours, consisting of relatively thick and 
frequently branched processes. They make up between 6-10% of RGCs in the 
central retina increasing to about 8-10% over much of the retina except in the 
nasal retina where parasols make up 20% or more of the RGC population from 
eccentricities of 7mm (Silveira and Perry, 1991). Within each group of midget 
and parasol cells, there is an increase in dendritic field size with eccentricity.  
 
The midget cells with their high sampling density function to preserve visual 
acuity and transmit chromatic information in the visual pathway. The parasol 
cells on the other hand respond strongly to achromatic or luminance stimuli, 
contrast and motion (Dacey, 1996; Dacey, 2004; Callaway, 2005). On the basis 
of their response to light stimulation, both midget and parasol cells are also 
grouped into ON-centre (depolarise at light onset) and OFF-centre (depolarise 
at light offset) varieties.  
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1.2.4 ON and OFF Pathways of the Retina 
Photoreceptors are depolarised in the dark and release a neurotransmitter, 
glutamate, at the synapse with the bipolar cells. When a photoreceptor absorbs 
light, the cells hyperpolarise and there is a decrease in the rate of glutamate 
release, which is detected by two types of bipolar cells with opposing 
sensitivities to glutamate. ON-bipolar cells (depolarising bipolar cells), 
depolarise in response to light onset and OFF-bipolar cells (hyperpolarising 
bipolar cells) hyperpolarise in response to light (or depolarise in response to 
light cessation). The ON- and OFF- bipolar cells then transmit their signal to 
their respective ON- and OFF RGCs (Figure 1.6) (Kolb, 2003). 
 
 
Figure 1.6. A schematic diagram showing the ON and OFF pathways of the human retina. 
ON-centre ganglion cells are activated when light falls on the centre of their receptive 
fields, whereas OFF-centre ganglion cells fire in response to light falling on their fields’ 
periphery leaving their centre dark. Horizontal cells convey antagonistic surround 
signals to bipolar cells and thence to ganglion cells. Ganglion cells have receptive fields, 
an area in space within which the RGC responds to a light stimulus (Hartline, 1938). RGC 
receptive fields are modelled as the difference between Gaussian distributions of centre 
and surround receptive fields, which gives them a so-called “Mexican-hat” shape (see 
lower section of figure), reflecting their integration of opposing information about 
centres and surrounds. In the fovea (right), ganglion cells have much narrower receptive 
fields and each carries information from a single cone. A cone feeds information to two 
of these midget ganglion cells; at all times each foveal cone transmits either an ON or an 
OFF signal to the brain. This signal also carries a colour message regarding the type of 
cone (red or green) it comes from (Kolb 2003). 
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Cones synapse directly on to either ON-bipolar cells or OFF-bipolar cells which 
in turn synapse with ON-centre and OFF-centre RGCs respectively. Each L- or 
M- cone in the central fovea, in contrast with the rest of the retina, connects to 
two midget ganglion cells, via two midget bipolar cells, so at all times each cone 
can either transmit a dark-on-light (OFF) signal or a light on-dark (ON) 
message. The S-cone pathway is mediated by the blue-cone bipolar cells which 
in turn contact the small bistratified RGCs which exhibit blue ON/yellow OFF 
responses (Kouyama and Marshak, 1992; Dacey and Lee, 1994; Martin et al., 
1997; Calkins, 2001; Szmajda et al., 2008). The bistratified RGCs of the S-cone 
pathway have two tiers of dendrites which make synaptic connections in two 
separate strata of the IPL. A bistratified RGC has a major dendritic tier 
branching in stratum 5 of sublamina b and a smaller tier of dendrites in stratum 
1 of sublamina a (Dacey, 1993a). Its axon projects to the koniocellular layers of 
the LGN (Martin et al., 1997). The signal that goes to the brain therefore has 
both spatial and spectral information (Kolb, 2003).  
 
 
Figure 1.7. The rod pathway. In the rod pathway, rod bipolar cells connect first to the AII 
amacrine cells. The amacrine cells then transmit the information to the ON-bipolar cells 
of the cone pathway for onward transmission to the ON centre RGCs. The amacrine cells 
at the same time directly inhibit the OFF-centre RGCs (Kolb, 2003). 
 
Rods, however, contact only rod bipolar cells, which depolarize in response to 
light stimulation (Rowling, 1987; Kolb, 2003) (Figure 1.7). The rod bipolar cells 
do not synapse directly with RGCs, instead they synapse with amacrine cells 
which in turn excite cone-ON bipolar cells, but inhibit cone-OFF bipolar cells in 
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order to send signals to the RGCs. In addition to this primary rod pathway, two 
more pathways enable rods to feed into retinal circuits (Euler et al., 2014). The 
secondary rod pathway involves gap junctions between rods and cones, 
enabling rod signals to enter the cone pathways in the outer plexiform layer 
(Tsukamoto et al., 2001; Euler et al., 2014). A tertiary rod pathway has been 
demonstrated in some mammals: in this pathway, rod terminals make direct 
basal contacts with some types of OFF-cone bipolar cells (Hack et al., 1999; 
Sharpe and Stockman, 1999). 
 
 
1.3 Autosomal Dominant Optic Atrophy 
Autosomal Dominant Optic Atrophy (ADOA) is a hereditary optic neuropathy 
presenting in childhood and characterized by bilateral optic nerve head (ONH) 
pallor and loss of visual function including reduced visual acuity, paracentral or 
centro-coecal visual field loss and colour vision defects (Votruba et al., 1998a).  
The disease is caused primarily by a mutation in the autosomal nuclear gene, 
OPA1, leading to degeneration in the RGCs (Alexander et al., 2000; Delettre et 
al., 2000). The disease is also known as Kjer’s Optic Atrophy and is named 
after Dr Poul Kjer who described the disease in 19 Danish families in 1959 
(Kjer, 1959). 
 
ADOA is one of the primary hereditary optic neuropathies, a group of inherited 
genetic disorders which all selectively cause the death of the RGCs in the 
retina. The other primary hereditary optic neuropathies are autosomal recessive 
optic atrophy, X-linked recessive optic atrophy and the maternally inherited 
Leber’s hereditary optic neuropathy (LHON). ADOA and LHON are the 
commonest types of hereditary optic neuropathies (Votruba et al., 2003a; Yu-
Wai-Man et al., 2009). The common clinical features in these conditions are 
reduced visual acuity, colour vision defects, central visual field defects and optic 
disc pallor. Visual loss is typically bilateral, symmetrical and irreversible once 
RGC loss has occurred (Votruba et al., 2003a; Newman and Biousse, 2004). 
The common finding of central or centro-coecal scotoma in these conditions is 
because they preferentially affect the papillomacular nerve fibre bundle. 
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LHON is characterised by a severe and sudden loss of vision in one eye 
occurring in the second decade in affected individuals. In nearly all cases, the 
second eye is affected within six months of onset. LHON is a primary 
mitochondriopathy, in that it is caused by a point mutation within the 
mitochondrial genome. Over 95% of LHON pedigrees are known to harbour one 
of three mitochondrial DNA (mtDNA) point mutations: m.3460G>A, 
m.11778G>A and m.14484T>C, which all involve genes encoding complex I 
subunits of the mitochondrial respiratory chain. The mode of transmission is 
maternal and affected males are more predisposed to lose vision (Yu-Wai-Man 
et al., 2009). 
 
1.3.1 Prevalence and Epidemiology 
The prevalence of ADOA is between 1 in 50,000 in most populations worldwide, 
to as high as 1 in 8,000 in Sicily, Italy. (Krill et al., 1970; Kjer et al., 1996; 
Votruba et al., 2003a; Yu-Wai-Man et al., 2010a; Gallus et al., 2012; Lenaers et 
al., 2012; Chen et al., 2013). In Sicily (Gallus et al., 2012), and in Denmark (Kjer 
et al., 1996) where the prevalence 1 in 12,000, a founder effect accounts for the 
high prevalence. 
 
In the United Kingdom, the prevalence of the disease is estimated at 1 in 
35,000 with the minimum point prevalence based on molecularly confirmed 
cases of the disease is approximately 1 in 50,000 (Yu-Wai-Man et al., 2010a). 
The affected male to female ratio is reported to be 1.06:1 (Yu-Wai-Man et al., 
2010a), which confirms earlier reports that males and females are equally 
affected (Johnston et al., 1979; Votruba et al., 1998a).  
 
1.3.2 Clinical Features 
The disease was first described by Batten (1896) and also by Snell (1897), who 
is generally credited as the first to describe a form of optic atrophy separate 
from Leber’s hereditary optic atrophy (LHON) (Votruba et al., 1998a; Delettre et 
al., 2002). For many years, clinicians then debated whether all inherited forms 
of optic atrophy were part of the manifestation spectrum of LHON, as described 
by Theodore Leber, or whether they were different disease entities. Wolfgang 
Jaeger in 1954, published genealogical and clinical findings in an extended 
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German family spanning 5 generations, thereby establishing autosomal 
dominant optic atrophy as a distinct disease entity (Jaeger, 1954; Fuhrmann et 
al., 2010). He demonstrated from the pedigree that the disease was inherited as 
a dominant trait and included male-male transmission, in contrast to LHON 
where only females transmit the disease (Man et al., 2002; Votruba et al., 
2003a). In addition, he pointed out the presence of blue yellow colour vision 
disturbances in the affected subjects in this family in contrast to the red-green 
defect typically present in families with LHON (Fuhrmann et al., 2010). 
 
Iverson (1958) also reported congenital optic atrophy in three generations which 
helped establish a clear autosomal dominant pattern of inheritance of the 
disease thereby distinguishing it from Leber hereditary optic atrophy (Kelly et 
al., 2012). However, it was only when the Danish ophthalmologist Kjer 
described 19 families with autosomal dominant atrophy that the disease was 
definitively recognised (Kjer, 1959; Delettre et al., 2002). 
 
ADOA is now a well-established clinical entity and clinical diagnosis is based on 
(1) age and mode of onset, which usually is in childhood and of gradual onset, 
(2) reduced visual acuity, usually moderate to severe, (3) temporal disc pallor, 
(4) colour vision defect, usually blue-yellow, (5) centro-coecal scotoma, and (6) 
an autosomal dominant inheritance pattern established by family history or 
genetic investigation (Kjer et al., 1996; Votruba et al., 1998a). The positive 
identification of mutations in the OPA1 gene (or other implicated genes 
discussed later in section 1.3.7) may be used to confirm the diagnosis 
especially in suspected cases of individuals with no family history. It is also 
important that all other causes of optic neuropathy are excluded. Patients with 
ADOA, however, show marked intra- and interfamilial variations in clinical 
features and this is thought to be indicative of the highly variable expression of 
the OPA1 gene. The observed wide variation in clinical presentation may be 
due to allelic heterogeneity, change in disease severity with age and the effects 
of other modifying genetic and/or environmental factors (Votruba et al., 1998a). 
 
ADOA may also be associated with extra-ocular neurologic features such as 
deafness, progressive external ophthalmoplegia, muscle cramps, hyper-reflexia, 
ataxia, stroke or multiple sclerosis-like symptoms. In these cases, the disease is 
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termed Autosomal Dominant Optic Atrophy Plus (ADOA+) and it is a syndromic 
form of the disease (Yu-Wai-Man et al., 2010b). Another syndromic form of 
ADOA associated with cataract is called Dominant Optic Atrophy and Cataract 
(DOAC), but it occurs rarely (Anikster et al., 2001). This review will focus on the 
ADOA caused by OPA1 (non-syndromic form) as the subject of the study. 
 
1.3.2.1 Visual Acuity 
The commonest ocular symptom presented in ADOA is blurred vision usually 
occurring within the first decade. The age of onset is usually reported between 4 
and 8 years, however, a later age of onset is not uncommon (Votruba et al., 
1998a; Johnston et al., 1999; Yu-Wai-Man et al., 2010a). For example, one 
study showed a bimodal distribution for the age of onset with peaks at 5 years 
and between 21 and 30 years. Furthermore, there has been at least one 
reported case of an original case presenting a late onset acute visual loss at 62 
years (Nochez et al., 2009). Late onset cases are thought to reflect cases with 
sub-clinical symptoms which were not detected until later when the disease 
progressed (Votruba et al., 1998b; Yu-Wai-Man et al., 2010a). 
 
The decrease in visual acuity is gradual, bilateral and irreversible (Johnston et 
al., 1979; Votruba et al., 1998a; Johnston et al., 1999; Yu-Wai-Man et al., 
2010a). Votruba et al (1998a), in a study of 87 affected individuals from 21 
families reported the median best corrected visual acuity (BCVA) was 6/36, 
while Yu-Wai-Man et al (2010a), recorded ~6/60 as the mean visual acuity in 
their study of 45 affected individuals from 17 families. However, BCVA in 
affected individuals covers a wide range from 6/6 to count fingers (Kline and 
Glaser, 1979; Votruba et al., 1998a; Johnston et al., 1999; Yu-Wai-Man et al., 
2010a) and highlights the wide phenotypic variation of the disease. Visual acuity 
is often symmetrical in the majority of patients, however, there is asymmetry of 
two lines or more on the Snellen visual acuity in 8 – 17 % of affected individuals 
(Kline and Glaser, 1979; Votruba et al., 1998a; Yu-Wai-Man et al., 2010a); with 
a striking example of an individual with VA of 6/9 and 6/60 in the right and left 
eye respectively (Kline and Glaser, 1979).  
 
Visual acuity generally tends to decline with age although there are 
considerable intra and inter-familial variations (Votruba et al., 1998a; Johnston 
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et al., 1999). The visual prognosis in ADOA is comparatively better than in 
LHON and some affected individuals maintain adequate vision (6/12 or better) 
for driving (Votruba et al., 1998a; Cohn et al., 2008). Notwithstanding the loss of 
visual acuity in ADOA, there are cases of individuals with normal BCVA (6/9 or 
better) in both eyes (Kline and Glaser, 1979; Votruba et al., 1998a; Johnston et 
al., 1999). For example, Johnston et al (1999), found individuals with normal VA 
(6/6) in both eyes, but who had mild colour vision defects, temporal or diffuse 
optic disc pallor and a positive family history of ADOA. In addition, they bore the 
specific haplotype associated with the disease and were therefore classified as 
affected with ADOA, but mildly so. These individuals with normal BCVA 
represented 9% of the number of the study participants with ADOA. Therefore, 
Johnston et al (1990) recommended that in the context of a family with ADOA, a 
mild degree of temporal or diffuse pallor of the optic disc and minimal colour 
vison defects, are highly suggestive of an individual being affected even if the 
visual acuity is normal.  
 
1.3.2.2 Ocular Motility 
Nystagmus is an uncommon finding and if present is seen in individuals with 
severe visual impairment. For example, Hoyt (1980), found four patients with 
nystagmus (among 31 ADOA affected patients); none of which had visual acuity 
better than 20/200. Votruba et al, 1998, examined 87 affected individuals and 
found only four patients with nystagmus, all of which were horizontal. These 
patients had visual acuities of 3/60, counting fingers, hand motion and light 
perception. 
 
1.3.2.3 Optic Nerve Head 
A distinctive feature in ADOA is bilateral temporal optic disc pallor (Johnston et 
al., 1979; Kline and Glaser, 1979; Votruba et al., 1998a; Johnston et al., 1999). 
The pallor is typically symmetric, wedge-shaped and not commonly associated 
with the cupping or increased intraocular pressure seen in primary open angle 
glaucoma (Figure 1.8 A, arrowed) (Votruba et al., 1998b). In some cases 
however, there is diffuse pallor involving the entire optic nerve head (ONH), 
while in others the pallor is subtle (Votruba et al., 2003b).  
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Figure 1.8. Ophthalmologic description of an ADOA patient. Left column displays control 
eye, right column shows affected eye. (A) Fundus photograph comparing control eye 
(left) to affected eye (right) showing temporal disc pallor; (B) Optical Coherence 
Tomography shows the retinal nerve fibre layer (black line) is reduced in DOA; (C) Visual 
field examination disclosing centro-coecal scotoma in DOA patient, only the blind spot is 
seen in control patient; (D) Results from a desaturated 15-Hue test presenting tritan 
defect (blue-yellow axis) in the ADOA patient (Lenaers et al., 2012) 
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There are also affected individuals who have normal looking optic nerve heads. 
Generally, best visual acuity is associated with least degree of pallor (Votruba et 
al., 1998a; Yu-Wai-Man et al., 2010a). However, severity of functional loss is 
not necessarily reflected in the disc appearance and gross visual field defects 
may be associated with anything from temporal pallor to complete atrophy of 
the disc (Votruba et al., 1998a; Yu-Wai-Man et al., 2010a). These differences 
highlight the clinical heterogeneity in ADOA. Other common optic disc findings 
include saucerisation, peripapillary atrophy and a cup to disc ratio of > 0.5 (Yu-
Wai-Man et al., 2009) 
 
One study found that individuals with ADOA have significantly smaller optic 
nerve heads than their age matched control counterparts, indicative of a smaller 
population of axons at birth (Barboni et al., 2010). This feature, however, may 
be mutation specific since stratification of ONH size by OPA1 mutation showed 
that normal sized ONH was associated with two mutations while the smallest 
size was linked to the ADOA+ phenotype. Thus, mutations in the OPA1 gene 
may determine the feature of a smaller optic disc size and this in turn may have 
relevance for ADOA pathogenesis. Furthermore, OPA1 gene polymorphic 
variants may contribute to the normal variability of ONH size in the general 
population (Barboni et al., 2010). 
 
Histologic examination of the optic nerve by Johnston et al (1979), and Kjer et 
al, (1983) showed a significant reduction in the retinal nerve fibre layer (RNFL) 
thickness of affected individuals in comparison to controls (Figure 1.8B). The 
measurement of circumpapillary RNFL using optical coherence tomography 
(OCT) in more recent studies confirmed this and showed marked thinning 
around the optic disc, more pronounced in the temporal quadrant, in affected 
individuals (Milea et al., 2010; Barboni et al., 2011; Yu-Wai-Man et al., 2011a). 
These studies showed that the RNFL thickness in patients with ADOA 
compared to age matched controls, was reduced by about 50 – 60% in the 
temporal quadrant and about 40 – 50% in the inferior quadrant (Table 1.1). 
Within the cohort, individuals with ADOA+ phenotypes or severe visual 
impairment acuity were found to have more marked RNFL thinning. 
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Table 1.1. RNFL thickness data for OPA1 patients and normal controls (Yu-Wai-Man et al., 
2011a) 
Quadrant 
  
Mean RNFL thickness (SD) (μm) P-valueb 
OPA1 (N=80) Controls (N=30) %-age decrease 95% CI 
 
Average 54.11  
(11.98) 
98.77 
(10.86) 
45.2 40.2–50.2 <0.0001 
Temporal 33.44 
(8.31) 
81.60 
(14.31) 
59.0 53.7–64.4 <0.0001 
Inferior 61.84 
(18.72) 
122.70 
(20.14) 
49.6 43.0–56.2 <0.0001 
Superior 71.00 
(21.58) 
122.00 
(14.86) 
41.8 34.9–48.8 <0.0001 
Nasal 49.99 
(12.76) 
67.43 
(17.59) 
25.9 16.9–34.8 <0.0001 
 
Table 1.2. Comparison of age-related RNFL loss in various studies (Modified from 
Barboni et al, 2011) 
Quadrant Parikh et al 
2007  
(n = 187) 
Budenz et al 
2007  
(n = 328) 
Sung et al, 
2009 
(n = 226) 
Barboni et al, 2011 
controls  
(n = 43) 
ADOA  
(n = 32) 
Average 0.16* 0.20* 0.25* 0.30* 0.19 – 0.20* 
Temporal  0.20* NA 0.06* 0.16 0.05 – 0.02 
Superior 0.23* NA 0.34 * 0.26 0.36 – 0.42* 
Nasal 0.12 NA 0.24* 0.36* 0.04 – 0.13* 
Inferior 0.08 NA 0.36* 0.40* 0.30 – 0.32* 
Values are in micrometres per year: NA – not available; * -Significant at p < 0.05 
 
Interestingly, the rate of RNFL thinning as a function of age in patients with 
ADOA (0.19 – 0.20 um/year) was within the range reported for normal 
individuals in other studies (Table 1.2). Since ADOA was previously reported to 
be associated with smaller ONH sizes (Barboni et al., 2010), it was 
hypothesized that the relative deficit in RNFL thickness is established before the 
second decade of life and the gradual reduction in best corrected visual acuity 
with age may be a consequence of the superimposed loss of fibres associated 
with normal ageing.  
 
1.3.2.4 Pupillary Reaction 
Another interesting finding is that there is usually no afferent pupillary defect in 
DOA patients and, if present, it is significantly less marked than the visual deficit 
would predict. This is similarly the case in LHON suggesting that the 
melanopsin RGCs, a subpopulation of ganglion cells responsible for pupillary 
reactions, are largely spared in both diseases (Bremner et al., 2001; Lenaers et 
al., 2012). Recently, Perganta et al (2013) reported that the pupillary reflex was 
similarly preserved in a mouse model of ADOA (Perganta et al., 2013). 
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1.3.2.5 Visual Fields 
Central, centro-coecal and paracentral scotomas with sparring of the periphery 
are the most common field abnormalities in DOA (Figures 1.8C). The scotoma 
generally affects the central 20 – 30o visual field (Fuhrmann et al., 2010)  These 
findings are consistent with the primary involvement of the papillomacular 
bundle in this condition. Affected individuals show a spectrum of defects ranging 
from a small discrete enlargement of the blind spot to a subtotal visual loss 
(Johnston et al., 1979; Kjer et al., 1996; Votruba et al., 1998b; Johnston et al., 
1999; Yu-Wai-Man et al., 2009). In one study, age and duration of disease were 
correlated with the mean field deviation in the affected patients. In the older 
patients and those affected for longer the mean deviation diverged from the age 
matched norm (Votruba et al., 1998a) 
 
1.3.2.6 Colour Vision 
The colour vision defect in ADOA is often reported as an acquired blue-yellow 
loss or tritanopia (Figure 1.8D) (Krill et al., 1971; Hoyt, 1980). A suggested 
reason for the frequency of tritan defects was that, since the short wavelength 
sensitive system mediating the blue-yellow channel has fewer cells than the 
medium and long wavelength sensitive system mediating the red-green 
channel, a percentage loss of RGCs in the blue-yellow channel was more 
devastating than an equal percentage loss in the red-green channel (Johnston 
et al., 1999). However, other studies showed a generalised dyschromatopsia 
involving both the blue-yellow and red-green axes, with a minority having pure 
tritanopia (<10%) (Votruba et al., 1998a; Yu-Wai-Man et al., 2009). In one study 
cohort, there were a number of children with marked protan or protan/deutan 
deficits who had relatively good visual acuities (Votruba et al., 1998a). The 
colour vision deficiencies are therefore not confined to the tritan axis, although it 
is the more severely affected axis (Holder et al., 1998; Johnston et al., 1999).  
 
1.3.3 Syndromic dominant optic atrophy  
The syndromic form of ADOA (ADOA+) is associated with extra-ocular features 
including neurosensory hearing loss, progressive external ophthalmoplegia, 
ataxia, myopathy and peripheral neuropathy, stroke or multiple sclerosis (Payne 
et al., 2004; Yu-Wai-Man et al., 2010b). ADOA+ patients usually experience 
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more severe visual deficits and represent up to 20% of DOA patients with an 
OPA1 mutation (Amati-Bonneau et al., 2008; Hudson et al., 2008; Yu-Wai-Man 
et al., 2010a; Yu-Wai-Man et al., 2010b). 
 
The most prominent manifestation after optic atrophy in these patients is 
bilateral sensori-neural deafness (occurs in about 60% of cases) beginning in 
late childhood and early adulthood (Yu-Wai-Man et al., 2010b). Sensori-neural 
hearing loss ranges from subclinical to severe forms and is associated with a 
particular OPA1 mutation; a heterozygous guanine to adenine (G>A) transition 
in the second nucleotide at codon 445 in the OPA1 gene, resulting in an 
arginine-445-to-histidine (R445H) substitution in the GTPase domain (Shimizu 
et al., 2003; Amati-Bonneau et al., 2005). The combinations of external 
ophthalmoplegia, ataxia, myopathy or peripheral neuropathy are usually 
manifest after the third decade of life and are associated with all types of 
mutations; however, there was an increased risk with missense mutations and 
with mutations located within the GTPase region (Yu-Wai-Man et al., 2010b).  
 
The mean age of onset of these plus features suggests a chronological pattern: 
visual failure occurs within the first decade, followed by deafness in late 
childhood to early adulthood, and then a combination of ataxia, myopathy, 
peripheral neuropathy and progressive external ophthalmoplegia from the third 
decade of life onwards (Figure 1.9). Subclinical neurological defects reported in 
some “pure” ADOA patients also appeared to be age dependent suggesting that 
multisystem involvement in OPA1 ADOA may be more pervasive than 
previously thought, but that the risk of developing clinically overt extra-ocular 
disease increases with age (Baker et al., 2011). 
 
In the spectrum of ADOA+ phenotypes, a severe early-onset neuromuscular 
phenotype (hypotonia, delayed motor development, ataxia, dysphagia, and 
gastrointestinal disability) caused by compound heterozygous mutations in the 
OPA1 in two siblings has been described (Schaaf et al., 2011) and there have 
also been reports of patients presenting extra-ocular features in the absence of 
visual loss (Yu-Wai-Man et al., 2010b). 
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Figure 1.9. Evolution of the major clinical features observed in ADOA+ syndromes. POE – 
progressive external ophthalmoplegia (Yu-Wai-Man et al., 2010b) 
  
1.3.4 The OPA1 Gene and its Functions 
The OPA1 gene maps to chromosome 3q28-q29 and comprises 29 exons of 
spanning more than 100kb genomic DNA of which 28 are coding exons 
(Alexander et al., 2000; Delettre et al., 2000) (Figure 1.10). The gene encodes 
eight OPA1 isoforms resulting from alternate splicing of exons 4, 4b and 5b 
(Figure 1.11) and the presence of these exons specifies the function of the 
isoform. By including the alternatively spliced exons 4, 4b, and 5b, the OPA1 
gene contain 31 exons (Delettre et al., 2001; Olichon et al., 2007).  
 
  
Figure 1.10. A composite diagram depicting human chromosome 3 showing the position 
of OPA1 (left) (Delettre et al., 2000) and a schematic representation showing the encoding 
of OPA1 (exon 4b isoform) gene (right). (Elachouri et al., 2011) E1 – E29 - OPA1 exon 1 to 
exon 29. MTS – Mitochondrial targeting sequence; GED – GTPase effector domain. 
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Figure 1.11: Alternative splicing patterns in human OPA1. Schematic representation of 
the 8 alternative transcripts found by RT-PCR. Numbers indicate exons (Delettre et al., 
2001). 
 
OPA1 protein is found in many tissues of the body: in the heart, skeletal 
muscles, liver, testes, the ear, and most abundantly in the brain and retina. In 
the eye, OPA1 is present in the cells of the RGC layer, inner and outer 
plexiform layers and the inner nuclear layer (Aijaz et al., 2004; Pesch et al., 
2004; Kamei et al., 2005).  
 
The OPA1 protein is a dynamin-related guanosine triphosphatase (GTPase) 
made up of 960 amino acids (Alexander et al., 2000; Delettre et al., 2000; 
Davies and Votruba, 2006). GTPases are a large family of enzymes that bind 
and hydrolyse guanosine triphosphate (GTP) to guanosine diphosphate (GDP). 
Dynamin-related proteins have three characteristic domains, a GTPase domain, 
a central domain that is conserved among all dynamins, and a GTPase effector 
domain (GED); and are associated with diverse cellular processes, including the 
release of transport vesicles, fusion and fission of mitochondria, cell division 
and resistance to viral infections (Heymann and Hinshaw, 2009). Other 
examples of dynamin related GTPases are mitofusions and dynramin-related 
protein-1 (DRP1) (Santel and Fuller 2001; Smirnova et al. 2001; Chen et al. 
2003; Olichon et al. 2003). 
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The OPA1 protein contains a mitochondrial targeting sequence (MTS), by which 
it is imported into mitochondria, a GTPase domain, a central dynamin domain, 
and a GED (Figure 1.10) (Chen and Chan, 2005; Davies and Votruba, 2006). 
Within the cell, the protein is found in the inner mitochondrial membrane where 
it is involved in mitochondrial fusion and helps regulate mitochondrial 
morphology (Chen and Chan, 2005; Fuhrmann et al., 2010). It is also involved 
in oxidative phosphorylation (OXPHOS) required to produce cellular ATP (Lodi 
et al., 2004; Lodi et al., 2011). In addition, it plays a protective role by 
sequestering cytochrome-c within the mitochondrial cristae thereby inhibiting 
cellular apoptosis (Olichon et al., 2003). There is also evidence that OPA1, 
specifically the exon-4b isoforms influences replication of mitochondrial DNA 
and is involved in the maintenance of the mitochondrial DNA (Elachouri et al., 
2011). 
 
1.3.5 Pathogenesis and Molecular Genetics of ADOA  
Most mutations in the OPA1 gene leads to a haplo-insufficiency situation where 
the mutated transcripts are degraded by mRNA decay (Alexander et al., 2000; 
Delettre et al., 2000; Lenaers et al., 2012). This mRNA decay leads to ~50% 
reduction in the amount of OPA1 protein produced, thus affecting mitochondrial 
function. This is thought to result in an insufficient energy supply to the highly 
energy demanding neurons of the optic nerve, notably the papillomacular 
bundle, thereby causing blindness by compromising axonal transport in the 
RGCs (Alexander et al., 2000; Puomila et al., 2005).  
 
There are over 300 mutations of the OPA1 gene which cause ADOA 
(http://mitodyn.org/home.php?select_db=OPA1, accessed 14/10/2015) and the 
majority arise in the GTPase and dynamin central regions coded by exons 8 to 
24 (Figure 1.12) (Thiselton et al., 2002; Davies et al., 2007; Ferre et al., 2009; 
Ferre et al., 2015). About 26% of the mutations are missense, 16% lead to 
frameshift mutations, 14% are nonsense and 6% are deletion or duplication. 
The different mutations in OPA1 are not related to the severity of the disease 
and genotype/phenotype correlations are difficult to infer, however, missense 
mutations and mutations occurring in the GTPAse domain increase the risk of 
developing ADOA+ phenotypes in affected individuals (Yu-Wai-Man et al., 
2010b; Barboni et al., 2014). In this respect, secondary nuclear genes are 
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suspected to control the severity of the disease in non-syndromic DOA (Puomila 
et al., 2005). 
 
 
Figure 1.12 Distribution of 233 pathogenic mutations of OPA1 gene. (A) Exons involved 
in the variants are shown as blue bars; the variants in the intronic neighbourhood of the 
exons are shown as red bars. (B) Protein consequence type. (C) Affected domain. Alt - 
alternative exon; bp - base pairs; GED - GTPase effector domain (Ferre et al., 2015). Red 
arrow indicates the site of a nonsense mutation in the B6:C3Opa1Q285STOP mouse model 
of ADOA (Davies et al. 2007). 
 
1.3.6 Peculiar Susceptibility of RGCs in ADOA 
It is unclear why mutations in OPA1 leading to ADOA primarily affect the RGCs 
even though the OPA1 gene is present in all body tissues (Aijaz et al., 2004; 
Davies and Votruba, 2006; Sarzi et al., 2012). It is thought that the disease 
exploits certain peculiar anatomical and physiological constrains of the optic 
nerve (Yu-Wai-Man et al., 2011b). One such feature is that the axons of RGCs 
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only acquire a myelin sheath beyond the lamina cribrosa. In the pre-laminar 
section, the generation and propagation of action potentials are therefore less 
efficient and require greater energetic input (Carelli et al., 2004; Yu-Wai-Man et 
al., 2011b). There is therefore a greater accumulation of mitochondria in the 
pre-laminar (unmyelinated) region than the post-laminar region, creating a 
differential concentration of mitochondria across the lamina cribrosa (Bristow et 
al., 2002; Yu Wai Man et al., 2005). The pre-laminar regions of the optic nerve 
could therefore be viewed as a vulnerable metabolic chokepoint, magnifying the 
consequences of any impairment in mitochondrial oxidative phosphorylation, 
however subtle. As the energetic fuelling of RGC in the central retina is further 
restricted due to the physical constraints imposed by the macula blood vessel 
organisation, it is hypothesised that ATP synthesis in the RGCs of patients is 
limited and cannot fulfil the physiological energetic requirements required for 
long term cell survival due the uncoupling of mitochondrial respiration by the 
mutation (Alavi et al., 2007; Davies et al., 2007). Interestingly, in two family 
members with optic atrophy and hearing loss due to a pathogenic OPA1 
mutation, the defect was localised to the terminal unmyelinated portions of the 
cochlear nerve, which is another cranial nerve marked by a dramatic transition 
between unmyelinated and myelinated segments (Huang et al., 2009).  
Furthermore, RGCs are the only neurons of the body that are exposed to the 
day long stress of light, which generates oxidative species favouring the 
apoptotic process (Osborne et al., 2008). Therefore, the mitochondrial fragility 
conferred by OPA1 mutations together with the photo-oxidative stress could 
precipitate RGC premature death. Another hypothesis relates to the observation 
in a mouse model that neuronal tissues and glycolytic muscles on the one hand, 
and oxidative tissues and the heart, on the other, compensate differently for the 
loss of mutated OPA1 transcripts (Sarzi et al., 2012). A common mitochondrial 
cytochrome oxidase defect is observed in the retina, optic nerve and glycolytic 
muscle fibres, whereas brain, oxidative muscles and heart are unaffected. In the 
retina, the cytochrome oxidase defect precedes the onset of visual failure and is 
thought to contribute to the pathological mechanism leading to RGC death.  
 
1.3.7 Other Loci Associated with Hereditary Optic Atrophy 
The first ADOA locus, OPA1, located on 3q28 was initially considered unique 
(Eiberg et al., 1994; Bonneau et al., 1995). However, some ADOA families were 
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shown to exclude linkage to the OPA1 locus suggesting genetic heterogeneity 
of the disease (Seller et al., 1997; Kerrison et al., 1999). Subsequently, 
additional loci and genes were identified in patients with ADOA phenotypes, but 
these were associated with different modes of inheritance or syndromic forms 
(Table 1.3 and 1.4).  
 
Table 1.3. Loci and genes of hereditary optic atrophy. Adapted from Lenaers et al, 2012 
Locus Chromosome Gene Mode of Inheritance Reference 
OPA1 3q28-29 OPA1 Dominant (Alexander et al., 2000; 
Delettre et al., 2000) 
OPA2 Xp11.4-p11.21 Unknown X-linked (Assink et al., 1997) 
OPA3 19q13.2-q13.3 OPA3 Dominant/recessive (Anikster et al., 2001) 
OPA4 18q12.2-q12.3 Unknown Dominant (Kerrison et al., 1999) 
OPA5 22q12.1-q13.1 Unknown Dominant (Barbet et al., 2005) 
OPA6 8q21-q22 Unknown Recessive (Barbet et al., 2003) 
OPA7 11q14.1-q21 TMEM126A Recessive (Hanein et al., 2009; 
Hanein et al., 2013) 
OPA8 16q21-q22 Unknown Dominant (Carelli et al., 2011) 
 
Table 1.4. Clinical features associated with ADOA caused by mutations in OPA 1 – 8. 
Adapted from Lenaers et al, 2012 
Locus Optic 
Atrophy 
Deafness Poly 
neuropathy 
Myopathy 
CPEO 
Cardio-
myopathy 
Cataract 
OPA1 + +/- +/- +/- - - 
OPA2 + - - - - - 
OPA3 + - - - - + 
OPA4 + - - - - - 
OPA5 + - - - - - 
OPA6 + - - - - - 
OPA7 + +/- - - +/- - 
OPA8 + +/- - - +/- - 
Legend: (+) = systemic; (+/-) = possible; (-) = never reported 
 
OPA4 and OPA5 were mapped to chromosome 18q12.2-q12 and chromosome 
22q12.1–q13.1 respectively (Kerrison et al., 1999; Barbet et al., 2005); 
however, the underlying genes are currently unknown. The phenotype of 
affected patients with OPA4 and OPA5 was similar to that of patients 
harbouring OPA1 mutations. OPA3 and TMEM126A (OPA7) are two other 
genes that have been identified so far. They both encode mitochondrial proteins 
ubiquitously expressed and associated to the inner mitochondrial membrane. 
OPA3 mutations may be inherited in a dominant or recessive pattern while 
TMEM126A mutations are inherited in a recessive pattern (Reynier et al., 2004; 
Hanein et al., 2009; Huizing et al., 2010; Hanein et al., 2013).  
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OPA3 mutations were first identified in Iraqi Jewish families with Type III 3-
methylglutaconic aciduria (Costeff syndrome); an autosomal recessive 
neurodegenerative disorder characterised by optic atrophy, progressive 
neurodegeneration, increased urinary levels of 3-methylglutaconic acid, and 
elevated plasma 3-methylglutaric acid levels (Anikster et al., 2001). Pathogenic 
mutations were subsequently found in two independent French families 
segregating both optic atrophy and premature cataract in an autosomal-
dominant mode of inheritance (ADOAC) (Reynier et al., 2004). However, OPA3 
mutations are likely to be extremely rare, especially in isolated optic atrophy 
cases; two large scale screening of individuals with hereditary optic atrophy 
without OPA1 mutations did not identify any pathogenic OPA3 mutations (Yu-
Wai-Man et al., 2010a; Yu-Wai-Man et al., 2011c). 
 
Mutations in the OPA7 gene cause a non-syndromic autosomal recessive optic 
atrophy. It has a juvenile onset and it is extremely rare; it has so far been found 
in only five families, all of Algerian or Moroccan descent (Desir et al., 2012; 
Hanein et al., 2013). Thus to date, OPA1 is the major gene responsible for 
ADOA, accounting for at least of 60 – 70% all the patients, whereas all the other 
genes or loci only contribute each for less than 1% of the patient cohort (Ferre 
et al., 2009; Yu-Wai-Man et al., 2010a). The clinical features of the various OPA 
loci are summarised in Table 1.4. 
 
1.3.8 Current Management 
The management of ADOA patients consists in regular ophthalmologic 
examination, including measurement of visual acuity, colour vision, visual fields 
and OCT and refraction. In the experience of the author and from anecdotal 
reports, this provides re-assurance to patients and promotes their psychological 
wellbeing.  To date, no specific treatment exists, but low-vision aids in patients 
with severely decreased visual acuity can be beneficial (Lenaers et al., 2012). 
Patients should be registered as visually impaired or severely visually impaired 
to assist in visual rehabilitation, education and employment. As a general health 
measure, patients should be strongly advised to avoid smoking and to moderate 
their alcohol consumption since and smoking and alcohol are associated with 
an increased risk of visual failure (Yu-Wai-Man et al., 2011b). Genetic 
counselling should be given to families with ADOA and pregnant women can 
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request prenatal testing (amniocentesis or chorionic villus sampling) after 
having been appropriately counselled. 
 
Since the pathogenic mutations in ADOA (and LHON) eventually destabilise 
complex I resulting in a reduction in ATP synthesis and increased ROS levels, 
an attractive treatment strategy is to restore the flow of electrons along the 
mitochondrial respiratory chain by bypassing the blockage occurring at the level 
of complex I and enabling or maximising the direct shuttling of electrons to 
complex III. Ubiquinone is an essential carrier that ensures the efficient transfer 
of electrons along the mitochondrial respiratory chain. Idebenone is a synthetic 
analogue of ubiquinone and a randomised controlled trial carried out in 85 
patients with LHON showed beneficial effects and no adverse drug reactions in 
the active arm of the cohort on a dose of 900mg/day (Klopstock et al., 2011; 
Klopstock et al., 2013). Consequently, a pilot study on 7 patients with ADOA 
was carried out and showed variable improvements in visual acuity and visual 
field mean defects in 5 patients (Barboni et al., 2013). Idebenone is 
commercially available under the name Raxone® (Santhera Pharmaceuticals 
Ltd, Liestal, Switzerland) in 150mg tablets and it is the first medicine to be 
approved by the European Union for the treatment of visual impairment in 
adolescents and adult patients with LHON 
(http://www.santhera.com/index.php?mid=15&vid=&lang=en, accessed 
15/10/2015). More research is being carried out on the efficacy and safety of 
the medicine in the treatment of LHON and ADOA (Yu-Wai-Man et al., 2014). 
 
In the area of developing treatment, near-infrared light (NIR) has been shown to 
improve mitochondrial function and cellular survival in various models of wound 
healing, neurodegeneration and methanol-induced retinal toxicity (Desmet et 
al., 2006). The potential of NIR in rescuing RGC loss is also being tested in a 
mouse model of ADOA (M Votruba 2015, personal communication, October). 
An open labelled study of EPI-743, another ubiquinone analogue, for patients 
with ADOA is under preparation (Yu-Wai-Man et al., 2014). The National 
Institute for Health Research (NHIR) is spearheading an ambitious translational 
research programme for rare genetic diseases in the United Kingdom. Inherited 
optic neuropathies have been selected as one of the priority disease themes. 
The purpose of the study is to undertake deep phenotyping of patients with 
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LHON and ADOA to define the natural history of the visual loss and to identify 
the most sensitive parameters for monitoring disease progression. Importantly, 
this study will provide useful information on the visual outcome measures that 
are most likely to reveal a clinically meaningful treatment effect in future clinical 
trials for pipeline neuroprotective agents.  
 
1.3.9 Mouse Models: What they tell us about OPA1 in ADOA 
Mice are widely used as genetic disease models due to the relative ease of 
genetic manipulation and high homology to the human genome. The murine 
retina shows relatively good homology to the human retina, rendering the 
mouse suitable for modelling a wide range of human visual diseases with a 
genetic basis (Smith et al., 2002). Three mouse models have so far been 
published providing insight into the pathophysiology regarding ADOA (Alavi et 
al., 2007; Davies et al., 2007; Sarzi et al., 2012). However, these models are 
not perfect because of the range of anatomical limitations in comparing the 
murine eye to the human eye.  
 
A description of the B6:C3Opa1Q285STOP mouse model of ADOA which was 
developed previously in our laboratory is provided below to highlight the points 
of interest relevant to this study. A summary of the characteristics of the three 
ADOA mouse models is provided in Table 1.5. 
 
1.3.9.1 The B6:C3Opa1Q285STOP Mouse Model 
Davies et al (2007) generated mutant mice carrying an ethylnitrosourea (ENU)-
induced mutation in the Opa1 gene, resulting in a truncated protein. The mutant 
mouse was generated by screening an ENU-mutagenised DNA archive from 
C3HeB/FeJ males and selecting a heterozygous nonsense mutation in exon 8 
(arrowed in Figure 1.12), which codes for a C–T transition at 1051 base pairs 
(Q285STOP). This mutation causes protein truncation at the beginning of the 
dynamin GTPase, close to the location of a number of human disease 
mutations (c.868C>T (R290 W) and c.869G>T (R290Q) (Ferre et al., 2005; 
Davies et al., 2007; Williams et al., 2011). 
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Western blot analysis in heterozygous mutants showed that the mutation 
resulted in in approximately 50% reduction in Opa1 protein in the retina and all 
tissues suggesting that haploinsufficiency underlies the pathophysiological 
mechanism. The homozygous mutation was embryonic lethal by 13.5 days 
post-coitum. Fibroblasts taken from the muscle of Opa1 +/- adult heterozygotes 
showed an increase in mitochondrial fission and fragmentation compared to 
wild-type littermates, highlighting the importance of OPA1 in proper 
mitochondrial function and morphology. Davies et al (2007) concluded that the 
OPA1 GTPase contains crucial information required for the survival of RGCs 
and that OPA1 is essential for early embryonic survival. 
 
In addition, electron microscopy revealed the slow onset of optic nerve 
degeneration starting from 9 months (White et al., 2009); while visual function in 
heterozygotes demonstrated by optokinetic drum testing and the circadian 
running wheel was reduced from 12 months (Davies et al., 2007). However, 
there was no significant change in the number of axons per area optic nerve 
between wild-type and Opa1+/- mice at 6, 9 and 24 months of age to suggest 
RGC death (White et al., 2009; Williams et al., 2010). Further investigations 
revealed a selective dendritic pruning in ON-centre RGCs, with no significant 
changes in the OFF-centre RGCs in mutant mice starting at about 10 months 
(Figure 1.13) (Williams et al., 2010; Williams et al., 2012). The phase of active 
dendritic pruning was accompanied by significant changes in synaptic density, 
synaptic structure and mitochondrial morphology within the synaptic bouton 
(Williams et al., 2012). These findings imply that synaptic atrophy coincides with 
or precedes dendritic atrophy, suggesting that dendritic atrophy (and 
consequently visual dysfunction) may be driven at the level of the synapse. 
Notably, all these changes occurred in the absence of significant RGC loss and 
preceded visual loss.  
 
Visual electrophysiology (VEP and ERG) testing in 11 and 13 month old mutant 
mice showed deficits consistent with RGC dysfunction (Barnard et al., 2011). 
The a-wave and b-wave of the photopic ERG showed no significant difference 
between wild-type controls and mutant mice. However, there was a significant 
reduction in the photopic negative response (PhNR) amplitude, an ERG 
component known to reflect RGC function (Viswanathan et al., 1999; 
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Viswanathan et al., 2000; Viswanathan et al., 2001), in mutant mice compared 
to wild-types (Figure 1.14). (A detailed description of the PhNR is presented in 
section 1.4.2.5 and 1.4.3.). This electrophysiological finding and the novel 
finding that ADOA selectively affects the ON-RGCs provided the basis for this 
project to examine the ON and OFF RGC function separately in affected ADOA 
patients using electrophysiologic techniques. 
 
 
 
Figure 1.13. Selective dendritic pruning of ON-centre RGCs in Opa1 deficiency. Examples 
of ON- and OFF-centre RGCs from an adult (10-month-old) wild-type mouse showing 
their normal dendritic arbours (A and B respectively). Scale bar = 25 µm. The dendrites of 
ON-centre RGCs ramify in sublamina b (close to the level of the cell body) and the 
dendrites of OFF-centre RGCs ramify in sublamina a (close to the inner nuclear layer). 
Total dendritic length is reduced in the ON-centre RGCs of 10- to 15-month-old and >20-
month-old mice (C) while remaining statistically unchanged in OFF-centre RGCs. 
P = Student’s t-test, %Δ = percentage change from wild-type. GCL = ganglion cell layer; 
IPL = inner plexiform layer (Williams et al., 2010).  
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Figure 1.14. Reduction in the photopic negative response amplitude of the light-adapted 
ERG in Opa1+/− mice.Averaged traces for each genotype (n = 5 for both). Stimulus 
intensity shown on right, values are in log cd.s/m2. Quantification of (B) amplitude of b-
wave, (C) time-to-peak of b-wave, (D) amplitude of PhNR and (E) time-to-peak of PhNR. 
Plotted values are mean + SEM, n = 5. * = p < 0.05, *** = p < 0.001: significance of 
Bonferroni post-tests after repeated measures two-way ANOVA with genotype and 
stimulus intensity as factors. Wild-type control (Opa1+/+) traces and values are shown in 
black empty symbols, heterozygote mutants (Opa+/-) are in grey/filled symbols (Barnard 
et al., 2011). 
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Table 1.5. Comparison of the characteristics of three mouse models of ADOA. Modified from William et al. 2011. 
Characteristic B6:C3-Opa1Q285STOP (Davies et al., 2007) B6:C3-Opa1329-355del (Alavi et al., 2007) Opa1delTTAG (Sarzi et al., 2012) 
Mouse type Strain: C3H:C57B1/6J Strain: C3H:C57B1/6J Strain: C57BI6/J 
Mutation Exon 8; nonsense mutation 
At DNA level: c. 1051 C>T 
At protein level: p.Q285X; 50% reduction in 
protein levels 
Intron 10; splice site mutation 
At DNA Level: c. 1065+5G>A 
At protein level: p.329-355del; 50% reduction 
in protein levels 
Exon 27; deletion 
At DNA level: c. 2708-2711 delTTAG 
At protein level: 25-50% reduction in protein 
level 
Homozygous 
mutant 
Embroyonic lethality <E13.5 Embroyonic lethality ca8.5 Embroyonic lethality <E10.5 
Mitochondria mtDNA copy number: no significant 
difference compared to wild-type 
counterparts. Morphology: powdered 
appearance, increased mitophagy 
mtDNA copy number: no significant 
difference compared to wild-type 
counterparts. Morphology: disorganised 
cristae 
mtDNA copy number: increased in neuronal 
tissues, especially optic nerve. Morphology: 
disorganised cristae, increased mitohpagy 
Visual function and 
electrophysiology 
Decreased visual function assessed by OKN 
and circadian running wheel 
Reduced PhNR amplitude 
Decrease in VEP amplitude 
No significant change in ERG even in aged 
mice 
Increased latency in VEP 
No significant reduction in VEP amplitude 
No significant changes in ERG 
ERG stimulus Full-field white flash on white background. 
Flash duration = 4 msec; Flash luminance = 
0.0, 1.0, 1.4 log cd.s/m2; Background = 30 
cd/m2 (Barnard et al., 2011) 
Full-field white flash on white background. 
Flash duration = Not given; Flash luminance 
= -2.0, -1.0, 0.0, 1.0 log cd.s/m2; Background 
= 30 cd/m2 (Jaissle et al., 2001) 
Not given 
Plus phenotype Increased transfer arousal, longer freezing 
periods, decreased locomotor activity 
No COX-SDH ragged red fibres, no hearing 
loss 
Abnormal clutching reflex, tremor, decreased 
locomotor activity, lighter weight, less body 
fat than wild-type, no COX-SDH ragged red 
fibres, no hearing loss 
Encephalomyopathy, Ataxia, Peripheral 
neuropathy, Cardiomyopathy, Severe 
hearing loss, Premature ageing 
Optic nerve Demyelination, myelin clumping, watery 
degeneration, no axon loss 
Demyelination; disorganisation, swollen and 
distorted axons, complete loss of large 
axons, significant loss of small axons 
Demyelination, myelin vacuolisation, swollen 
axons 
RGC population 
and morphology 
Dendritic atrophy of ON-centre RGC with age 
No significant difference in population 
Reduction with age starting at 13 months Reduction with age starting at 16 months 
ON-/OFF-RGC 
lamination 
examined 
Yes No No 
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1.4 Ocular Electrophysiology 
Electrophysiologic techniques provide a valuable objective non-invasive means 
of assessing the integrity of the visual pathway. The electroretinogram (ERG), 
the electro-oculogram (EOG) and the visual evoked potential (VEP) are the 
most commonly used types in clinical practice (Weisinger et al., 1996; Wolpert 
and Tsang, 2011). The ERG provides an objective assessment of retinal 
function whereas the EOG evaluates the function of the retinal pigment 
epithelium-photoreceptor complex. The VEP evaluates the pathway to the 
striate cortex (Weisinger et al., 1996). Other electrophysiologic techniques 
include the electromyogram for the assessment of the extra-ocular muscles and 
the electronystagmography, for measurement of nystagmus and eye 
movements (http://www.iscev.org/standards/proceduresguide.html, accessed 
22/08/2016).  
 
Two important characteristics make electrophysiologic techniques different from 
others; they are both functional and objective. Many ocular tests such as 
angiography, ultrasonography and OCT are objective, but provide structural 
information rather than functional, and some, such as perimetry and contrast 
sensitivity test are functional, but not objective (Movassat, 2012). Clinical 
electrophysiological testing became practical in the middle of the twentieth 
century, but a wide variety of procedures were used by different laboratories to 
elicit responses. Comparing data among research or clinical reports was 
therefore very difficult and this impeded both clinical care and the interpretation 
of clinical research. The International Society of Clinical Electrophysiology of 
Vision (ISCEV) was founded in 1961 in recognition of the need for 
standardisation of these techniques and since 1989, ISCEV has published 
standards for clinical electrophysiological techniques (Marmor and Zrenner, 
2006). This review focuses on the ERG which was the electrophysiological 
technique used in this thesis. 
 
1.4.1 The Electroretinogram 
The term “electroretinogram” refers to a number of electrodiagnostic waveforms 
or techniques that test retinal function (Figure 1.15). The different ERG types 
are produced by manipulating the stimulus and testing conditions in order to 
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investigate different cell types, layers or areas of the retina (Wolpert and Tsang, 
2011). A single flash of light evokes a transient ERG (Figure 1.15, A – C, E) 
while a flickering stimulus (e.g. 30 Hz) evokes a flicker or steady state ERG 
Figure 1.15F). A patterned stimulus can also be used to evoke a pattern ERG 
(discussed later in section 1.4.3). In all cases, electrodes placed on the cornea 
or conjunctiva and around the orbit record changes in the electrical potential of 
the eye in response to specific (light) stimuli (Weisinger et al., 1996).  
 
 
Figure 1.15. Diagram of the six basic ERGs defined by the ISCEV Standard. Bold 
arrowheads indicate the stimulus flash; solid arrows illustrate a-wave and b-wave 
amplitudes dotted arrows exemplify how to measure time-to-peak (t or time-to-peak). The 
headings describe the stimulus (and response) names by their state of light adaptation 
and the flash strength in photopic cd.s/m2 (McCulloch et al., 2015). 
 
1.4.2 The Flash Electroretinogram 
The flash ERG is a recording of the summed potential changes generated by 
the retina in response to a single flash of light (Figure 1.16) (Fishman, 2001). 
This retinal potential can be recorded in all vertebrates and in many 
invertebrates, e.g. Drosophila, however, the waveforms for each species are 
different (Fishman, 2001; Wolpert and Tsang, 2011). Different waveforms are 
also produced under different recording conditions (e.g. photopic or scotopic) 
and stimulus parameters (e.g. frequency of stimulation, wavelength, luminance, 
duration and size of stimulus). The focus of this review is on the human ERG 
elicited under photopic conditions.  
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Figure 1.16 Representative full-field ERGs showing the recorded response to (A) a brief 
flash and (B) a long duration flash. In response to the long duration flash, the ERG is 
separated into ON and OFF components as indicated on the time axis. The positive going 
wave interrupting the descending limb of the b-wave arrowed in A is the i-wave. 
Diagrams are not to scale. 
 
The major components of the photopic ERG in humans are shown in Figure 
1.16. A brief flash ERG comprises the a-wave, b-wave and photopic negative 
response (PhNR). In addition to these, other components can be identified on 
the ERG by manipulating experimental recording conditions. These components 
include the early receptor potential and c-wave (not shown, both best recorded 
under dark adapted condition in response to a bright flash), the oscillatory 
potentials (seen as wavelets riding on the ascending limb of the b-wave in 
Figure 1.15B) and the i-wave (arrowed in Figure 1.16A) (Perlman, 2001). The d-
wave is a component seen only in long duration ERGs (Figure 1.16B) (Perlman, 
2001). The PhNR is also separated into the PhNR-ON and PhNR-OFF using a 
long duration flash (Viswanathan et al., 1999). 
 
The words “brief” or “short” and “long” are arbitrary qualifiers used by 
electrophysiologists to refer to stimulus durations in relation to the temporal 
integration time of photoreceptors. The integration time refers to the time within 
which a photoreceptor summates or collects a sample of photons while 
producing a single response (Warrant, 1999; Kolloniatis and Luu, 2007).  For 
rods it is about 100 msec while for cones it is 10-15 msec (Kolloniatis and Luu, 
2007). Brief flashes (shorter than the photoreceptor integration time) produce a 
combined response from the ON and OFF pathways of the retina while long 
duration flashes (>100ms) separate the ERG into ON and OFF components 
(Sieving, 1993; Kondo et al., 2000; Sustar et al., 2006). In this thesis, the terms 
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“brief ERG” and “long ERG” will be used in reference to ERGs obtained with 
brief and long duration flashes respectively.  
 
The ERG components are evaluated by measuring both amplitude and timing 
characteristics (Figure 1.17). The latency is the time from the onset of the 
stimulus until the beginning of the response and the time-to-peak is the time 
from the onset of the light stimulus until the peak amplitude response. The 
amplitude is the vertical displacement of the response from a given baseline at 
a given time, although commonly, the term refers to the maximum displacement 
measured at the time-to-peak (Weisinger et al., 1996; Fishman, 2001).  
 
 
Figure 1.17. Methods of measuring ERG waveform amplitudes (A) and time relationships 
(B). The b-wave amplitude is measured from trough of a-wave to peak of b-wave, O, while 
a-wave is measured from baseline. Latency of response refers to time from stimulus 
onset to beginning of the waveform (illustrated for a-wave), while time-to-peak (b-wave 
response illustrated) is measured from stimulus onset to peak of the subcomponent 
(Fishman, 2001). 
 
Three types of flash ERGs can be further identified according to the area of the 
retina being tested. The first is the full-field ERG, where the entire retina is 
illuminated and the second is the focal ERG, where a localised area of the 
retina (often the macula) is illuminated. The components and cellular origins of 
the full field and focal ERG are similar and can therefore be subjected to the 
same analysis (Kondo et al., 2008a). Nevertheless, there are distinct 
characteristics in their waveforms which reflect the areas of the retina being 
assessed. These distinctions will be discussed later in Chapter 4 where full-field 
and focal ERGs are compared. “Full-field” and “focal” ERGs will be qualified 
appropriately throughout this thesis. 
 
Chapter 1 
56 
 
The third type of flash ERG is the multifocal ERG which comprises many local 
ERG responses recorded quasi-simultaneously (Figure 1.18) (Sutter and Tran, 
1992; Hood et al., 2012). The recording technique, waveform and components 
of the multifocal ERG are distinct and will not be further discussed in this 
review. The interested reader may, however, refer to the following for further 
details (Sutter, 2000; Hood et al., 2002; Harrison et al., 2006).  
 
 
Figure 1.18. The multi-focal ERG. (A) Representative hexagonal mfERG stimulus array 
with 103 elements, half of which are illuminated at any one time; (B) Diagram of an 
mfERG response. (C) Sample of a single mfERG trace showing the designation of the 
major components and the recommended method of measuring the amplitude and time-
to-peak. Adapted from Holder et al (2012). 
 
1.4.2.1 Origins of the ERG Components 
The flash ERG is the most commonly performed and the best understood 
electroretinographic test. Understanding the retinal sources of its components is 
fundamental to interpreting the results obtained using this technique. The 
components of the ERG are formed by the summation of the active retinal 
elements at any given moment after the stimulus onset (Granit, 1933; Frishman, 
2006; Wolpert and Tsang, 2011). Several approaches have been used over the 
years to determine the origins of ERG components (Frishman, 2006). During 
current source-density analysis, microelectrodes are used to identify the retinal 
layer from which the electrical signals originate (Heynen and van Norren, 1985; 
Baker et al., 1988; Xu and Karwoski, 1994; Xu and Karwoski, 1995; Xu and 
Karwoski, 1997; Karwoski and Xu, 1999). Alternatively, pharmacological agents 
may be used to block synapse between the retinal layers to isolate the origin of 
the signal (Hood et al., 1999; Viswanathan et al., 1999; Luo and Frishman, 
2011). In humans, the effect of diseases known to affect specific populations of 
retinal neurons on the ERG subcomponents provides further evidence for their 
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origin (Viswanathan et al., 2001; Miyata et al., 2007; Kondo et al., 2008b) as 
does the change in the ERG waveform under different adaptation and stimulus 
conditions (Robson and Frishman, 1998). 
 
Granit’s classic analysis in 1933 of the scotopic transient ERG in the rod-
dominated cat retina demonstrated that the long ERG consisted of three 
processes, called PI, PII and PIII (Figure 1.19). He recorded the ERG from the 
anaesthetised cat using corneal electrodes and observed the gradual removal 
of the different components as the level of anaesthesia was deepened. The 
Roman numerals designated the order in which the different components 
disappeared.  
 
 
Figure 1.19. Granit’s component analysis of the ERG of a cat to a 2-sec light stimulus. (A) 
Composite diagram showing the processes I, II and III (broken lines) that give rise to the 
a-. b-, c- and d-waves. (B) Shows the individual traces of the three fundamental 
processes that combine to make the ERG. Adapted from Granit (1933) 
 
The PI component is a slow, corneal-positive wave; PII is also a corneal-
positive wave that rises relatively fast to peak amplitude and then recovers to an 
intermediate potential while the light is stimulus is still on. The last component 
P-III, which was the most resistant to the level of anaesthesia, is a cornea-
negative wave that develops faster than the other two and remains as a 
negative potential for as long as the light stimulus is on. He showed that the 
ERG signal was a composite of these PI, PII and PIII processes, which 
dominated the ERG at different times giving rise to the c-, b- and a-waves 
respectively (Granit, 1933; Perlman, 2001). Granit’s component analysis has 
been modified slightly over the years, but remains the basis for understanding 
the ERG.  
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1.4.2.2 The a-wave 
The a-wave is the first negative deflection seen on a conventional 
electroretinogram (Figure 1.16). Its appearance is dependent on the state of 
adaptation of the eye and the intensity of the stimulus. The a-wave is best seen 
with bright stimuli (> 10 cd.s/m2) in the dark-adapted eye, in which case it 
contains both rod and cone responses when using a white flash (Frishman, 
2006; McCulloch et al., 2015). However, only the first 10 – 12 msec of the a-
wave reflect photoreceptor activity (Hood and Birch, 1993; Marmor et al., 2004); 
the remaining part of the wave contains additional contributions from post-
receptoral cells (see later discussion in this section). Under both dark and light 
adapted conditions, the a-wave is truncated by the rise of the b-wave 
(Frishman, 2006).  
 
Granit’s PIII component can be divided into two components: a fast PIII and a 
slow PIII (Murakami and Kaneko, 1966). The a-wave is shaped by the leading 
edge of Granit’s fast PIII component. ERG recordings with intra-retinal 
microelectrodes in animals point to the photoreceptor layers as the origin of the 
fast PIII (and therefore the a-wave) (Brown and Wiesel, 1961a; Brown and 
Wiesel, 1961b; Brown, 1968). Further evidence was provided by studies 
clamping the inner retinal circulation (Brown et al., 1965; Brown, 1968). Since 
the inner layers of the neural retina are supplied by the retinal vasculature and 
the photoreceptors by the choroidal plexus, clamping the retinal circulation 
suppressed electrical activity proximal to the photoreceptors resulting in the 
removal of the b-wave while leaving the a-wave intact. 
 
Pharmacological dissection has confirmed the photoreceptoral origins of the a-
wave, but has also revealed post-receptoral contributions (Sillman et al., 1969; 
Bush and Sieving, 1994). L-glutamate is the neurotransmitter of the 
photoreceptors as well as the bipolar cells in all vertebrate retinas (Massey, 
1990). Therefore, exposing the retina to agonists or antagonists of L-glutamate, 
can effectively block synaptic transmission from the photoreceptors and isolate 
the contribution of the photoreceptors to the ERG.  
 
Aspartate, a known agonist for glutamate, in high concentrations blocks 
transmission from photoreceptors to bipolar cells owing to accumulation of 
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excess glutamate in the extracellular space. ERGs recorded after injection of 
aspartate show the b-wave is removed while the a-wave remains, providing 
further evidence for the photoreceptoral origins of the a-wave (Sillman et al., 
1969). L-2-amino-4-phosphonobutyric acid (APB), is a more specific agonist 
which blocks metabotrophic transmission and hence eliminates light-evoked 
responses of depolarizing (ON) bipolar cells and thus the more proximal ON 
pathway contributions (Slaughter and Miller, 1981). In contrast, cis-2,3-
piperidine dicarboxylic acid (PDA) is a specific glutamate antagonist which 
blocks major ionotropic glutamate receptors in the retina and hence eliminates 
signal transmission to hyperpolarizing (OFF) bipolar cells and horizontal cells as 
well as amacrine and ganglion cells in both ON and OFF pathways (Slaughter 
and Miller, 1983).  
 
 
Figure 1.20. Post-receptoral contributions to the a-wave of the macaque ERG. (A) 
Comparison of the effects of aspartate and cobalt to the effect of APB and APB+PDA on 
the photopic ERG a-wave of three different eyes of two monkeys. The inset at the top 
shows 400ms traces of eye#1 to the 200ms stimulus of 2.01 log cd/m2 on a steady 
background of 1.33 cd/m2. The bottom three traces show the first 40ms after flash onset 
(indicated by arrow) to the same stimulus. (B) Stimulus response function (V log I plot) of 
the photopic a-wave of the macaque measured at times corresponding to the a-wave 
peak in the control responses (solid circles). Amplitudes after APB (open circles) and 
after APB+PDA (triangles) were measured at the same time as the trough of the control a-
waves measures at the same stimulus intensity. In this figure, as in part A, APB has no 
effect on the a-wave amplitude. In contrast, PDA reduced the amplitude (Bush and 
Sieving, 1994).  
Using these agents, Bush and Sieving (1994) showed that the amplitude of the 
a-wave in a macaque retina was reduced by a combination of PDA and APB, 
but not APB alone (Figure 1.20A). The reduction in a-wave amplitude with the 
addition of PDA (APB+PDA in eye 3) showed that post-receptoral PDA 
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sensitive components (OFF-bipolar cells, horizontal cells, amacrine and RGCs) 
contributing to the a-wave were removed. When the effects of APB + PDA on 
the photopic a-wave were evaluated over a wide range of stimulus strengths, 
the proportion of the response due to post-receptoral cells declined from about 
50% at the lower luminance to about 25% at the highest luminance where the a-
wave was saturated (Figure 1.20B). 
 
The slow component of the PIII cannot be identified in a regular ERG response 
due to the large amplitude positive PI wave. However, by separating the retina 
from the pigment epithelium, PI can be eliminated and by exposing the retina to 
drugs, such as aspartic acid, that block synaptic transmission from the 
photoreceptors to the neurons in the inner nuclear layer, the PIII component can 
be isolated and studied (Witkovsky et al., 1975). Measurements of the 
extracellular concentration of potassium ions and of the isolated PIII component 
of the ERG at different retinal depths reveal the involvement of retinal glial 
(Müller) cells in the generation of the slow PIII. The Müller cells are highly 
permeable to potassium ions. Therefore, the reduction in the extracellular 
concentration of potassium ions in the photoreceptor layer, due to light 
absorption in the photoreceptors, elicits changes in the trans-membrane 
potential of the Müller cells and is expressed as the slow P-III component of the 
ERG (Perlman, 2001). This slow PIII process contributes to the shape of the c-
wave. 
 
1.4.2.3 The b-wave and oscillatory potentials 
The largest component of the flash ERG is the cornea-positive b-wave (Figure 
1.16). It is dominated by Granit’s PII component (Figure 1.19). It follows 
immediately after the a-wave. It is a very sensitive component and can be 
recorded at low luminances approximating perceptual threshold (Frishman et 
al., 1996). The b-wave appears within 25 to 35 msec in photopic conditions and 
40 to 60-ms in scotopic conditions, peaking about 40 to 80 msec later. The b-
wave amplitude appears large under scotopic conditions because there is little 
a-wave present to oppose its actions, but it achieves a maximum when 
recorded under dark adapted conditions to a bright flash (i.e. mixed rod and 
cone response). Often the b-wave will have several low-amplitude oscillatory 
waves, called oscillatory potentials evident on the rising edge especially when a 
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series of bright flashes are presented to the dark adapted eye (Asi and 
Perlman, 1992; Janaky et al., 1996; Wachtmeister, 1998; McCulloch et al., 
2015). Oscillatory potentials are thought to arise from feedback mechanisms in 
the inner retina, most likely generated by amacrine cells (Wachtmeister, 1998; 
Rangaswamy et al., 2006). 
 
In the brief ERG, the b-wave is a summed response arising from the ON and 
OFF bipolar cells (Sieving, 1993; Sustar et al., 2006). Some earlier studies had 
also implicated the Müller cells in the generation of the b-wave (Miller and 
Dowling, 1970; Heynen and van Norren, 1985), but later evidence showed that 
the b-wave was relatively unaffected when barium ions were administered to 
block Müller cell activity in the frog and rabbit retina (Xu and Karwoski, 1994). In 
contrast, administration of APB, a glutamate known to eliminate the ON-bipolar 
cell response, was shown to extinguish the b-wave in the mudpuppy and 
salamander (Stockton and Slaughter, 1989). Therefore, although Müller cell 
activity may contribute to the b-wave, it is now generally accepted that the b-
wave directly reflects the activity of the ON-bipolar cells (Xu and Karwoski, 
1994; Stockton and Slaughter, 1989).  
 
1.4.2.4 The d-wave 
The d-wave is a positive potential in the ERG at light offset in the photopic ERG 
(Figure 1.16B). The d-wave is not normally found with short duration stimuli; it is 
observed only when the ON and OFF retinal responses are separated using 
light stimuli of relatively long duration (>100ms). In the photopic ERG elicited by 
brief flashes, the d-wave is merged with the b-wave (Sieving, 1993; Sustar et 
al., 2006).  
 
Current source density analysis of the d-wave in frog retina shows it originates 
primarily from the hyperpolarising (OFF) bipolar cells with a small contribution 
from photoreceptors (Sieving, 1993; Sieving et al., 1994; Xu and Karwoski, 
1995). The d-wave was reduced or eliminated in monkey retina by the injection 
of PDA or kynurenic acid (KYN), which both block responses of OFF bipolar 
cells as well as horizontal cells and inner retinal amacrine and ganglion cells 
(Figure 1.21) (Sieving, 1993). The effect of PDA was not replicated by blocking 
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inner retinal cells with N-methyl-D-aspartate (NMDA), confirming the role of the 
OFF bipolar cells.   
 
 
Figure 1.21. Reduction of the d-wave by kynurenic acid (KYN) in a monkey photopic ERG 
elicited with 200 msec flash. KYN blocks OFF pathway, elevates the plateau (arrow 
heads) and causes a negative waveform swing at stimulus termination (Sieving, 1993) 
 
1.4.2.5 The Photopic Negative Response (PhNR) 
The PhNR is a slow negative potential seen after the b-wave in a normal 
photopic ERG for a brief flash (Figure 1.16A). For a long duration flash, the 
PhNR is seen again as a negative going potential after the d-wave (Figure 
1.16B). Here, the PhNR which follows the b-wave is termed as the PhNR-ON 
and represents an on-response of RGCs during stimulus onset; the PhNR-OFF 
refers to the PhNR seen after the d-wave and represents an off-response of 
RGCs to stimulus offset (Viswanathan et al., 1999; Kondo et al., 2008a). 
 
The PhNR was named and fully described by Viswanathan et al (1999) 
although Spileers et al (1993) had reported observing it as a new negative cone 
response evoked by brief red LED flashes in human subjects. Spileers et al 
(1993) called their new cornea-negative response the photopic threshold 
response (PTR), hypothesising that it was an analogue to the scotopic threshold 
response (Sieving et al., 1986; Sieving and Nino, 1988; Wakabayashi and 
Sieving, 1988; Frishman et al., 1993). Viswanathan et al (1999) on the other 
hand, conducted a more detailed experiment on macaque monkeys using red 
LED flashes on a rod saturating blue background. They explored the 
characteristics of the PhNR to various luminance levels, flash durations, 
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induced glaucoma and pharmacological agents and subsequently implicated 
the RGCs and their axons as the major contributors to the PhNR in monkey and 
human retina. 
 
The PhNR to brief and long duration stimuli were both eliminated in the 
macaque monkey by intravitreal injection of tetrodotoxin (TTX), a drug which 
blocks sodium dependent action potentials that occur in all RGC and some 
amacrine cells (Figure 1.22). The PhNRs were also significantly reduced in 
monkeys with laser induced experimental glaucoma that destroys RGCs 
(Viswanathan et al., 1999; Rangaswamy et al., 2007).  
 
 
Figure 1.22. ERG responses in a monkey to 200ms stimuli (A) and 5ms flash (B) before 
(left column) and after (middle column) intravitreal injection of TTX in the same eye. The 
difference ERG (right) was obtained by subtracting the ERG after TTX (B) from the 
control (A). The PhNRs are indicated by red arrowheads (Viswanathan et al., 1999). 
 
Later studies also showed that the PhNR was significantly reduced in human 
patients with primary open glaucoma (Colotto et al., 2000; Viswanathan et al., 
2001; Gotoh et al., 2004; Machida et al., 2008b; North et al., 2010; Horn et al., 
2011; Kremers et al., 2012; Pangeni et al., 2012; Preiser et al., 2013), and in 
other ocular diseases known to cause RGC or optic nerve dysfunction (Gotoh et 
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al., 2004; Rangaswamy et al., 2004; Chen et al., 2006; Kizawa et al., 2006; 
Ueno et al., 2006a; Chen et al., 2008; Matsumoto et al., 2009; Matsumoto et al., 
2011; Moon et al., 2011; Nakamura et al., 2011b; Wang et al., 2012; Morny et 
al., 2015).  
 
These observations strongly implicate RGC spiking activity in the generation of 
the PhNR. Furthermore, in intra-retinal microelectrode recordings in cats, local 
signals of the same time course as the PhNR were largest in and around the 
optic nerve head indicating RGC axon involvement in generating the PhNR. 
However, the disruption of the PhNR by Ba2+ in cats, indicates that there is also 
glial involvement in mediating the generation of the response (Viswanathan and 
Frishman, 1997). Additionally, the PhNR was reduced in EAST Syndrome 
(epilepsy, ataxia, sensorineural deafness and renal tubulopathy syndrome) 
patients with known mutations of the KCNJ10 gene, a condition in which the 
primary K+ channels of the Muller cells are impaired (Thompson et al., 2011). 
 
There is also evidence suggesting that the generators of the PhNR are species 
dependent. While the PhNR in humans, monkeys and cats, originates from the 
spiking activity of RGCs and their axons (Viswanathan et al., 1999; 
Viswanathan et al., 2001; Hood et al., 2002), the PhNR in rodents is believed to 
receive significant input from the amacrine cells (Bui and Fortune, 2004; Miura 
et al., 2009; Smith et al., 2014), although both are TTX-sensitive inner retina 
neurons. This is thought to be due to the greater proportion of amacrine cells in 
rodents than in primates (Bui and Fortune, 2004; Machida et al., 2008a; Miura 
et al., 2009). Section 1.4.3 discusses the characteristics of the PhNR in more 
detail. 
 
1.4.3 The Characteristics of the PhNR  
As with other components of the ERG, the amplitude and time-to-peak are the 
data typically analysed for the PhNR (Fishman, 2001; Movassat, 2012). These 
are both affected by factors such as luminance, duration and spectral 
composition of the stimulus flash as well as the background on which the flash 
is presented (Viswanathan et al., 1999; Colotto et al., 2000; Viswanathan et al., 
2001; Sustar et al., 2006; Rangaswamy et al., 2007; Mortlock et al., 2010; Binns 
et al., 2011). In addition, for long duration stimuli (>100ms), the photopic ERG 
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waveform is separated into ON and OFF components, while for brief flashes 
(<10ms) the ON and OFF responses overlap as seen in figure 6 (Sieving, 1993; 
Viswanathan et al., 1999; Sustar et al., 2006). Additional factors affecting the 
PhNR, especially the amplitude, include age of the subject, area of the retina 
stimulated (full field or focal) and the type of electrodes used in the recording 
(Viswanathan et al., 2001; Mortlock et al., 2010; Machida et al., 2011).  
 
In both animal and human trials, the time-to-peak of the PhNR has been difficult 
to pinpoint owing to the broad trough of the PhNR which impedes accurate 
assessment of the most negative point in the trough. In addition, a small 
positive potential that occurs in the falling phase of the b-wave or just after it, 
especially in the brief PhNR, called the i-wave (Figure 1.16 and 1.23), often 
interferes with the PhNR under certain luminance conditions (Viswanathan et 
al., 1999; Viswanathan et al., 2001; Rangaswamy et al., 2007; Sustar et al., 
2009; Machida, 2012). Horn et al (2011), has also recently described a similar 
potential on the falling phase of the d-wave, calling it the ioff-wave. This makes it 
difficult to accurately determination the amplitude of the responses as well. 
 
 
Figure 1.23. Different techniques used in measuring PhNR amplitude ; (A) peak to trough; 
(B) pre-stimulus baseline to trough; (C) b-wave amplitude to PhNR amplitude ratio. The 
letters a, b and i represent the a-, b- and i-waves respectively.  
 
As yet, the International Society for Clinical Electrophysiology of Vision (ISCEV) 
does not have a standard protocol for recording or analysing the PhNR. Various 
investigators have thus used different combinations of stimulus and background 
parameters as well as measuring techniques in an attempt to find the optimal 
parameters for quantifying the PhNR (for example (Viswanathan et al., 1999; 
 
A 
b 
a 
i 
PhNR 
B C 
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Colotto et al., 2000; Drasdo et al., 2001; Rangaswamy et al., 2007; Binns et al., 
2011). Notwithstanding this, three common techniques have been used by 
various studies in measuring the PhNR amplitude. These are (i) from peak of b-
wave to the trough of the PhNR, (ii) from pre-stimulus baseline to PhNR trough, 
or (iii) from either peak of b-wave or pre-stimulus baseline to a fixed time point 
in order to overcome the influence of the i-wave (Figure 1.23).  
 
The ratio of the b-wave to the PhNR amplitude has also been used as a 
potentially less variable means of PhNR assessment and Mortlock et al (2010) 
reported that the ratio of b-wave to PhNR amplitude showed the lowest level of 
inter-individual, inter-session and inter-ocular variability of all the measurement 
techniques. Measurements taken from the pre-stimulus baseline were found to 
have the highest coefficient of variation (CoV), as well as the poorest inter-
session and inter-ocular repeatability, whether the measurement was taken to 
the trough or to a fixed time-point. In contrast, measurements taken from the 
peak of the b-wave to either the trough or the fixed time-point had a much 
improved CoV, comparable with and often better than the a- and b-waves 
(Colotto et al., 2000; Fortune et al., 2004; Mortlock et al., 2010). However, peak-
to-trough measurements of the PhNR may be confounded by the influence of 
the b-wave amplitude on the measured PhNR and thus require careful analysis 
for accurate interpretation (Mortlock et al., 2010; Binns et al., 2011). The 
influence of recording parameters and demographic factors on the PhNR are 
discussed in the following subsections. 
 
1.4.3.1 Effect of Stimulus Duration 
For a series of brief flashes of increasing duration, but equal luminance, Kondo 
et al (2008) found that time-to-peak of focal PhNR in macaque increased over a 
limited range and then stabilised (Figure 1.24). For a fixed luminance of 55 phot 
cd/m2, the time-to-peak was approximately 75ms for a 5ms flash. This became 
longer with increasing stimulus durations and reached a maximum time-to-peak 
of 110ms for a 50ms flash (Figure 12A, red dashed vertical lines). Further 
increases in the stimulus duration did not change the time-to-peak of the PhNR, 
but resulted in the separation of the waveform into ON- and OFF-responses. 
The gradual increase in the time-to-peak of the PhNR most likely resulted from 
an increase in stimulus energy and the increase in the midpoint of the stimulus.  
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The amplitude of the focal PhNR also increased with increasing stimulus 
durations when the stimulus durations were shorter than 30 to 50ms. This 
increase in the amplitude is most likely due to the increase in the stimulus 
energy (Figure 1.24B). Further increases in the stimulus duration led to a slight 
decrease in the PhNR amplitude and the emergence of the d-wave and the 
PhNR-OFF. This is similar to the b-wave response to increasing stimulus 
duration described by Sustar et al (2006). They reported that the b-wave 
amplitude reached its peak value with a 10ms flash and decreased with longer 
duration flashes. From 25 to 200ms flash duration the b-wave amplitude did not 
change significantly. 
 
 
Figure 1.24. (A) Representative focal ERGs elicited from a rhesus monkey by different 
stimulus luminances (2–55 phot cd/m2) and different stimulus durations (5, 10, 30, and 
150 ms). The amplitude of PhNR increases with increasing stimulus duration and 
luminance. (B) Effect of stimulus duration on the focal PhNR showing representative 
focal ERGs elicited by different stimulus durations (5-150ms) for a constant stimulus 
luminance of 55 phot cd/m2. Vertical dotted line: peak of the PhNR. The asterisks (*) 
represent the PhNR-OFF, which appears only when the ERG is separated into ON- and 
OFF components by long duration flashes (100 and 150ms). The values of stimulus 
energy (cd.s/m2) are also indicated for brief flashes of 5 to 30ms (Kondo et al., 2008a). 
 
For long duration flashes, it is not clear what the effect of increasing stimulus 
duration has on the time-to-peak of the PhNR-OFF. The PhNR-OFF time-to-
peak was reported to be about 114 – 117 +10 msec by Viswanathan et al 
(1999). However, in their study and in others (Rangaswamy et al., 2007; Horn et 
al., 2011) the waveform and timing characteristics of the off-response varied 
considerably, making accurate measurements of the PhNR-OFF problematic.  
 
B A 
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1.4.3.2 The Effect of Stimulus luminance 
Generally, increasing stimulus luminance leads to an increase in the amplitude 
and a decrease in the time-to-peak of ERG components. The change in the 
amplitude and time-to-peak continues till maximum amplitude or minimum time-
to-peak is reached and further increases in the stimulus lead to no significant 
changes in the response. At this point, the response is said to be saturated and 
it is particularly notable in photopic ERGs (Fishman, 2001). Some 
subcomponents (e.g. the photopic b-wave), however, show a reduction in the 
amplitude to further increases in stimulus luminance. This is the so called 
photopic-hill phenomenon (Wali and Leguire, 1992; Kondo et al., 2000). Under 
scotopic conditions, the saturation point is not as notable because the amplitude 
and time-to-peak of components continue to increase and decrease 
respectively beyond the “saturation point” as cone elements become active in 
response to the higher luminance. The saturation point therefore becomes the 
threshold at which cone elements are activated (Fishman, 2001). 
 
The increase in PhNR amplitude in response to stimulus luminance is depicted 
in Figure 1.25, taken from the Viswanathan et al (1999) study. It shows 
increases in the amplitude of the PhNR for both the brief and long duration 
stimulus in a full field ERG. Viswanathan et al (1999) also reported a decrease 
in the time-to-peak with increasing stimulus luminance. The brief PhNR 
amplitude plateaus at about 2.0 log phot td beyond which the amplitude begins 
decrease (Viswanathan et al., 2001; Chen et al., 2006; Rangaswamy et al., 
2007; Miyata et al., 2008; Sustar et al., 2009; Binns et al., 2011). The 
relationship between the stimulus strength and the response can be described 
by stimulus-response functions (S/R functions) and Binns et al (2010) have 
showed that the amplitude-response data for brief flashes of low to moderate 
luminance can be fitted to a generalised Naka-Rushton function (Figure 1.26). 
 
The generalised Naka–Rushton function: 𝑉 =
𝑉𝑚𝑎𝑥∗ 𝐼𝑛
(𝐼𝑛+𝐾𝑛)
, is a sigmoidal curve, 
where V = response amplitude; Vmax = the maximum amplitude; I = stimulus 
intensity; K = the semi-saturation constant i.e. the stimulus intensity at which the 
amplitude is at a half of Vmax; and n = an exponent describing the slope of the 
function, at the point where stimulus strength = the exponent, K. The function 
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has been shown to describe the increase in b-wave amplitude with increasing 
stimulus intensity (Binns et al., 2011). This reportedly provides a good fit to data 
across a range of intensities, although the relationship breaks down at high 
intensities for both light and dark-adapted b-waves. 
 
 
Figure 1.25. ERG responses to a series of long duration (left) and brief (right) red stimuli 
of increasing luminance on a rod saturating blue background showing the PhNR in 
macaque monkeys (arrowed) (Viswanthan et al., 1999) 
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Figure 1.26. Sample ERGs recorded from a subject using DTL (a) and skin (b) active 
electrodes. RE data are shown in black and LE in grey. Panel (c) shows the amplitudes of 
the b-wave and PhNR-ON (PT and BT) plotted as a function of stimulus intensity, with 
best fitting Naka-Rushton function. PT amplitudes are measured from peak of b-wave to 
trough of PhNR and BT amplitudes are measured from baseline to trough. Note the 
decrease in amplitude in PhNR amplitude beyond 2 log phot td.s (Binns et al., 2011) 
 
The amplitude of the PhNR-OFF has, however, been more difficult to 
characterise because of difficulties encountered in measuring it (Viswanathan et 
al., 2001; Rangaswamy et al., 2007). Notwithstanding, Horn et al (2011) 
reported a general increase in the PhNR-OFF amplitude in response to 
increasing stimulus luminance (Figure 1.27). They showed that both in normal 
subjects and glaucoma patients, the PhNR-OFF amplitude increased as 
stimulus luminance was increased, although the amplitude for glaucoma 
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patients at each level was significantly lower than for controls (p=<0.001). They 
could not demonstrate saturation of the PhNR-OFF since only three intensities 
(40, 60 and 80 cd/m2) were tested. Nevertheless, their results confirm that the 
PhNR-OFF amplitude increases with stimulus luminance as has been observed 
in other studies (Viswanathan et al., 1999; Viswanathan et al., 2001; 
Rangaswamy et al., 2007) 
 
 
Figure 1.27. Plot of amplitudes (top row) and time-to-peak (bottom row) of long duration 
ERG components as a function of stimulus luminance in 12 controls (open symbols) and 
12 glaucoma patients (closed symbols). Analysis of repeated measurements indicated 
significant dependence (p < 0.001) of all amplitudes and of the a- and d-wave time-to-
peak on stimulus luminance. (Horn et al., 2011). 
1.4.3.3 The Effect of Stimulus and Background Colour (Wavelength)  
ISCEV recommends that cone ERGs be recorded using white-flash stimuli on a 
white background light (“white-on-white”) (McCulloch et al., 2015). However, 
studies have suggested that this may not be the most appropriate stimulus for 
eliciting the PhNR (Viswanathan et al., 1999; Rangaswamy et al., 2007; Sustar 
et al., 2009). Viswanathan et al (1999) who published the first study on the 
PhNR, used red-flash stimuli on a rod saturating blue background (“red-on-
blue”) to record the PhNR. While this has widely been adopted as a recording 
protocol (Rangaswamy et al., 2004; Kondo et al., 2008a; Tamada et al., 2009; 
Mortlock et al., 2010; Binns et al., 2011), some other studies have investigated 
the effect of other stimulus wavelength on the PhNR.  
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Figure 1.28. ERG amplitude response to increasing luminance of stimuli of different 
wavelengths. (A) Results from Rangaswamy et al (2007) showing mean PhNR amplitude 
as a function of stimulus luminance for red on blue, white-on-white and blue on yellow 
(left) and for red on white, green on blue and blue on white (right). Red on blue and white 
on white have been superimposed on the right plot for comparison. (B) Intensity-
response functions of the a-wave, b-wave and PhNR for different stimulus wavelengths 
recorded from control subjects. Red flash on blue background (red line) produces 
significantly higher PhNR amplitudes across the range except for the lowest and highest 
intensities. From Sustar et al. (2009). 
 
Rangaswamy et al (2007) conducted an experiment on macaque monkeys to 
determine the wavelength of stimulus and background that best isolate the 
PhNR and maximise amplitude. They compared a combination of red, white, 
blue and green flashes on scotopically matched white, blue and yellow 
backgrounds. For every colour combination, the PhNR amplitude increased as 
stimulus luminance was increased, though in case of white on white and green 
on blue, the PhNR was not evident until the stimulus luminance was 
considerably greater than was needed for the other colours (Figure 1.28A, 
right). Consequently, they found that red on blue and blue on yellow were 
generally the most effective stimuli. For these colour combinations, the PhNR 
amplitude rose steadily and nearly linearly with the logarithm of stimulus 
luminance (i.e. much less rapidly than in direct proportion to stimulus 
luminance) over the whole range of luminance studied (Figure 1.28, left). 
However, selective pharmacological inhibition of inner retinal activities using 
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TTX and PDA after TTX, showed the PhNR elicited by the red on blue stimulus 
to be less contaminated by other negative potentials also from the inner retina 
(presumably from horizontal cells). In other words, red-on-blue stimuli elicit a 
PhNR with more RGC responses i.e. a larger signal was generated, than the 
other colours, especially in the low and intermediate stimulus range. 
(Rangaswamy et al., 2007) 
 
Sustar et al (2009) corroborated the results of Rangaswamy et al (2007) in a 
similar study on human subjects using different coloured stimuli (4msec flashes) 
of varying stimulus luminance (0.08 to 7.5 cd.s/m2) on a steady rod saturating 
blue background. They observed that the red on blue stimulus produced the 
highest PhNR amplitude for brief flashes (4msec) of luminance up to 2.5 
cd.s/m2 after which they observed a dip in the amplitude (Figure 1.28B). Their 
findings further revealed that the PhNR amplitude to a red stimulus was 
significantly correlated to the pattern ERG amplitude (especially the N95 
component) and visual field defects in glaucoma patients. (Sustar et al., 2009) 
 
Kremers et al (2012) have however suggested that when both the stimulus and 
background are specified in photopic photometric terms (i.e. if stimulus and 
background luminance for different wavelengths are matched photopically), all 
chromatic combinations produce a similar amplitude PhNR, except for a blue 
flash on an orange background, which gives a larger response. The authors of 
previous studies into the spectral sensitivity of the PhNR have mainly used 
different stimuli at a fixed scotopic background luminance (Rangaswamy et al., 
2007; Sustar et al., 2009). However, Kremers et al. (2012) assessed the 
spectral sensitivity of the PhNR by presenting coloured flashes of varying 
luminance on different coloured backgrounds of varying luminance (which were 
photopically matched to each other i.e. 10, 25, 50, 100 and 250 cd/m2). They 
found that the largest PhNR amplitude in normal subjects was produced by a 
458 nm (blue) flash on a 591 nm (amber) background. They attributed this to 
possible contribution from S-cone or rod-driven responses. In addition, the best 
stimulus condition used to separate the PhNR of normal subjects and glaucoma 
patients was a 1 cd.s/m2 458 nm flash on a 10 cd/m2 591 nm background 
(Kremers et al., 2012). 
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This reflects the findings of Drasdo et al (2001), who also found that a stimulus 
designed to elicit an S-cone response gave a better separation in PhNR 
amplitude between controls and people with glaucoma than a red on blue 
protocol (Drasdo et al., 2001). Kremers et al (2012), state however, that their 
stimulus composition of a short wavelength flash (to which rods are sensitive) 
on a long wavelength background (which desensitise L- and M-cones) may 
have introduced rod driven responses into the data; as such the PhNR 
amplitude observed would not be an entirely cone driven response. In addition, 
the effectiveness of this stimulus in distinguishing between normal and 
glaucomatous eyes, measured using the area under the receiver operating 
characteristic (ROC) curve, was 0.81; a value lower than the results (> 0.90) in 
other studies using a red on blue stimulus (Viswanathan et al., 1999; Sustar et 
al., 2009) 
 
The above discussion confirms that the PhNR can be elicited by a brief flash 
using various combinations of stimuli and background colours. However, the red 
on blue stimulus remains the best for eliciting a truly cone dominated PhNR. 
 
1.4.3.4  Effect of Age 
In an experiment on normal human subjects, Viswanathan et al (2001) found 
the PhNR time-to-peak averaged by age-group (subjects aged 20 – 80+ years) 
in response to a 6ms flash (1.7 log td.s), showed a slight increase in time-to-
peak with age (Figure 1.29). This increase was however not significant. 
Furthermore, they observed a decrease in the PhNR amplitude with age in both 
controls and participants with POAG. The correlation was however not 
significant. Miyata (2007) also did not observe a significant correlation between 
PhNR amplitude and age for controls subjects and for ADOA patients. 
 
It therefore appears that while there is a tendency towards a decrease in 
amplitude with age both in healthy controls and in participants with RGC 
dysfunction, the correlation is not significant.  
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Figure 1.29. (Left) PhNR times-to-peak for a 1.7 log phot td.s flash of group averaged 
responses of normal subjects in age bins (number in each bin indicated in brackets) 
plotted as a function of mean age in each bin. The straight line represents the best-fitting 
linear regression line. (Right) PhNR amplitudes for the same flash intensity for all 
primary open angle glaucoma patients (filled symbols), suspects (filled circles with 
centre dot) and control subjects (open symbols) in the same age range plotted as a 
function of age. The thick (bottom) and thin (top) lines represent the best fitting linear 
regressions through the patient (r = -0.24, p<0.07) and control (r = 0.26, p < 0.3) data 
respectively. Note the correlation was not statistically significant (Viswanathan et al., 
2001). 
 
1.4.3.5 Comparing Full Field PhNR to Focal PhNR 
The full field ERG reflects the function of the entire retina. Studies have noted, 
however, that the full field ERG is not as effective in detecting defects when 
assessing diseases that affect localised areas of the retina, for example, in early 
stage glaucoma and macular degeneration (Tamada et al., 2009; Machida, 
2012). In these circumstances a focal ERG is more sensitive than the full field 
ERG. In a focal ERG, a spot of light (of a given size) is directed towards the 
area of interest on the retina and responses are recorded from that discrete 
area. In order to ensure that the responses are focal, the effect of stray light 
generating responses from the peripheral retina are minimised or eliminated by 
using a desensitising background or surround (Brindley and Westheimer, 1965; 
Colotto et al., 2000; Kondo et al., 2008a). 
 
A number of studies show that the focal PhNR is produced by the same inner 
retinal neurons as the full field PhNR (Kondo et al., 2008a; Kurimoto et al., 
2009). Figure 1.30 shows that the effect of TTX on the focal PhNR is similar to 
that of the full field PhNR (compare to Figure 1.22). In addition, the changes in 
the waveform in response to stimulus parameters such as duration, luminance 
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and wavelength are similar for the focal and full field PhNR. The focal PhNR, 
however, has comparatively lower amplitudes due to the smaller retinal area it 
assesses. Nevertheless, the focal PhNR is found to be more sensitive than the 
full field PhNR in detecting localised RGC defects (Tamada et al., 2009; 
Machida et al., 2011; Morny et al., 2015). 
 
 
Figure 1.30. Focal macular ERG. A) Representative focal macular ERGs recorded from 
the superior and inferior macular areas in a rhesus monkey to brief (upper traces) and 
long duration (lower) traces. (B) Shows the effect on the traces after TTX. (Kurimoto et 
al., 2009) 
 
Tamada et al. (2009) for example, found that in eyes with central visual field 
defects (in which other areas of the visual field remained unaffected) only the 
focal PhNR amplitudes were significantly reduced; the full field PhNRs were not 
significantly different from those of control eyes (Tamada et al., 2009). Machida 
et al. (2011) compared the focal and full-field ERGs of glaucoma patients at 
different stages of the disease progression and found that in early to 
intermediate glaucoma, the sensitivity of using PhNR amplitude (peak to trough) 
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to detect glaucoma was 88 - 93% for the focal ERG compared to 38 – 59% for 
the-full field ERG. These therefore showed the focal ERG has a higher 
diagnostic ability in detecting early and intermediate glaucoma than the full field 
ERG. 
 
Another advantage of the focal PhNR is that the stimulus size and shape can be 
modified and this can allow for comparison between different areas of the retina 
background (Seiple et al., 1986; Colotto et al., 2000; Kurimoto et al., 2009; 
Machida et al., 2011). For example, in the experiment by Kurimoto et al (2008) 
focal ERGs were recorded from the superior and inferior macular as well as the 
nasal and temporal macular using a semi-circular stimulus in five rhesus 
monkeys (Figure 1.30). Their findings revealed that the superior macular PhNR 
amplitude was 27% and 23 % greater than the inferior macular PhNR amplitude 
for brief and long duration stimuli respectively (Figure 1.30A). The nasal macula 
produced a response which was 27% and 25% greater than the temporal 
macular for brief and long duration stimuli respectively (Kurimoto et al., 2009). 
These asymmetries were, however, eliminated after intravitreal injection of TTX; 
in contrast the superior-inferior and nasal-temporal asymmetries remained in 
the TTX sensitive components (shown in Figure 1.30B as the subtracted 
component). These observations showed that the asymmetries were caused by 
TTX sensitive spiking activities of inner retinal neurons (Kurimoto et al., 2009). 
Their findings are in agreement with histological studies into monkey (Perry and 
Cowey, 1985) and human (Curcio and Allen, 1990) retina which report the RGC 
density to be higher in the superior and nasal retinas compared to the inferior 
and temporal retinas respectively. 
 
1.4.4 The Pattern ERG (PERG) 
The pattern electroretinogram (PERG) is a mass response from the retina 
evoked by pattern stimulation (e.g. checkerboard or grating) of constant 
luminance. (Bach et al., 2013). It is usually recorded from the macula and 
provides information about RGC function. Consequently the PERG is used 
extensively in the assessment of disease that are associated with loss of RGC 
function (Holder, 2001; Bach and Poloschek, 2013; Vincent et al., 2013) 
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Figure 1.31. Representative diagrams of the PERG. (A) transient PERG recorded at 2Hz 
(4rps) and (B) steady state PERG recorded at 8.3 Hz (16 rps). Adapted from (Bach et al., 
2013) 
 
The waveform of the PERG is determined by the temporal frequency of the 
stimulus patterned stimulus (Figure 1.31). A transient PERG is recorded to 
stimulus frequencies <4 reversals per second (rps) (equal to 2 Hz) and the 
steady state PERG is recorded to stimulus frequencies >8 repetitions per 
second (rps) (4 Hz). The transient PERG comprises an initial negative 
component with a time-to-peak of approximately 35ms (N35), followed at 45-
60ms by a much larger positive component (P50) and a large negative 
component at 90-100ms (N95) (Figure 1.31A). The steady state PERG 
produces a sinusoidal response (Figure 1.31B) and it may be measured either 
directly from peak (P) to trough (N) or by assessing the second harmonic of the 
signal using a fast Fourier transform.  
 
The ISCEV standard PERG is a transient response, recorded to abrupt contrast 
reversal of a black and white checker-board pattern with central fixation. This is 
the PERG employed in this study and will be the focus of this review.  
 
1.4.4.1 Origins of the PERG 
When a subject gazes at a reversing pattern such as a checker-board with an 
equal number of light and dark patches, the total quantity of light entering the 
eye (luminance) remains constant as the pattern reverses, but in the region of 
the retinal image, there are repetitive local changes (ON/OFF) in illumination 
(Bach and Hoffmann, 2006). That is, the region of the retina stimulated by a 
square that goes from dark to bright, will produce an ON-response while the 
adjacent region stimulated by a bright to dark square will produce an OFF 
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response. A pattern reversal stimulus will then elicit responses from bright and 
dark patches that are of the same magnitude, but have a different sign. When 
recorded from a corneal electrode, which averages across the entire retina, 
linear responses will cancel out. Remarkably however, any imbalance between 
the two responses will not cancel out and will therefore be revealed. The 
imbalance between the two responses is due to nonlinear properties of the 
underlying neural substrate such as a response with a strong ON component, 
but no OFF component, a generator with a very rapid adaptation or a response 
from the interaction of neighbouring bright and dark patches (border contrast). 
Thus while the flash ERG is evoked by solely by changes in stimulus 
luminance, the PERG is evoked by changes in stimulus contrast as well. The 
PERG thus contains a luminance (retinal illuminance) response and a pattern 
specific response (Drasdo et al., 1987; Bach and Hoffmann, 2006). 
 
The retinal origins of the PERG have been investigated using current-source 
density analysis (Sieving and Steinberg, 1987; Baker et al., 1988), 
pharmacological interventions (Viswanathan et al., 2000; Luo and Frishman, 
2011), pathophysiological conditions in animals (Mafei and Fiorentini, 1981; 
Maffei et al., 1985) and humans (Harrison et al., 1987; Holder, 1997; Holder et 
al., 1998) and the assessment of the parameter dependencies of the 
electrophysiological response (Drasdo et al., 1987; Thompson and Drasdo, 
1989; Thompson and Drasdo, 1994). These all show a fairly consistent picture 
that the N95 component of the PERG is a contrast related component 
generated by RGCs. The P50 is in part RGC derived, but also has origins distal 
to the ganglion cells (Viswanathan et al., 2000; Holder, 2001; Luo and 
Frishman, 2011). 
 
1.4.4.2 Recording the PERG 
PERGs are small signals, typically around 2-8µV across a normal population, 
making PERG recording more challenging than standard flash ERGs. The 
stimulus for the ISCEV standard PERG is a black and white reversing 
checkerboard. The width of the individual checks (check size) is 0.8o (+0.2o) 
and the mean width of the stimulus field is 15o (+3o). It is not necessary to use a 
square field, but it is important that there are equal number of white and black 
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patches. Otherwise the PERG signal is contaminated with a luminance 
response (Bach and Hoffmann, 2006). 
 
The contrast between black and white squares should be at least 80% and the 
mean luminance for the white areas should be greater than 80 cd/m2. PERG 
signals are affected by optical blur and as such electrodes which degrade the 
optical image cannot be used (e.g. contact lens electrodes); fibre, foil or loop 
electrodes are recommended in this case. PERGs are recorded with pupils 
natural pupils and participants should also wear their appropriate spectacle 
correction where required (Bach et al., 2013). 
 
1.4.5 Electrophysiological Findings in ADOA 
Visual electrophysiological findings provide additional evidence for the primary 
loss of RGCs and the sparing of the outer retinal layers in ADOA. The pattern 
visual evoked cortical potentials (PVEP) are often absent or when recordable, 
have reduced amplitudes and delayed latencies (Berninger et al., 1991; Holder 
et al., 1998; Reis et al., 2013). The multifocal VEP is also abnormal especially in 
the central field. The PERG shows an abnormal P50:N95 ratio and a reduction 
in the amplitude of the N95 waveform consistent with GCL dysfunction. The 
amplitude of the P50 component may also be reduced, but this is not a 
consistent feature in ADOA patients (Berninger et al., 1991; Holder et al., 1998). 
 
The standard flash ERG is normal in patients with ADOA, except in severe 
cases suggesting sparing of or a minimum impact on the photoreceptors and 
bipolar cells in most patients (Johnston et al., 1979; Holder et al., 1998; Granse 
et al., 2003). The multifocal ERG amplitudes have also been reported to be 
normal (Granse et al., 2003), however, another study (Reis et al., 2013) 
reported a reduction in amplitudes.  
 
Following the discovery of the PhNR (Viswanathan et al., 1999), one study 
looked at the brief PhNR elicited with a white on white stimulus in humans and 
reported a significant reduction in the PhNR amplitude in participants with 
ADOA (Miyata et al., 2007). They also reported a reduction in oscillatory 
potentials. In the mouse model developed previously in our laboratory, the 
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PhNR was shown to be selectively attenuated in mutant mice with relative 
sparing of the a-wave and b-wave (see section 1.3.9). Altogether, the 
electrophysiological findings in ADOA point to RGC dysfunction affecting the 
central retina. A summary of the electrophysiological findings in ADOA from the 
various studies are provided in Table 1.6.  
 
Table 1.6. Summary of electrophysiological findings from previous studies 
Study Flash 
ERG 
Pattern 
ERG 
Multifocal 
ERG 
Flash 
VEP 
Patten 
VEP 
Multifocal 
VEP 
Berninger 
et al., 
1991 
NA Normal 
P50, 
reduced 
N95 
NA NA Reduced 
amplitudes 
in severe 
patients 
only 
NA 
Granse et 
al., 2003 
Normal NA Normal NA NA Reduced 
amplitudes 
in central 
field 
Miyata et 
al., 2007 
Selective 
reduction 
in PhNR 
and OP 
amplitude 
in patients 
NA NA NA NA NA 
Holder et 
al., 2008 
NA Reduced 
N95 
amplitude, 
N9:P50 
ratio, 
reduced 
P50 in 
some 
patients 
NA Normal Absent and 
if present, 
reduced 
amplitudes 
and 
delayed 
latencies 
NA 
Reis et al., 
2013 
 Reduced 
N95 and 
P50 
amplitude 
Reduced 
amplitudes  
 Reduced 
amplitude, 
increased 
time-to-
peak 
Reduced 
amplitudes 
in central 
ring 
NA = Not applicable 
 
 
1.5 Rationale of the Study 
ADOA is a progressive inherited optic neuropathy characterised by childhood 
onset, optic atrophy, a central to centro-coecal visual field loss and colour vision 
loss (Votruba et al., 1998). The disease is caused by mutations in the OPA1 
gene which affect mitochondrial integrity and function. The mutations lead to the 
death or loss of RGCs eventually resulting in visual loss (Alexander et al., 2000; 
Delettre et al., 2000).  
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The PhNR is a negative going potential occurring immediately after the b-wave 
in a brief flash cone ERG, and in a long duration flash ERG, it is seen again 
after the d-wave. The PhNR elicited by a red on blue stimulus can be used to 
assess RGC function. Using a long duration flash, the PhNR is separated into 
ON and OFF components which can be used to separately investigate the ON 
and OFF pathways.  
 
In the only study to have evaluated the PhNR in humans with ADOA, significant 
reductions in amplitude have been reported in the small (n=8) sample (Miyata et 
al., 2007), but no comparative or longitudinal data are available. Although these 
results highlight the diagnostic potential of the PhNR in ADOA, they used a brief 
white flash to evoke a full field PhNR, which provides a poor signal to noise ratio 
compared to a red on blue flash, and cannot distinguish ON and OFF 
components. A recent study in a mouse model shows that the ON-centre 
RGCs, but not the OFF-centre RGCs, are preferentially affected early in the 
disease process prior to visual loss (Williams et al, 2010). This finding therefore 
needs to be investigated in humans with ADOA and deserves full exploration.  
 
In addition, reports on the use of idebenone in LHON have been encouraging 
(Klopstock et al., 2011). Pharmacological trials and gene therapy rescue in a 
mutant mouse model of ADOA, B6;C3-Opa1Q285STOP (Davies et al., 2007) are 
currently underway and  if successful, these will lead the way to human 
therapeutic trials. It is therefore essential to detect and quantify early human 
disease and monitor subtle changes in status due to therapy with suitable, 
relevant biomarkers and end-points. 
 
 
1.6 Hypothesis 
On the basis of the above, it was hypothesised that 
1. a selective reduction in the ON ganglion cell response (PhNR-ON) in 
humans should be diagnostic for ADOA and seen very early in the 
disease and  
2. the PhNR-ON amplitude, and specifically the ratio of PhNR-ON to PhNR-
OFF (PhNR-ON:PhNR-OFF), will decrease as the disease progresses. 
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1.7 Aims of the Study 
The primary aim of this thesis was to assess the effect of OPA1 mutation 
causing ADOA on the ON and OFF pathway of the retina in individuals affected 
by the disease using a long duration ERG elicited by a red on blue stimulus. 
The specific objectives of this study were  
1. to optimise an electrophysiological protocol for recording the focal and 
full-field PhNR ON and PhNR OFF components using a long duration red 
flash on a rod suppressing blue background (red on blue stimulus) in 
healthy participants 
2. to record focal and full-field long duration ERGs using a red on blue 
stimulus as well as pattern reversal ERGs and full-field brief flash ERGs 
in participants with ADOA and to compare them to recordings from 
controls.  
3. to record and compare baseline measures which will include visual 
acuity, contrast sensitivity, colour vision, perimetry, and optical 
coherence tomography (OCT) in participants and in controls. 
4. to determine and compare the diagnostic potential of the red on blue long 
duration PhNRs and other electrophysiological tests used in previous 
studies (i.e. the PERG and brief flash PhNR) 
5. to assess the relationship between the long duration PhNRs and other 
clinical tests of the retina (i.e. visual acuity, contrast sensitivity, visual 
field sensitivity and optical coherence tomography). 
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 CHAPTER TWO – ELECTROPHYSIOLOGICAL 
PROTOCOL DEVELOPMENT 
 
 
2.1 Introduction 
The overall aim of this project was to explore retinal function of patients with 
ADOA using electrophysiology. The ocular electrophysiology methods used in 
this study were the focal and full-field long duration flash ERG, the full-field brief 
flash ERG and the PERG.  
 
As there was no published standard protocol for recording the PhNR-ON and 
PhNR-OFF, a pilot project was carried out in healthy controls to develop a 
suitable protocol for measuring these components. The protocol for recording 
the full-field brief ERG was adopted from an earlier study conducted in the 
same laboratory (Mortlock et al., 2010) and is described later in Chapter 5. The 
PERG recording protocol was as recommended by ISCEV and is described 
later in Chapter 3. This chapter describes the general methods and ERG 
recording equipment used throughout the study as well as experiments 
conducted to determine an appropriate protocol for measuring the focal PhNR-
ON and PhNR-OFF components. Specific methods used in the different 
experiments will be described under their respective sections. 
 
2.2 General Methods 
2.2.1 Participants 
All participants recruited as controls at the protocol development stage were 
healthy adults recruited from students and staff of the School of Optometry and 
Vision Sciences, Cardiff University as well as their friends and family. Inclusion 
criteria were best corrected visual acuity of 0.1 logMAR or better in the test eye, 
clear ocular media (< Grade 2, LOCS-III (Chylack et al., 1993)), a normal retinal 
appearance and normal colour vision. Exclusion criteria were history of ocular 
disease or systemic disease known to affect visual function. The study 
conformed to the Declaration of Helsinki and was approved by the National 
Health Service (NHS) Research Ethics Committee for Wales (REC Reference 
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02/9/001) as well as the ethics committees of the School of Optometry and 
Vision Sciences, Cardiff University. All participants provided their written 
consent after receiving a participant information sheet and having the 
opportunity to ask questions.  
 
2.2.2 Light Stimulator 
Flash stimuli and light backgrounds for focal and full-field long duration ERGs 
were generated by a modified light emitting diode (LED) miniature Ganzfeld 
stimulator (Figure 2.1A) (CH Electronics, Bromley, Kent, UK). (Details of the 
modification to the stimulator are provided in section 2.2.3). The stimulator head 
contained blue (469 nm), green (521 nm), amber (597 nm) and red (660 nm) 
LEDs. The luminance of each LED was controlled by an analogue dial on the 
control box. The dial had a minimum setting of 0 and maximum of 1000. The 
relative spectral profiles and the photometric properties of the LEDs are 
provided in Figure 2.2A and Table 2.1 respectively and the luminances of the 
LEDs in response to the dial settings are plotted in Figure 2.2B. 
 
Focal stimulation was produced by mounting the modified miniature Ganzfeld 
LED tube into the middle of a light box (44 cm x 44 cm x 10 cm) such that the 
circular stimulus subtended 20o diameter at a viewing distance of 15.6cm 
(Figure 2.1B and C). The face of the light box (towards the viewer) was made of 
transparent Perspex covered on the back with diffuser sheet. The focal stimulus 
was thus in the plane of the face of the light box. A strip of white LEDs (colour 
temperature > 7000K) lined the inside of the box and the LEDs were passed 
through a blue filter (Lee Filter 068 Sky Blue; peak transmission of ~75% for 
wavelengths 425 – 450 nm; Lee Filters, Hampshire, UK) to produce a blue 
surround background needed to desensitise the peripheral retina and minimise 
or eliminate the effect of stray light. (The spectral profile of the net output of blue 
surround is shown in Figure 2.2). Luminance of the surround was controlled by 
a variable voltage dial (Figure 2.1B). A pair of cross hairs centred in the middle 
of the stimulus served as the fixation target. Full-field ERGs were recorded by 
holding the stimulator head directly to the eye (Figure 2.1D). All the equipment 
used in this project met the ISCEV recording requirements (Marmor et al., 
2009). 
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Figure 2.1. A photograph showing the equipment used for recording the focal ERGs. (A) 
Front view. (B) Side view of the light box with the miniature Ganzfeld stimulator head in 
place. The voltage controller controls the luminance of the LEDs in the light box. (C) 
Cartoon showing the positions of the participant and the focal stimulus when recording 
focal ERGs. (D) Position of the miniature Ganzfeld held directly to the eye when 
recording full field ERGs. Note that the rod saturating blue background was on 
constantly with the flashing red stimulus superimposed on the blue background. 
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Figure 2.2. (A) Relative spectral profiles of light sources used in this study measured 
using a spectro-radiometer (Specbos 1201, Horiba Jobin Yvon, Middlesex, UK). The 
spectra of the LEDs are shown in thick lines and that of the blue desensitising 
background is shown as a dashed blue line. (B) Graph showing the changes in 
luminance of the four LEDs in the miniature Ganzfeld to the dial settings from 0 
(minimum) to 1000 (maximum). Luminances were measured using Minolta CS-100 
(Konica Minolta, Osaka, Japan) on 21/02/2013. 
 
Table 2.1. Photometric properties of light sources used in the study. 
LED 
Peak 
wavelength, nm FWHM 
Chromaticity 
Coordinates 
Colour 
Purity, % x y 
Red 660 23.20 0.71 0.28 97.65 
Blue 469 20.30 0.12 0.09 96.25 
Green 521 47.20 0.79 0.68 71.40 
Amber 597 17.70 0.60 0.40 99.70 
Blue surround 454 19.80 0.16 0.12 81.50 
Amber surround 615 94.00 0.59 0.40 97.50 
FWHM = Full width at half maximum 
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2.2.3 Calibration of equipment 
In the pilot study, all stimuli and background lights were calibrated using an LS-
110 spot photometer (Konica Minolta, Osaka, Japan). In experiments conducted 
after the pilot study, an ILT 1700 Research Radiometer with Y#29295/R#1032 
luminance detector (model SED033, Able Instruments and Controls, Reading, 
UK) was used, because of its better performance at measuring very brief 
flashes. The computer monitor used for pattern ERG recordings was calibrated 
with a spot photometer (LS-110; Konica Minolta, Osaka, Japan) which is 
recommended by ISCEV for measuring the luminance of a small area (Brigell et 
al., 2003). The wavelengths of the light sources were measured using a 
Specbos 1201 spectro-radiometer (Horiba Jobin Yvon, Middlesex, UK) 
 
At the start of the study, it was noticed that the maximum luminance produced 
by the red LED in the miniature Ganzfeld stimulator was 35 cd/m2 when it was 
set up for focal ERG recording (Figure 2.2B). This was lower than required for 
the study. In order to increase the luminance of the red LED for recording focal 
ERGs, the stimulator was modified as follows. A hemispherical diffusion cap, 
which was originally fitted to the miniature Ganzfeld stimulator, was found to be 
responsible for attenuating the luminance of the LEDs. It was therefore removed 
and replaced with a series of white diffusion sheets (Lee Filters: 216 white 
diffusion, 250 ½ white diffusion and 251 ¼ white diffusion; Lee Filters, 
Hampshire, UK) which produced a relatively homogenous plane surface without 
sacrificing luminance. The diffusers were introduced at different stages during 
the pilot study. The LEDs were re-calibrated after each change (i.e. dial settings 
were changed) to ensure the required luminances were obtained. The dial 
settings, corresponding luminance and dates are provided in Appendix I. This 
modified configuration of the miniature Ganzfeld stimulator was also used to 
record the full field ERG (i.e. the plane diffuser system was maintained). A 
transparent Perspex cover was fitted over the stimulator head to keep the 
diffusing sheets in place when the stimulator was in the hand-held mode.  
 
In addition, the different coloured LEDs took different amounts of time to attain a 
stable luminance after they had been switched on. The “warm-up” times for the 
various LEDs were measured (Table 2.2) and a 30-minute time allowance was 
made before starting ERG recordings.  
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Table 2.2. Minimum warm-up time for LEDs in miniature Ganzfeld stimulator 
LED Red Green Blue Amber 
Minimum warm up time, mins 20 10 10 30 
 
2.2.4 Electrodes 
In this study, ERGs were recorded monocularly with Dawson-Trick-Litzow (DTL) 
fibre electrodes (Unimed Electrode Supplies, Surrey, UK) as active (in the test 
eye) and contralateral reference (in the occluded non-test eye) electrodes. This 
configuration improves signal to noise ratio (Coupland, 2006; Bach et al., 2013).  
 
When using DTL electrodes, the placement of the fibre is a key consideration as 
it affects response amplitudes (Smith and Lamb, 1997; Hebert et al., 1999). In 
this study, the DTL fibre was placed in the lower fornix of each eye and the 
loose end fastened using medical tape at the inner canthus (Blenderm, Viasys 
Healthcare Ltd, Warwick, UK). Although this method produces about a 30% 
reduction in amplitude of signals as compared to placing the DTL on top of the 
lower lid margin in apposition to the cornea, the former produces more 
repeatable signals that are less contaminated by blinks and eye movement 
artefacts (Hebert et al., 1999). A silver-silver chloride 9-mm diameter, touch-
proof skin electrode (Viasys Healthcare Ltd, Warwick, UK), placed at the mid-
frontal forehead was used as the ground electrode.  
 
2.2.5 Electronic recording system 
Signals were digitally averaged and bandpass filtered from 1 to 100 Hz (unless 
otherwise indicated) using a Medelec Synergy system (Oxford Instruments 
PLC, Surrey, UK). The sampling rate was 1 KHz. Signals were recorded in 
blocks of 10 - 20 responses, with a total of 40 – 60 averaged per trace. Four to 
eight traces were obtained for each stimulus condition. The traces were 
superimposed on each other and visually inspected to confirm signal 
repeatability and averaged off-line into a single trace containing 160 – 300 
averages. An automatic artefact rejection system removed signals 
contaminated by large eye movements and blinks.  
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2.2.6 Procedures 
At least one eye (test eye) of the subject was dilated with one drop of 1% 
Tropicamide. While the subject waited for mydriasis (20 – 30minutes), the 
miniature Ganzfeld stimulator was turned on for the LEDs to warm-up. The 
subject’s forehead was scrubbed with gel (Nuprep, D.O. Waver and Co, Aurora, 
CO) in order to reduce the impedance. The electrode cup for the ground 
electrode was filled with electrolyte gel (Teca, Pleasantville, NY) and then 
attached with surgical tape (Blenderm, EM, St. Paul, MN) to the mid-frontal 
forehead. The DTL electrodes was attached to their holders and placed in the 
lower fornix of each eye; the holder and the free end of the fibre were secured 
with surgical tape at the outer canthus and nose respectively. All leads from the 
electrodes were secured to the nape, with enough allowance for head 
movements. 
 
When the test eye was fully dilated, the electrodes were plugged into the 
Medelec Synergy system. The resistances of the electrodes were checked to 
ensure each was below 4kΩ.  The participant was then seated in front of the 
stimulus (which had been allowed to warm-up for 30 mins) and pre-adapted for 
a minimum of 5 minutes prior to testing. If subjects complained of irritations or 
discomfort with the DTL that interfered with the recordings, a drop of 0.5% 
Proxymethacaine was administered in each eye to ease the discomfort.  
 
2.2.7 Signal Analysis 
The ERGs were exported into a Microsoft Excel 2013 spreadsheet and Fourier 
analysed offline to remove high frequency signals above 50Hz. Fourier analysis 
was based on the approach by Stroud (1986). The cut-off frequency was 
determined from a visual inspection of the power spectrum plot which showed 
that most of the power was concentrated in the first 20 harmonics and had 
levelled off at 25 harmonics (50Hz) (see Appendix VI). The amplitude of the a-
wave was measured from baseline to trough, and the b-wave amplitude was 
measured from the trough of the a-wave to the peak of the b-wave as 
recommended by ISCEV (Marmor et al., 2009). The PhNR-ON was measured 
from peak of b-wave to the negative trough immediately following the b-wave. 
The d-wave was measured from the time point of stimulus offset to the first 
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maximum peak (Sustar et al., 2006; Horn et al., 2011). The PhNR-OFF was 
measured from the peak of d-wave to the most negative trough immediately 
after the d-wave (Horn et al., 2011) (Figure 2.3). The peaks and troughs of the 
components were identified objectively within a predefined time window using 
Microsoft Excel 2013.  
 
 
Figure 2.3. A representative diagram of a focal long duration ERG recorded from one 
participant. It shows the various ERG components and how they were measured. a = a-
wave; b = b-wave d = d-wave 
 
 
2.3 Experiment 1: Determining Stimulus Duration 
2.3.1 Introduction 
The waveform of the ERG changes with stimulus duration. In a brief flash ERG 
(<50ms), the ON- and OFF responses are superimposed while for longer 
duration stimuli, the responses are separated (Evers and Gouras, 1986; 
Sieving, 1993; Kondo et al., 2008a). In these studies, the OFF responses were 
clearly separated when stimulus duration was 100ms or greater. Stimulus 
duration also affected both amplitude and time-to-peak of the ERG components. 
For example, in a study using macaque monkeys, Kondo et al (2008) observed 
that the b-wave and PhNR amplitudes of the focal ERG increased with duration 
up to about 50msec and then decreased just as the d-wave (OFF responses) 
began to emerge. They also found that the time-to-peak of the PhNR, increased 
from 75 msec for a 5 msec flash to 110 msec when the stimulus duration was 
 
a 
b 
PhNR-on 
PhNR-off 
d 
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50 msec. Further increases in the stimulus duration did not change the time-to-
peak significantly. 
 
The purpose of this experiment was therefore to study the effect of stimulus 
duration on the focal PhNR in human subjects and to select the optimum 
stimulus duration for the main study. A red stimulus spot on a blue illuminated 
background was used because it has been reported that this colour combination 
is most effective in eliciting large PhNRs especially at weak to moderate 
stimulus intensities (Viswanathan et al., 2001; Rangaswamy et al., 2007). 
  
2.3.2 Methods 
Three healthy participants were recruited for this experiment and prepared as 
described in section 2.2.6 above.  
 
A 20o diameter red flash stimulus (55 cd/m2) on a blue rod-suppressing 
background (100 scot cd/m2), was generated by the miniature Ganzfeld 
stimulator. The flash and background luminance used in this study were based 
on values reported as being optimal for eliciting the focal PhNR in macaque 
(Kondo et al., 2008a). The luminance of the blue surround from the light box 
was calibrated to provide the same scotopic luminance as the blue LED in the 
miniature Ganzfeld stimulator. The stimulus duration was increased from 50 to 
250 msec in 50 msec steps on a 500 msec time base. The stimulus repetition 
rate was fixed at 2 Hz. An additional ERG with a flash duration of 500 msec and 
1 Hz frequency on a 1 sec time base was recorded from one participant. A 
minimum of 180 responses were averaged for each major trace. Signals were 
analysed as described in section 2.2.7. The ERGs of the three individuals were 
inspected to look for qualitative changes in waveform with an increase in 
stimulus duration. Time-to-peak and amplitudes were also plotted as a function 
of stimulus duration. 
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Figure 2.4. The effect of increasing stimulus duration on the ERG components is shown for three participants in this study. The red vertical 
dashed lines represent the point of stimulus offset. Red upward arrows show the PhNR-ON, the down arrow and asterisks show the d-wave and 
PhNR-OFF components respectively. Right inset shows the ERG recorded from one participant (C231) using a 500msec flash on a 1sec sweep 
duration.  
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2.3.3 Results 
Figure 2.4 shows the focal ERGs of the three participants in response to 
different stimulus durations of 50 to 250 msec. As stimulus duration increased, 
the waveform was separated into ON and OFF components corresponding to 
the on and off phases of the stimulus respectively. The ON component 
consisted of the a-wave, b-wave and PhNR-ON. The OFF components 
consisting of the d-wave (red downward arrow) and PhNR-OFF component 
(asterisks) began to emerge when stimulus duration reached 100msec.  
 
However, the traces recorded using stimulus duration of 200 and 250 msec 
showed the d-wave and the PhNR-OFF more clearly separated from the ON-
responses. It can also be observed that when stimulus duration was 250 msec, 
the traces appeared level off between 200 and 250msec. This was checked 
with a 500msec flash which showed that the ON responses returned to baseline 
by 250msec (Figure 2.4 inset).  
 
The mean amplitude of the b-wave and PhNR-ON decreased with stimulus 
duration and approached a plateau with the 250msec flash (Figure 2.5). The d-
wave and PhNR-OFF on the other hand increased in amplitude and also 
approached a plateau with the 250msec flash. 
 
 
Figure 2.5. Effect of stimulus duration on (A) b-wave (filled dots) and d-wave (open dots) 
amplitudes and (B) PhNR-ON (filled circles) and PhNR-OFF (open dots) amplitudes. The 
black dots represent the mean and the coloured dots are for individuals 
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2.3.4 Discussion  
The results show a progressive separation of the ON and OFF responses with 
increasing stimulus duration. However, distinct d-wave and PhNR-OFF 
components were seen with the 200 and 250msec flash duration in this study. 
This is similar to findings reported in focal ERGs obtained from macaque using 
similar recording parameters (Kondo et al., 2008a).  
 
The effect of stimulus duration on the b-wave and d-wave amplitude was similar 
to reports from other studies investigating the full-field ERG (Evers and Gouras, 
1986; Sieving, 1993; Sustar et al., 2006). In this study, the decreasing PhNR-
ON amplitude and the increasing PhNR-OFF amplitude which mimicked the 
behaviour of the b-wave and d-wave respectively, also approached a plateau 
with the 250msec duration. This is important as it signifies the complete 
separation of the ON and OFF components when the plateau is reached. This 
was confirmed by the return of the ON components to baseline within 250 msec 
when the 500msec flash was used. 
 
2.3.5 Conclusion 
In conclusion, the 250 msec stimulus flash duration was selected for the main 
study since it produced optimal delineation of the PhNR-ON and PhNR-OFF 
components of the focal ERG. In addition, it was the same stimulus duration 
used by Colotto et al (2000) to study the focal PhNR-ON and PhNR-OFF 
components. 
 
 
2.4 Experiment 2: Determining Stimulus Luminance 
2.4.1 Introduction 
The amplitudes of ERG waveforms vary as a function of stimulus luminance 
and the increase is not always monotonic. For example the b-wave of the brief 
flash ERG initially increases in amplitude with increasing stimulus luminance, 
but after reaching a peak at a luminance of about 0.5 – 0.86 log cd.s/m2, it 
gradually declines creating the so called photopic hill (Wali and Leguire, 1992; 
Binns et al., 2011). The b-wave amplitude of long duration flash on the other 
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hand reaches a plateau at higher luminances without decreasing whereas the 
d-wave exhibits the photopic hill phenomenon (Kondo et al., 2000). 
 
In order to determine the effect of stimulus intensity on the focal PhNR 
waveform, and to optimise experimental parameters, a second set of 
experiments was undertaken. Previous investigators (Kondo et al., 2008a), 
determined that 55 cd/m2 maximised the focal PhNR signal in monkeys and did 
not produce stray light. As such, this experiment investigated the intensity 
response relationship for the focal PhNRs for a range of luminances from 2 – 55 
cd/m2. 
 
2.4.2 Methods 
The stimulus set up was as described in section 2.3.2, but in this study the 
stimulus duration was fixed at 250ms, while the luminance was varied from 2 – 
55 phot cd/m2 (Table 2.3). Three subjects (2 males, age 29 and 24 years; 1 
female, age = 37 years) were recruited for this experiment and prepared as 
described in section 2.2.6. A minimum of 180 responses were averaged for 
each major trace. The recording equipment and procedures for preparing the 
participants are described in section 2.2. The ERG amplitudes were measured 
as described previously in 2.2.7. The amplitudes of the ERG sub components 
were plotted against flash luminance for each individual. The mean amplitudes 
were however, normalised and plotted as a function of the luminance.  
 
Table 2.3. Luminance and dial settings used in this study. 
Luminance, cd/m2 2 4 7 12 17 26 40 55 
Dial Setting 198 230 272 339 412 556 772 989 
 
2.4.3 Results 
Generally, all the ERG components increased in amplitude and became more 
prominent with increasing stimulus luminance (Figure 2.6 and 2 7). The PhNR-
ON and PhNR-OFF were discerned in two subjects (C245 and C247) from 4 
cd/m2 and upwards and were visible in all three subjects from 7 cd/m2 (shown 
by red arrows in Figure 2.6) 
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Figure 2.6. ERGs of three control participants showing the effect of luminance on the focal long duration ERG. Thick black traces are averaged traces of 
the light coloured individual traces. All traces band-passed at 1-100 Hz except traces for C231 (bandpass = 1 – 1KHz). The PhNR-ON and PhNR-OFF 
components (red arrows) were first discernible in participants C245 and C247 at 4cd/m2 and later in participant C231 at 7cd/m2. 
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Figure 2.7. Plot of stimulus luminance (x-axis) against amplitude (y-axis)for the traces 
shown in Figure 2.6 (above). The plot on the extreme right represents the normalised 
averaged amplitudes of the corresponding components for the three participants. 
 
The mean amplitude of the a-wave showed a linear increase with stimulus 
luminance whilst the mean amplitudes of the b-wave, PhNR-ON, d-wave and 
PhNR-OFF increased steadily from the lowest luminance and tapered off 
towards the highest tested luminance (Figure 2.7). The response of d-wave 
amplitude to luminance was different in all three subjects, however, when the 
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data were normalised and averaged (extreme right), the plot showed an 
increase in amplitude with luminance. The PhNR-OFF showed a general 
increase in amplitude with luminance for all three subjects. 
 
2.4.4 Discussion 
This experiment set out to determine the optimum stimulus luminance for 
isolation of the PhNR-ON and PhNR-OFF using a red-on-blue stimulus. The 
results indicate that the PhNR-ON and PhNR-OFF, as well as the b- and d-
wave amplitudes increased with stimulus luminance and approached a plateau 
at the higher luminances. The a-wave, however, did not show any such 
plateauing effect over the luminance range tested. The greatest amplitude was 
obtained for all waveforms with the most luminous stimulus, 55 cd/m2. A similar 
behaviour of the a- and b-wave was reported by Kondo et al (2000) for a full-
field ERG. They also showed that the d-wave exhibited a photopic hill 
phenomenon i.e. with increasing stimulus luminance, the d-wave amplitude 
increased to a maximum and then decreased. This was not observed in this 
study with the d-wave over the recorded luminance range. Examination of the 
PhNR-ON and PhNR-OFF luminance-response curves in Figure 2.7 indicates 
that still larger PhNRs may be obtained with still higher stimulus intensities i.e. 
the function has not saturated even at the highest luminance used. However, it 
was reported that using focal stimulation with luminances >55 cd/m2 may be 
contaminated by peripheral stray light (Kondo et al., 2008a). Furthermore, 
equipment limitations prevented the delivery of higher luminances. The 55 
cd/m2 was therefore selected as optimal luminance, similar to the luminance 
reported by Kondo et al (2008).  
 
2.4.5 Conclusion 
The focal PhNR-ON and PhNR-OFF are optimally elicited using a red flash of 
luminance 55cd/m2 on a blue background with luminance 100 scot cd/m2. 
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2.5 Experiment 3: Determining optimal stimulus and background colours 
(wavelengths) 
2.5.1 Introduction 
The ISCEV standard recommends using a white flash on a white desensitising 
background for clinical full-field flash ERG. However, various studies 
investigating the PhNR have used different combinations of stimulus and 
background colours and popular among these is the red flash on blue 
background. Previous studies have shown that red flashes on a rod saturating 
blue background gives higher amplitude responses than other combinations of 
chromatic or achromatic stimuli (Viswanathan et al., 1999; Viswanathan et al., 
2001; Rangaswamy et al., 2007; Sustar et al., 2009). Rangaswamy et al (2007) 
and Sustar et al (2009) posit that the amplitude of the PhNR elicited by stimuli 
of different colours depends not only on the strength of the stimulus, but also on 
the specificity of each coloured stimulus for a single type of cone and the 
effectiveness of the rod-saturating background in adapting the cones that are 
activated. As such combinations of monochromatic light, which are more 
specific for a single cone type and induce the least spectral antagonism are 
best for eliciting the PhNR. A red-on-blue is thus effective because the red 
stimulus selectively stimulates the L-cones while the blue background 
selectively adapts the rods and S-cones.  
 
Some studies into ADOA suggest that the S-cone pathway is more affected by 
the disease than the L and M cones (Holder et al., 1998; Johnston et al., 1999) 
while others suggest the disease has no preference for any particular cone 
pathway (Votruba et al., 1998a; Reis et al., 2013). An S-cone dominated ERG 
may also be elicited using a blue-on-amber stimulus (Gouras et al., 1993; Arden 
et al., 1999; Vincent et al., 2013). This experiment was therefore conducted to 
investigate the effect of different combination of stimulus and background 
wavelength on the human focal ERG and to optimise parameters for the main 
study. 
 
2.5.2 Methods 
The experiment was conducted using the equipment and methods described in 
section 2.3.2. However, the flash duration was fixed at 250 msec. In addition, 
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different combinations of stimulus flash and background wavelengths were 
recorded and are described in Table 2.4  
 
Table 2.4. Flash and background parameters 
Flash (Peak 
wavelength) 
Photopic Luminance, 
cd/m2 (Dial Setting) 
Background (Peak 
wavelength) 
Scotopic Luminance, 
scot cd/m2 
Red (660nm) 55 Blue (469nm) 100 
Amber (597nm) 55 Blue (469nm) 100 
Green (521nm) 55 Blue (469nm) 100 
Blue (469nm) 55 Amber (597nm) 52 
Blue (469nm) 55 Green (521nm) 100 
Red (660nm) 55 Amber (597nm) 52 
Green (521nm) 55 Amber (597nm) 52   
Blue (469nm) 55 Amber (597nm) 104 
Blue (469nm) 55 Amber (597nm) 115 
For simplicity, luminance values have been rounded up to nearest whole number 
 
The initial aim of this experiment was to record ERGs using flashes with a 
luminance of 55cd/m2 on backgrounds with a luminance of 100 scot cd/m2. 
However, the maximum photopic luminance produced by the amber LED was 
300 cd/m2 which equates to 52 scot cd/m2 (= 2000 scot td for 7mm pupil), 
assuming light emitted was monochromatic at a wavelength of 597nm. This 
sufficiently produced the luminance required to suppress the rods (Aguilar and 
Stiles, 1954) and ERGs on amber backgrounds were recorded at this setting. In 
this set of experiments, five healthy participants (3 females and 2 males; aged 
22 - 26) were recruited for this experiment. However, data for two participants 
were not included in the results. One participant (C222) complained of 
discomfort from the glare of the stimulus lights and as such she often squinted 
and made small eye movements during the experiment which made the ERGs 
unreliable. In the case of the second participant (C246), a complete dataset was 
not available.  
 
Due to the limitation of the amber LED in the miniature Ganzfeld stimulator, two 
attempts were made to increase the amber background to at least 100 scot 
cd/m2. In the first attempt, a projector system was employed to increase the 
amber background luminance to 100 scot cd/m2. An amber filter (LEE Golden 
Amber) was fitted to a projector which was then used to floodlight the viewing 
surface of the light box. The projector was mounted on a stand and placed 
about 1.5m behind and to the side of the participant (i.e. when participant was 
seated for recordings). The projector was then angled in such a way that the 
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participants were not in the way of the projected beam. This method was 
successful in increasing the amber background to 600 cd/m2 (= 104 scot cd/m2). 
ERGs were recorded in two female participants (C258 and C259).  
 
In the second attempt, an amber filter (LEE Golden Amber) was fitted to an LED 
lamp. The lamp was placed on top of the light box and angled down so that the 
beam of the LED flood lit the viewing surface of the light box. This configuration 
was successful in increasing the luminance of the amber background to 665 
cd/m2 (115 scot cd/m2). ERGs were recorded from 2 additional healthy 
participants (C226 and C332).  
 
2.5.3 Results 
The ERGs obtained with the different stimuli combinations are shown in Figure 
2.8. The waveforms of the ERGs produced by the red, green and amber flashes 
on the rod-saturating blue background were similar. The ON pathway (a-wave, 
b-wave and PhNR-ON) and OFF pathway (d-wave and PhNR-OFF) responses 
were easily discernible in with these stimuli. 
 
The ERG waveforms produced by the blue-on-amber and blue-on-green stimuli 
were similar to each other, but different from the others (Figure 2.8, column 4 
and 5). The red-on-amber and green-on-amber ERGs, recorded from one 
individual, did not show discernible components (Figure 2.8 inset) and were not 
repeated for the other participants.  
 
Further ERGs were collected from two participants (C258 and C259) using the 
projector system to increase the luminance of the amber background to above 
100 scot cd/m2. However, the hum of the projector generated a lot of electrical 
noise and so this aspect of the experiment was discontinued (Figure 2.9). The 
second configuration, which used the external LED lamp to increase the 
luminance of the amber background, produced noise levels lower than the noise 
levels associated with the projector in the two participants tested (Figure 2.10). 
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Figure 2.8. Focal ERGs recorded from 3 participants C245, C248 and C249 using different combinations of flash and background colours. 
The luminance for all flashes was 55 cd/m2. The luminances of the blue and green backgrounds were 100 scot cd/m2 and that of the amber 
was 52 scot cd/m2 
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Figure 2.9. Focal ERGs recorded with blue flash (55 cd/m2) on an amber background (104 
cd/m2) in two participants A and B. The ERGs were recorded in blocks of 45 to 60 
responses (thin coloured lines) and averaged offline (thick black line). The projector 
created a lot of electrical noise (seen in the thin upper traces). The red line represents the 
averaged ERG after using Fourier analysis to remove high frequency noise (above 30Hz). 
The thick grey lines are focal blue on amber ERGs recorded from the same participants 
with the projector switched off (i.e. the amber background now reduced to 52 scot cd/m2) 
 
 
 
Figure 2.10. Focal ERGs recorded with blue flash (55 cd/m2) on an amber background 
(115 scot cd/m2) in two participants C226 and C232. The ERGs were recorded in blocks of 
45 to 60 responses (thin coloured lines) and averaged offline (thick black line). The red 
line represents the averaged ERG after using Fourier analysis to remove high frequency 
noise (above 30Hz). 
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2.5.4 Discussion 
The results showed that focal PhNR-ON and PhNR-OFF responses can be 
obtained using red, amber or green flashes on a rod saturating blue 
background. These assumed to be dominated by responses from the L and M 
pathway (Rangaswamy et al. 2007).  
 
It was also possible to record an S-cone dominated focal ERG with a blue flash 
on an amber or green background. These focal ERGs produced large PhNR-
ON components with little or no obvious PhNR-OFF responses since the S-
cone pathway does not exhibit OFF-responses. These ERGs are believed to be 
dominated by S-pathway responses (Arden et al., 1999). The results in this 
study were also qualitatively similar to S-cone ERGs recorded using a silent 
substitution method (Drasdo et al., 2001).  
 
2.5.5 Conclusion 
The optimal wavelength combination for eliciting an L and M pathway 
dominated ERG is the red flash on a rod saturating blue background. The 
optimal wavelength combination for eliciting an S-pathway dominated ERG is 
the blue flash on an amber background. 
 
 
2.6 Experiment 4: Comparison of ERGs Recorded from the Central, 
Nasal and Temporal Macula 
2.6.1 Introduction 
Previous studies show that there are regional variations in the amplitude and 
time-to-peak of the PhNR recorded across the macular area (Kurimoto et al., 
2009; Nakamura et al., 2011a). In addition,  it has been shown that the PhNR 
amplitude is well correlated with the average RNFL (Horn et al., 2011). These 
suggest that the PhNR amplitude would reflect the anatomical loss of retinal 
neurons induced by disease.  
 
In people with ADOA, the optic atrophy is often more prominent in the temporal 
disc and studies show that the retinal nerve fibre layer in affected individuals is 
more severely affected in the temporal quadrant as well. It may therefore prove 
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to be diagnostically beneficial to compare responses from different retinal 
locations. An exploratory study was therefore conducted to record focal ERGs 
from the central, nasal and temporal retina in order to investigate the retinotopic 
distribution of responses in healthy participants.  
 
2.6.2 Methods 
Focal ERGs were recorded from the central, nasal and temporal retina from 
three participants (two males, age = 24 and 26; one female, age 26). The 
stimulus configuration was as described in section 2.3.2, using a stimulus 
duration of 250msec, and the luminance of 55 cd/m2. To record from the central 
retina, the participant was asked to fixate on the cross hairs in the middle of the 
stimulus (Figure 2.11). An additional marker was positioned on the left and 
another on the right side of the stimulus field so that they were horizontally 
aligned to the centre of the red target.  
 
 
Figure 2.11. An illustration of a subject looking at the stimulus. Focal ERGs are recorded 
from the central, nasal and temporal retina when the subjects fixate at C, N and T 
respectively.  
 
To record from the nasal retina, the participant was asked to assume the 
primary position of gaze and the screen moved laterally till the marker on the 
nasal side of the participant’s field of view (N) was aligned to the participant’s 
line of sight. To record from the temporal retina, the screen was moved in the 
opposite direction until the temporal target relative to the participant’s visual 
field (T) was aligned to the participant’s line of sight. Amplitudes and times-to-
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peak were measured as described in section 2.2.7. The means of the 
amplitudes and times-to-peak of the PhNR recorded from the three locations 
were calculated and compared.  
 
2.6.3 Results 
Figure 2.12 shows the ERG waveforms for the tested areas and Table 2.5 
displays data showing amplitude and times-to-peak for the ERG components. 
The results show that in all three subjects, the largest PhNR-ON amplitudes 
were recorded in the central macula (average = 7.30, SD = 2.29) followed by 
the temporal macula (average = 6.33, SD = 2.12) and then the nasal macular 
(average = 6.01, SD = 1.40) in descending order.  
 
 
Figure 2.12. Focal ERGs from 3 subjects taken from nasal, central and temporal macular 
regions (left to right) 
 
A similar pattern was recorded for the PhNR-OFF with central macular being 
the largest (average = 5.43, SD = 1.29), followed by the temporal macula 
(average = 4.12, SD = 0.21) and the nasal being the least (average = 1.9 SD = 
0.50). It could not be reliably determined whether these differences in amplitude 
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between the three locations were statistically significant due to the limited 
number of participants in this study (n = 3). 
 
Table 2.5. Amplitude and time-to-peak of focal ERG components from nasal, central and 
temporal macular areas 
COMPONENT Par’t NASAL CENTRAL TEMPORAL 
Amp, 
µV 
Time, 
msec 
Amp, 
µV 
Time, 
msec 
Amp, 
µV 
Time, 
msec 
a-wave C246 1.95 23.00 2.81 25.00 1.97 25.00 
C254 1.08 22.00 2.49 20.50 1.21 19.50 
C265 1.29 27.00 0.68 19.00 0.55 17.50 
Avg 1.44 24.00 1.99 21.50 1.24 20.67 
SD 0.45 2.65 1.15 3.12 0.71 3.88 
CoV 31.26 11.02 57.76 14.52 57.10 18.79 
 
b-wave C246 5.41 56.50 6.27 56.00 3.92 55.00 
C254 3.73 54.00 5.92 53.50 3.38 52.00 
C265 3.11 57.50 2.63 52.50 1.89 52.50 
Avg 4.08 56.00 4.94 54.00 3.06 53.17 
SD 1.19 1.80 2.01 1.80 1.05 1.61 
CoV 29.24 3.22 40.60 3.34 34.22 3.02 
 
PhNR-ON C246 7.50 125.00 9.94 104.00 8.78 114.00 
C254 5.83 115.50 6.17 115.50 5.27 110.50 
C265 4.71 150.50 5.80 136.50 4.96 104.00 
Avg 6.01 130.33 7.30 118.67 6.33 109.50 
SD 1.40 18.10 2.29 16.48 2.12 5.07 
CoV 23.35 13.89 31.33 13.89 33.52 4.63 
 
d-wave C246 3.69 64.00 5.03 57.00 3.83 56.00 
C254 2.57 53.50 4.11 57.00 2.14 45.00 
C265 1.76 59.50 3.70 58.50 0.94 57.00 
Avg 2.67 59.00 4.28 57.50 2.30 52.67 
SD 0.97 5.27 0.68 0.87 1.45 6.66 
CoV 36.32 8.93 15.94 1.51 63.05 12.64 
 
PhNR-OFF C246 2.26 129.00 6.92 102.50 4.37 103.50 
C254 1.33 116.00 4.64 106.00 3.99 114.50 
C265 2.11 121.00 4.72 121.00 4.00 107.00 
Avg 1.90 122.00 5.43 109.83 4.12 108.33 
SD 0.50 6.56 1.29 9.83 0.21 5.62 
CoV 26.47 5.37 23.85 8.95 5.17 5.19 
 
Table 2.5 also shows that the times-to-peak of the PhNR-ON and PhNR-OFF 
recorded from the nasal macula are the longest (average = 130 msec, SD = 
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18.10 and 122 msec, SD = 6.56 respectively) compared to the central (ON: 
118.67 msec; OFF: 109.83 msec) and temporal areas (109.50 msec; OFF: 
108.33 msec).  
 
2.6.4 Discussion 
These experiments showed that the focal PhNR-ON and –OFF can be 
measured from the central, nasal and temporal retina. It can be seen from the 
results that there are regional variations in the amplitudes and times-to-peak of 
the PhNRs. However, unlike published reports which show the nasal macula 
produces larger PhNR amplitudes than the temporal macula (Kurimoto et al., 
2009; Nakamura et al., 2011a), the results for this experiment showed that the 
temporal macula had greater amplitudes that the nasal macula. This could be 
due to the size of the stimulus in relation to the dimensions of the retina. 
 
The horizontal distance between the fovea and the temporal edge of the optic 
nerve head is about two disc diameters, equivalent to about 12o visual angle 
(Quigley et al., 1990; Remington, 2005). The optic nerve head is approximately 
6o in diameter (Jonas et al., 1992). This means that when the patient positions 
the eye for recording the nasal retina, the 20o stimulus overlaps the optic nerve 
head (Figure 2.13).  
 
Figure 2.13 Diagram showing the positions of the image of the stimulus on the retina 
during tests. Diagram is not to scale 
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Since the optic nerve head is insensitive to light, it leads to a loss in signal. The 
percentage of signal lost can be calculated as follows:  
𝑎𝑟𝑒𝑎 𝑜𝑓 𝑜𝑝𝑡𝑖𝑐 𝑛𝑒𝑟𝑣𝑒 ℎ𝑒𝑎𝑑
𝑎𝑟𝑒𝑎 𝑜𝑓 𝑠𝑡𝑖𝑚𝑢𝑙𝑢𝑠
∗ 100% 
 
= 
(3.02)𝜋
(10.02)𝜋
∗ 100% = 9.0 % 
 
In the case of the PhNR-ON, the amplitude in temporal macula was ~5% 
greater than in the nasal macula while for the PhNR-OFF, the amplitude in the 
temporal macula was more than 100% greater than the nasal macula. The 
percentage loss in signal in the nasal macula due to the presence of the ONH 
could therefore not completely explain the results obtained in this study. Since 
the number of participants in this study was small, a later study involving a 
larger sample size was conducted in Chapter 3 to further explore the 
observation made in this study. 
 
2.6.5 Conclusion 
The PhNR-ON and PhNR-OFF can be recorded from the central, nasal and 
temporal macula.  
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 CHAPTER THREE – A COMPARISON OF THE 
RETINOTOPIC CHARACTERISTICS OF THE 
PATTERN ERG AND FOCAL ERG 
 
 
3.1 Introduction 
The retinal ganglion cells (RGCs) are thought to give rise to the photopic 
negative response (PhNR) component of the flash ERG (Viswanathan et al., 
1999; Viswanathan et al., 2000; Viswanathan et al., 2001) and the N95 
component of the pattern ERG (PERG) (Arden et al., 1982; Thompson and 
Drasdo, 1994; Luo and Frishman, 2011). The amplitudes of both components 
are reduced in diseases affecting RGC function as well as following 
pharmacological blockade of inner retinal function (Viswanathan et al., 1999; 
Colotto et al., 2000; Viswanathan et al., 2000; Rangaswamy et al., 2004; Luo 
and Frishman, 2011; Preiser et al., 2013). Although the PhNR and PERG are 
both electrophysiological responses known to contain RGC contributions, the 
PhNR is elicited by changes in luminance (Viswanathan et al., 1999; 
Viswanathan et al., 2000; Rangaswamy et al., 2007; Sustar et al., 2009) while 
the PERG is generated by changes in contrast (Drasdo et al., 1987; Porciatti, 
1987; Thompson and Drasdo, 1989; Thompson and Drasdo, 1994). The 
purpose of this study, therefore, was to compare the retinotopic characteristics 
of these two responses recorded from the central, nasal and temporal macula in 
the same individuals. 
 
Furthermore, in the previous pilot study (section 2.6), it was observed that the 
PhNR amplitudes in the temporal macula were larger than the amplitudes 
recorded from the nasal macula, contrary to previous reports (Kurimoto et al., 
2009). Since there were only three participants in the previous pilot study, it was 
not possible to reliably determine whether the results were significant. This 
present study, which involved a larger number of healthy participants, therefore 
provided the opportunity to more reliably determine the veracity of the findings 
in the previous pilot study. 
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3.2 Methods 
3.2.1 Participants 
Eighteen healthy participants were recruited as previously described in section 
2.2.1  
 
3.2.2 ERG Recording 
Long duration focal ERGs were recorded using the equipment and procedures 
previously described in 2.2.2 – 2.2.6. The focal ERGs were recorded in 
response to a 20o diameter red flash (peak wavelength 664nm, 250msec, 55 
cd/m2, 2Hz) on a rod saturating blue background (454nm, 100 scot cd/m2).  
 
Transient PERGs were generated at 4 reversals per second on a computer 
monitor at 98% contrast. The screen was masked with a black opaque 
cardboard with a 13 x 13 cm square cut-out at the centre so that it produced a 
20o x 20o field at a viewing distance of 36 cm. The size of the individual check 
elements was 1o. Signals were digitally averaged and bandpass filtered from 1 -
100 Hz, at a sampling rate of 1 kHz using the electronic recording system and 
methods described in section 2.2.5. 
 
The PERG was always recorded first with normal pupils. Participants wore their 
corrective prescriptions where required (Bach et al., 2013). After the PERG 
recordings, at least one pupil (the test eye) was dilated using 1% Tropicamide in 
order to record the focal ERGs. The PERGs and focal ERGs were recorded 
from the central, nasal and temporal macula of the participants. To record the 
PERG from the central macula, the participant was asked to fixate on a red 
target located in the centre of the PERG stimulus field. An additional marker 
was positioned on the left and another on the right side of the stimulus field so 
that they were horizontally aligned to the central red target. To record from the 
nasal retina, the participant was asked to assume the primary position of gaze 
and the screen moved laterally till the marker on the nasal side of the 
participant’s field of view was aligned to the participant’s line of sight. To record 
from the temporal retina, the screen was moved in the opposite direction until 
the temporal target (relative to the participant’s visual field) was aligned to the 
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participant’s line of sight. In the case of the focal ERGs, the procedures 
described in section 2.6.2 were employed. 
 
3.2.3 Signal Analysis 
The ERGs were exported into a Microsoft Excel 2013 spreadsheet and Fourier 
analysed offline to remove high frequency signals above 30 Hz and 50 Hz for 
the PERG and focal ERGs respectively. Fourier analysis was based on the 
approach by Stroud (1986). The cut-off frequency for the PERG was 
determined from a visual inspection of the power spectrum plot, which showed 
that most of the power was concentrated in the first 10 harmonics (20 Hz) and 
had levelled off to a minimum at 15 harmonics (30Hz). The cut-off for the focal 
ERG was similarly determined; the power was concentrated in the first 20 
harmonics (40 Hz) and had levelled off to a minimum at 25 Hz (50 Hz) (see 
Appendix VI for the power spectrum plots). 
 
The amplitude and time-to-peak of the P50 and N95 of the PERG were 
measured as recommended by ISCEV (Bach et al., 2013). The P50 amplitude 
was measured from the trough of the N35 to the peak of P50. The N95 was 
measured from the peak of P50 to the trough of N95. In the focal ERGs, the a-
wave and b-wave were measured as recommended by ISCEV (McCulloch et 
al., 2015). The d-wave was measured from the time point of stimulus offset to 
the first maximum peak. The PhNR-ON amplitude was measured from peak of 
b-wave to a fixed time point in the trough of the PhNR-ON while the PhNR-OFF 
was measured from peak of d-wave to the a fixed time point in the trough of the 
PhNR-OFF. The fixed time points were determined by finding the times-to-peak 
of the PhNR-ON and PhNR-OFF components of the group-averaged trace for 
each location (Table 3.1). This method was adopted from the study by Mortlock 
et al (2010). All peaks and troughs of the other sub components were identified 
objectively as described in section 2.2.7. The ERGs recorded from the different 
locations were also inspected to look for qualitative changes in waveform. In 
order to account for the loss in signal in ERGs recorded from the nasal macula 
due to the presence of the optic nerve head in that location (assuming an 
angular radius of 3.5o (Curcio and Allen, 1990)), the nasal ERGs were multiplied 
by a factor of 1.11 for PERGs and 1.14 for focal ERGs. 
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Table 3.1. Fixed time points at which amplitudes of focal long duration PhNRs were 
measured  
Location PhNR-ON, msec PhNR-OFF, msec 
Central 105 361 
Nasal 120 397 
Temporal 104 361 
 
 
3.2.4 Statistical Analysis 
The distribution of the ERG data was checked for normality using the Shapiro-
Wilk test. Where data were normally distributed, comparisons between ERGs 
recorded from the central, nasal and temporal macula from participants were 
conducted using one-way repeated measures analysis of variance (ANOVA) 
with Bonferonni adjustment for multiple comparisons; otherwise a Friedman test 
(with post-hoc Wilcoxon Signed Ranked tests for post-hoc pairwise 
comparisons) was conducted. Differences between the locations were 
considered significant when p < 0.05. The relationship between PhNRs of the 
focal ERG and the N95 of the PERG were explored using regression analysis. 
Relationships were considered significant when p < 0.05. 
 
 
3.3 Results 
3.3.1 Comparison of Central, Nasal and Temporal Macula ERGs 
Transient pattern ERGs and focal flash ERG were recorded successfully from 
all three retinal locations in 18 healthy participants aged between 20 and 61 
years (mean + SD = 31 + 12 years) (Figure 3.1). The PERGs were 
characterised by a prominent positive peak, the P50, followed by a negative 
potential, the N95 (Figure 3.1A). The waveforms of the PERGs from the nasal 
macula were different to those from the central and temporal macula. In the 
nasal PERG, the descending limb of the P50 which usually continues 
uninterrupted into the trough of the N95 was interrupted by a positive going 
wave at a time point near the trough of the N95 (Figure 3.1A, arrowed in middle 
column). This also caused the most negative point of the N95 component to be 
displaced towards a later time-to-peak close to 150 msec. As this was out of the 
known normal range for the component, the nasal N95 was instead measured 
from P50 peak to the first trough before the interrupting positive wave. 
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Figure 3.1. The PERGs (A) and long duration focal ERGs (B) recorded from the central, nasal and temporal macula of participants. Thin coloured lines 
represent the traces from individual participants. Thick lines represent the group averaged traces in the various locations. Dotted lines represent the 
95% confidence interval. The red arrow in nasal PERG shows the positive wave interrupting the N95 trough. 
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Figure 3.2. Group-averaged traces from the three locations. Comparison between (A) central and nasal retina; (B) central and temporal retina; and (C) 
temporal and nasal retina. The single trace at the bottom of each comparison is the difference ERG between each pair the two locations. Dashed lines 
represent the 95% confidence intervals.
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The focal ERG was characterised by the a-wave, b-wave, PhNR-ON, d-wave 
and PhNR-OFF (Figure 3.1B). Once again, the traces from the nasal macula 
were different from those from the central and temporal retina. The trough of the 
PhNR-ON and the peak of the d-wave were broader than their central and 
temporal counterparts. Figure 3.2A shows pairwise comparisons of the group 
averaged PERGs from the three locations. The difference ERGs, obtained by 
subtracting one ERG from the other, showed that differences between the nasal 
and the central/temporal PERGs were more prominent in N95 components 
while the differences between the central and temporal PERGs were more 
prominent in the positive components. 
 
A repeated measures ANOVA showed that there were significant differences in 
the P50 and N95 amplitudes depending on the location from which they were 
recorded (Table 3.2). Post hoc tests using Bonferroni correction showed that 
the central P50 and N95 amplitudes were significantly greater than their 
counterparts recorded from the nasal and temporal retina. The nasal P50 
amplitude was significantly greater than the temporal P50, however, the N95 
amplitudes of the nasal and temporal macula were not statistically different. The 
contradiction between the differences observed in the graphs and the results 
from the statistical analysis is addressed in the discussion. The times-to-peak of 
the P50 and N95 components did not show a significant difference between the 
three locations.  
 
In Figure 3.2B, pairwise comparisons were made between the ERGs recorded 
from the three locations and the differences between them were highlighted by 
the difference ERGs. The difference ERGs were obtained by subtracting one 
ERG from the other (see legend of Figure 3.2). The differences between the 
nasal and the central/temporal focal ERGs were more prominent in their 
negative components while the differences between the central and temporal 
focal ERGs were more prominent in their positive components. The b-wave and 
d-wave amplitudes were significantly greater in the nasal than in the temporal 
macula. However, there were no significant differences in the a-wave, PhNR-
ON or PhNR-OFF amplitudes between the nasal and temporal macula. 
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Table 3.2. Statistical comparisons of central, nasal and temporal macula ERG 
components 
Component Central Nasal Temporal p-value 
P50  
 
A, µV 3.34 
+0.81 
2.83 
+0.60 
2.29 
+0.52 
Significant 
(p < 0.0001; P.Eta2 = 0.72) 
Pairwise: Cen > Nas > Tem (all 
significant at p < 0.0050) 
T, msec 53.08 
+3.11 
53.65 
+4.46 
52.06 
+3.89 
Not significant† 
χ2 (2) = 3.09; p = 0.2138 
N95 A, µV 5.39 
+0.92 
3.59 
+0.98 
4.02 
+0.85 
Significant 
(p < 0.0001; P.Eta2 = 0.85) 
Pairwise: Cen > Nas (p < 0.0001); 
Cen > Tem (p < 0.0001) 
T, msec 102.31 
+7.06 
95.61 
+9.41 
103.26 
+6.40 
Not significant 
(p = 0.0636; P.Eta2 = 0.29) 
a-wave A, µV 2.17 
+0.60 
1.38 
+0.70 
1.34 
+0.66 
Significant  
(p = 0.0001) 
Pairwise: Cen > Nas (p<0.0001); 
Cen > Tem (p < 0.0001) 
T, msec 23.56 
+1.79 
23.06 
+1.57 
22.63 
+1.50 
Not significant† 
χ2 (2) = 3.70; p = 0.1569 
b-wave A, µV 6.56 
+1.59 
5.14 
+1.25 
4.01 
0.92 
Significant 
p < 0.0001; P.Eta2 = 0.77 
Pairwise: Cen > Nas > Tem (all 
significant at p < 0.0010) 
T, msec 49.13 
+4.79 
50.13 
+3.86 
43.06 
3.75 
Significant† 
χ2 (2) = 27.09; p < 0.0001 
Pairwise: Cen > Tem (p= 0.0003); 
Nas > Tem (p = 0.0002) 
PhNR-ON A, µV 8.68 
+2.50 
6.18 
+1.66 
6.19 
+1.64 
Significant 
p < 0.0001; P.Eta2 =0.77 
Pairwise: Cen > Nas (p < 0.0001); 
Cen > Tem (p = 0.0000) 
T, msec 105.31 
+6.84 
120.69 
14.10 
103.44 
+5.70 
Significant 
(p < 0.0001; P.Eta2 = 0.70) 
Pairwise: Nas > Cen (p = 0.0029); 
Nas > Tem (p < 0.0001) 
d-wave A, µV 3.09 
+0.88 
2.66 
+0.79 
1.70 
+0.78 
Significant 
(p < 0.0001; P.Eta2 = 0.78) 
Cen  > Nas > Tem (all significant 
at p < 0.0500) 
T, msec 302.06 
+5.36 
306.34 
+9.35 
298.94 
+4.77 
Significant 
(p = 0.0066; P.Eta2 = 0.47) 
Pairwise: Cen > Tem (0.0454); 
Nas > Tem (p = 0.0050) 
PhNR-
OFF 
A, µV 4.21 
+1.29 
2.90 
+1.29 
3.34 
+1.10 
Significant 
(p = 0.0073; P.Eta2 = 46) 
Pairwise: Cen > Nas (p = 0.0057); 
Cen > Tem (p = 0.0188) 
T, msec 367.89 
+19.44 
401.28 
+22.13 
360.66 
+13.32 
Significant 
(p < 0.0001; Peta2 = 0.71) 
Pairwise: Nas > Cen (p = 0.0004); 
Nas > Tem (p = 0.0002) 
† - Data not normally distributed and Friedman test was used 
 
3.3.2 Relationship between the N95 and PhNR components 
The relationship between the long duration focal PhNRs and the N95 
component were explored using regression analysis. Scatter plots of the 
Chapter 3 
119 
 
relationship are shown in Figure 3.3. Generally, the focal PhNR-ON amplitude 
demonstrated a positive trend with the N95 amplitude in all locations, however, 
the regression coefficients were low (R2 < 0.2) and not significant (p > 0.05) 
(Table 3.3). The focal PhNR-OFF amplitude on the other hand showed a 
positive trend with the N95 amplitude in the central and temporal macula, but a 
negative trend in the nasal macula. The relationships once again were not 
significant.  
 
 
Figure 3.3. Scatter plots showing the relationship of the N95 (x-axis) amplitude with the 
PhNR-ON and PhNR-OFF amplitudes (y-axis) recorded (A) central, (B) nasal and (C) 
temporal macula of participants. The legend in A applies to B and C. The graphs are 
scaled equally. The equation of the regression lines are provided in Table 3.3. 
 
Table 3.3. Results of regression analysis of the PhNR components (y/dependent variable) 
and the N95 (x/independent variable) in the various locations. 
Location 
Dependent 
Component 
Equation R2 p-value 
Central 
PhNR-ON y = 0.4339x + 6.3455 0.0255 0.5246 
PhNR-OFF y = 0.5498x + 1.2482 0.1546 0.1076 
Nasal 
PhNR-ON y = 0.1555x + 5.6177 0.0085 0.7133 
PhNR-OFF y = -0.3450x + 4.1408 0.0687 0.2954 
Temporal 
PhNR-ON y = 0.6868x + 3.4242 0.1273 0.1450 
PhNR-OFF y = 0.641x + 0.7628 0.2437 0.0827 
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3.4 Discussion 
In this study, the retinotopic characteristics of the PERG and the long duration 
focal ERG in response to a red on blue stimulus in three retinal locations were 
compared in healthy participants. This study found that the positive going 
components of both the PERG (P50) and focal ERG (b-wave and d-wave) were 
greater in the nasal macula than in the temporal macula. This was similar to the 
findings in the previous pilot study (section 2.6.3). The P50 is in part derived 
from the RGCs, but also has origins distal to the RGCs, most likely the bipolar 
cells and photoreceptors (Arden et al., 1982; Holder, 1997; Holder, 2001; 
Holder et al., 2009; Luo and Frishman, 2011). The b-wave and d-wave are 
derived from the ON and OFF bipolar cells respectively (Brown, 1968; Evers 
and Gouras, 1986; Sieving et al., 1994; Ueno et al., 2006b). Given that the 
nasal macula has a greater photoreceptor density, and by implication a greater 
bipolar cell density, than in the temporal macula (Curcio et al., 1990), the results 
for the positive components were expected. 
 
However, this was not the case for the negative going components (N95 of the 
PERG, a-wave, PhNR-ON and PhNR-OFF for the long duration ERG). The 
mean amplitudes recorded for these parameters (except the a-wave) were 
larger in the temporal macula than in the nasal macula (Table 3.2). This was 
similar to the results from the pilot study (section 2.6.3). However, the 
differences in amplitude between the nasal and temporal macula for these 
parameters were not significant.  
 
The N95 and the PhNRs are primarily derived from the RGCs (Viswanathan et 
al., 1999; Viswanathan et al., 2000; Holder, 2001; Luo and Frishman, 2011) and 
RGC density is significantly greater in the nasal retina than in the temporal 
retina (Curcio and Allen, 1990; Silveira and Perry, 1991; Drasdo et al., 2007). 
The lack of statistical differences in the N95, PhNR-ON and PhNR-OFF 
amplitudes recorded from the nasal and temporal macula could thus be due to a 
number of factors. The PERG and focal ERG traces from the nasal macula 
were different in waveform compared to those from the central and temporal 
retina. In the PERG, the difference could possibly be due to the luminance 
imbalance caused by the presence of the ONH when the nasal retina was 
stimulated. Symmetry between light and dark areas of the PERG stimulus is 
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mandatory in generating the PERG signal (Bach et al., 2013). The overlap of 
the symmetric square patterns over the asymmetric oval ONH in the nasal 
retina would result in an asymmetry between light and dark areas. During 
pattern reversal a luminance component may thus be generated which could 
have contaminated the PERG signal and thus explain the interrupted N95 
component observed in nasal retinal PERGs.  
 
The difference in waveform of the nasal focal ERG could be due to the intrusion 
of components associated with the optic nerve head (Sutter and Bearse Jr, 
1999). Sutter and Bearse (1999) reported the presence of an optic nerve head 
contribution to the ERG which varied with distance from the optic nerve head. 
The 20o stimulus completely overlapped the optic nerve head when recordings 
were made from the nasal macula. The contribution of the optic nerve head 
component would thus be maximal in the recordings from the nasal macula and 
minimal in the recordings from the temporal macula. 
 
A number of studies have sought to establish the relationship between the N95 
of the PERG and the PhNR of the flash ERG in glaucoma patients since both 
components reflect RGC activity (Colotto et al., 2000; North et al., 2010; Preiser 
et al., 2013). They found that the N95 amplitude was significantly correlated 
with the brief flash red-on-blue PhNR amplitude (North et al. 2010; Preiser et al. 
2013) and the uniform field white-on-white PhNR-ON of the focal ERG (Colotto 
et al. 2000). The findings of these studies were consistent with the concept that 
the two parameters share similar retinal origins, which are the RGCs. In this 
study however, there was neither a significant relationship between the PhNR-
ON and the N95 nor the PhNR-OFF and the N95 amplitudes in healthy 
participants.  
 
Although the results of this study appear to stand in contrast to the earlier 
findings, Preiser et al (2013) also showed that there was no significant 
correlation between the PhNR to b-wave ratio (PhNR ratio; defined as the 
PhNR amplitude divided by the b-wave amplitude) and the N950.8 to N9516 ratio 
(N95 ratio; defined as the N95 amplitude generated by a 0.8o check size divided 
by the N95 amplitude generated by a 16o check size). They proposed that the 
significant correlation between the “raw” amplitudes of the PhNR and N95 may 
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be due to “trivial” factors like eye size or electrode position, which vary between 
eyes, but are common to the two measures. Calculation of the ratios, cancels 
these trivial factors out, leaving no significant correlation between individual 
PhNR ratio and PERG ratio values. They therefore suggested that lack of 
correlation between the PhNR and PERG ratios was because the two measures 
either tapped into different disease mechanisms or measured different RGC 
populations.  
 
If this was true to some degree, then a linear combination of the two measures 
should be a better discriminator for the presence of glaucoma. Their test of the 
hypothesis using receiver operating characteristics (ROC) curve, showed that 
the area under the curve (AUC) of the combined PhNR-and PERG ratios rose 
to 0.90 in comparison to that of the independent PhNR-ratio (0.80) and N95 
ratio (0.79) (Preiser et al., 2013). The results in this study in healthy participants 
may therefore support the proposal by Preiser et al (2013) that the PhNR and 
N95 arise from different classes of RGCs.  
 
Furthermore, as noted in the introduction, the focal ERG is produced in 
response to changes in stimulus luminance (Viswanathan et al., 1999; 
Viswanathan et al., 2000; Rangaswamy et al., 2007; Sustar et al., 2009) while 
the PERG is produced in response to changes in stimulus contrast (Drasdo et 
al., 1987; Porciatti, 1987; Thompson and Drasdo, 1989; Thompson and Drasdo, 
1994). The lack of correlation between the focal PhNR and the PERG may 
therefore be due to the different functional properties of RGCs that generate the 
responses. Additionally, since ERGs are affected by stimulus and background 
colour (Viswanathan et al., 1999; Rangaswamy et al., 2007; Sustar et al., 2009), 
the results in this study could be explained by differences in chromatic contents 
of the stimuli used to generate the PhNR (red on blue) and the PERG (black 
and white checkerboard). This is clinically relevant as it suggests that the 
PhNRs elicited by a long duration red on blue stimulus and the N95 component 
of the PERG provide different information about macula function.  
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3.5 Conclusion 
This study suggested that the focal PhNRs of the ERG elicited by a long 
duration red-on-blue stimulus and N95 of the PERG share some similar 
retinotopic characteristics, supporting previous reports that the PhNR and N95 
may share similar cellular origins. However, the N95 of the PERG was not 
significantly correlated with the PhNR-ON and –OFF parameters, suggesting 
that the PERG and the focal ERGs do not have identical generators and are 
providing distinct clinical information. This study also suggested that apart from 
regional RGC density, there are other factors (e.g. proximity to the ONH) which 
affect the amplitude and time-to-peak of the PhNRs and N95 components in the 
temporal and nasal retina. 
 
Chapter 4 
124 
 
 CHAPTER FOUR – THE RELATIONSHIP BETWEEN 
RETINAL GANGLION CELL DISTRIBUTION AND THE 
PHOTOPIC NEGATIVE RESPONSE 
 
4.1 Introduction 
The retinal ganglion cells (RGC) and their receptive fields (RGCf) are most 
densely packed in the centre of the retina and become increasingly sparse 
towards the retinal periphery (Curcio and Allen, 1990; Watson, 2014). RGCs 
also exhibit central-peripheral asymmetries in other properties such as cell size, 
axon length and size, dendritic field size, receptive field size, convergence to 
first and second order neurons, peak sensitivity, contrast sensitivity and contrast 
gain (Perry et al., 1984; Rodieck et al., 1985; Drasdo et al., 1987; Watanabe 
and Rodieck, 1989; Dacey and Petersen, 1992; Dacey, 1993a; Dacey, 1993b; 
Croner and Kaplan, 1995; Lee, 1996; Yamada et al., 1996; Lee et al., 1998; 
Dacey et al., 2000). These properties of the RGCs predict that RGC function 
depends on eccentricity. As such, an ERG component reflecting activity of the 
RGCs will be expected to exhibit properties that conform to known 
characteristics of RGCs. 
 
The photopic negative response (PhNR) is a negative going wave seen after 
the b-wave in a brief flash photopic (cone) ERG (Viswanathan et al., 1999; 
Viswanathan et al., 2000). When a long-duration flash is used to evoke the 
ERG, the PhNR is seen once after the b-wave (PhNR-ON) and again as a 
negative going wave after the d-wave (PhNR-OFF). These components are 
thought to reflect the activity of the ON- and OFF- pathways (Rangaswamy et 
al., 2007; Luo and Frishman, 2011). The PhNR, particularly when elicited by a 
red flash on a rod saturating blue background, is believed to primarily originate 
from spiking activity in RGCs and their axons with contributions from amacrine 
cells and possible involvement of associated glial cells/astrocytes of the retina 
(Viswanathan et al., 1999; Viswanathan et al., 2000; Frishman, 2006; 
Rangaswamy et al., 2007). In line with this theory, the PhNR amplitude is 
selectively reduced in retinal diseases affecting the RGC and/or optic nerve with 
relative sparing of the a-wave and b-wave, both of which are components from 
the outer retina (Colotto et al., 2000; Gotoh et al., 2004; Machida et al., 2004; 
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Ueno et al., 2006a; Miyata et al., 2007; North et al., 2010; Nakamura et al., 
2011b; Morny et al., 2015).  
 
The amplitude of an ERG is directly proportional to the area of stimulation and 
to the number of stimulated neurons (Errico et al., 1990; Murray et al., 2004).  
The response density of an ERG component can be calculated by dividing the 
amplitude of the response by the area from which it was recorded (Brindley and 
Westheimer, 1965; Errico et al., 1990; Sutter and Tran, 1992; Kondo et al., 
1998; Sutter and Bearse Jr, 1999). A response density profile can thus be 
created by calculating the response densities at different retinal eccentricities. 
The response density profile can then be matched to the topographical density 
profile of a class of retinal neurons of interest to determine the relationship 
between the response and the distribution of the neuron. If the number of 
neurons thought to produce a particular ERG component in a specified area is 
known, it follows that the response of a single neuron can be computed by 
dividing the amplitude by the number of neurons in that area. 
 
The following were therefore hypothesised. 
1. The amplitudes of the PhNRs will increase with increasing stimulus sizes 
2. The change in the response densities of the brief and long-duration 
PhNR with eccentricity would reflect the change in RGC receptive field 
density (i.e. the number of receptive fields per degree squared). 
3. The PhNR per RGC would increase from central to peripheral retina in 
consonance with known characteristics of RGCs that are directly linked 
to its functional output (e.g. cell size, dendritic field size, receptive field 
size). 
 
The separation of the ON and OFF components of the ERG using a long 
duration red flash on a blue saturated background (Viswanathan et al., 1999; 
Rangaswamy et al., 2007) provided an opportunity to determine the relationship 
between the response densities of the PhNR-ON and PhNR-OFF components 
and the receptive field densities of the ON- and OFF-RGCs. In addition, the 
brief flash PhNR elicited by a red on blue stimulus, which is optimal for 
assessing combined RGC function (Rangaswamy et al., 2007; Sustar et al., 
2009) enabled a determination of the relationship between the brief flash PhNR 
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and the general RGC density profile. The aim of this study therefore was to 
determine the relationship between the long duration and brief flash PhNRs and 
the distribution of RGCs across the retina using a red on blue stimulus of 
increasing area. In addition, it was sought to estimate the responses of single 
RGCs as a function of eccentricity on the basis of ERG recordings. 
 
A previous study by Errico et al (1990), qualitatively showed a close match 
between the density profile of a negative going wave seen after the b-wave, 
which they referred to as “PIII”, and a previously published density profile for 
cones (Osterberg, 1935). Errico et al therefore attributed the origins of their PIII 
component to the cones. However, this negative wave has now been 
established as the PhNR-ON component, a signal attributed to the activities of 
the ON-centre RGCs (Viswanathan et al., 1999; Viswanathan et al., 2000; 
Kondo et al., 2008a; Luo and Frishman, 2011). This therefore warrants further 
investigation. Errico et al (1990) may have erroneously attributed the PIII with 
cones rather than RGCs because the receptive field topographies of cones and 
RGCs are qualitatively similar; they peak at the centre and decrease rapidly 
towards the periphery (Osterberg, 1935; Curcio and Allen, 1990; Curcio et al., 
1990; Drasdo et al., 2007). 
 
Furthermore, since the discovery of the PhNR in 1999 by Viswanathan et al 
(1999), its response characteristics as a function of various stimulus parameters 
(e.g. luminance, duration, wavelength, etc.) have been reported with the aim of 
standardising its use in measuring RGC function (Rangaswamy et al., 2007; 
Miyata et al., 2008; Kurimoto et al., 2009; Sustar et al., 2009). These studies 
employed either focal stimuli of different sizes or full-field stimuli using brief or 
long duration flashes. A systematic study of the response characteristics of the 
PhNR amplitude to varying stimulus sizes, which has not yet been reported, will 
therefore be relevant to the standardisation of the PhNR recording protocol.  
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4.2 Methods 
4.2.1 Participants 
All participants were recruited from among staff and students of the School of 
Optometry and Vision Sciences, Cardiff University, as well as their friends and 
families. The study conformed to the Declaration of Helsinki and was approved 
by the ethics committee of the School. All participants provided their written 
consent after receiving a participant information sheet and having the 
opportunity to ask questions. All participants had a corrected visual acuity of 0.1 
logMAR or better with normal visual fields, and were aged between 18 and 50 
years. Six participants were recruited for Experiment 1 and 16 for Experiment 2. 
 
All ERGs and baseline tests in Experiment 1 were recorded by the author (EM). 
All ERGs and baseline tests in Experiment 2 (except for 3 participants) were 
recorded by a second year optometry student (KP) under the supervision of the 
author under the Cardiff Undergraduate Research Opportunities Programme 
(CUROP). Preliminary results of the project were presented as a poster at the 
CUROP 2015 exhibition. 
 
4.2.2 ERG Recording and Participant Setup 
All ERGs responses were elicited using a modified miniature Ganzfeld LED 
stimulator and recorded on a Medelec Synergy system. The equipment and 
procedure for recording the ERGs are described in detail in section 2.2.2 – 
2.2.6). 
 
ERGs were recorded using DTL fibre active electrodes and the pupils of 
participants were dilated in at least one eye using 1% tropicamide to a minimum 
of 7mm.  
 
4.2.3 Experiment 1: Long duration ERGs 
Focal long duration ERGs were recorded using a red circular stimulus (peak 
wavelength 660 nm, 250 ms, 50 cd/m2, 2 Hz) on a rod saturating blue 
background (peak wavelength 469 nm, 100 scot cd/m2). A desensitising blue 
background (peak wavelength 454 nm, 140 scot cd/m2) was used to minimised 
the effect of stray light (details in section 2). The angular diameters of the focal 
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stimulus were 5.5o, 10o, 15o, 20o, 30o, 45o and 60o (Figure 4.1); they were 
obtained by varying the viewing distance (Table 4.1). The stimulus sizes were 
chosen to address one of the objectives of this study, i.e. to compare focal 
ERGs recorded with different sized stimuli. As such, stimulus sizes that had 
been commonly used to record focal ERGs in previous studies by other 
laboratories (5o, 10o and 15o (Kondo et al., 2008a; Machida et al., 2008b)) and 
from this laboratory (20o and 30o) were selected. The stimulus size was then 
increased in 15o steps to obtain the 45o and 60o stimuli. Further increments 
beyond 60o could not be obtained, as the focal stimuli could not be placed 
closer than to the observer without touching the observer’s nose. The areas of 
the circular stimuli are shown in Table 4.1. A full-field long duration ERG was 
recorded by holding the modified miniature Ganzfeld directly to the eye. For the 
purpose of calculation, the angular diameter of the full-field stimulus was 
assumed to be 110o. The focal stimuli were centred on the fovea by asking the 
participant to fixate at the intersection of a pair of cross-hairs centred in the 
middle of the stimulus.  
 
4.2.4 Experiment 2: Brief flash ERGs 
Focal brief flash ERGs were recorded using the same setup as in Experiment 1 
except for the following changes. The duration, luminance and frequency of the 
red flash were 5 msec, 0.28 cd.s/m2 and 4 Hz respectively. The angular 
diameters of the stimulus were 5o, 10o, 15o, 20o, 30o and 60o; they were 
obtained by varying the viewing distance (Table 4.1). The 45o stimulus was 
discontinued after Experiment 1 as it did not provide additional information. The 
full-field ERG was recorded by holding the miniature Ganzfeld directly to the 
eye as in Experiment 1. 
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Figure 4.1. A schematic diagram of the stimulus sizes used in this study. Each circular 
stimulus was centred on the fovea. The numbers are the angular diameters the stimuli. 
 
Table 4.1. Dimensions of the stimulus sizes used in the study 
Stimulus 
Angular Size 
(Diameter), deg 
Viewing 
distance, 
cm 
Stimulus 
Angular Area, 
deg2 
Annulus 
Area, deg2 
Eccentricity 
(Midpoint of 
Annulus), deg 
5 66.42 19.63 19.63 1.25 
(5.5) (60.37) (23.76) (23.76) (1.38) 
10 
 
33.15 
 
78.54 
 
58.90 
(54.78) 
3.75 
(3.88) 
15 22.03 176.71 98.17 6.25 
20 16.45 314.16 137.44 8.75 
30 10.82 668.37 392.70 12.50 
(45) 7.00 (1590.43) (883.57) (18.75) 
60 
 
5.02 
 
2788.95 
 
2120.58 
(1237.00) 
22.50 
(26.25) 
110 NA 9464.83 6675.88 42.50 
Values in brackets apply to long duration stimulus used in Experiment 1. NA – not applicable. 
NB – The area of the optic nerve head (38.48 deg2; assuming a diameter of 7o and beginning at 
11o from the fovea (Watson, 2014)) has been subtracted from angular areas of stimuli >30o 
 
To compute the response density of components as a function of eccentricity, 
the following approach was adopted. The arithmetic difference in amplitude 
between two successive stimulus sizes was divided by the area of the annulus 
created by the said two stimulus sizes. For example, to find the amplitude of 
responses in the 10o annulus, the amplitudes of components in the 5o area were 
subtracted from the amplitudes of their respective counterparts produced by the 
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10o stimulus. This was then plotted as a function of the midpoint (in deg) of the 
annulus (distance between the inner and outer circle). The areas of the annuli 
and their midpoints (eccentricity) are shown in Table 4.1. 
 
For simplicity, stimulus sizes are referred to by their angular diameters (e.g. 
5.5o, 10o, etc.) rather than by their areas. The annuli are referred to by the 
diameter of the larger (outer) circle. For example, the 20o annulus is the annulus 
with an inner diameter of 10o and an outer diameter of 20o. 
 
4.2.5 Signal Analysis 
The ERGs were Fourier analysed to remove high frequency signals above 50Hz 
as described in section 2.2.7. The PhNR-ON (PhNR in Experiment 2) amplitude 
was measured from the peak of the b-wave to the trough of the PhNR. The 
PhNR-OFF was measured from the d-wave peak to the PhNR-OFF trough. An 
additional positive potential was observed immediately following stimulus off-set 
in ERGs produced by stimuli larger than 30o (arrowed in Figure 4.3). In these 
cases, the PhNR-OFF was measured from the second positive since its time-to-
peak corresponded to the d-wave in the smaller stimulus ERGs.  
 
4.2.6 Distribution of RGCs and their Receptive Fields 
Every RGC has a receptive field, an area in space within which the RGC 
responds to a light stimulus (Hartline, 1938; Barlow, 1953; Kuffler, 1953; Wassle 
et al., 1983; Lennie, 2003; Spillmann, 2014).  The distribution of RGCs and their 
receptive fields are therefore expected to be similar. However, RGC bodies 
within the central zone (up to ~4 mm (15o) eccentricity) are centrifugally 
displaced from their receptive fields due to the length of the laterally connecting 
Henle fibres and the oblique pathway through the bipolar cells (Curcio and 
Allen, 1990; Drasdo et al., 2007). The peak density of RGCs therefore occurs 
not at the foveal centre, but at a point 1 – 2 mm (3.5o – 5o) away from it and the 
local density of receptive fields in the central retina does not reflect the local 
density of RGC bodies (Curcio and Allen, 1990; Drasdo et al., 2007). By 
implication, the response to a stimulus of a given size is determined by the 
number of receptive fields covered by the stimulus, and not necessarily by the 
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number of RGCs in that specific area. Thus in this study, the PhNR density is 
compared to that of the RGCf. 
 
In this study, a formula by Watson (2014) was used in calculating RGCf field 
density (in deg2) as a function of eccentricity (in deg) in the human retina 
(Equation 1).  
 
Equation 1 
 
where dgf (r, k) is the density of RGCfs at eccentricity, r, in degrees along 
meridian, k; dgf(0) is the density of receptive fields at the centre of the fovea 
(33,163.2 RGCf/deg2), ak is the weighting function of the first term, r2 is the 
eccentricity at which RGC receptive field density is reduced by a factor of 4 (and 
spacing is doubled) and re,k is the scale factor by the index k. The values of the 
constants are provided in Table 4.2.  
 
Table 4.2. The values of constants for Equation 1 in four meridians (Watson, 2014) 
Meridian (k)* a r2 re 
Temporal 0.9851 1.058 22.14 
Superior 0.9935 1.035 16.35 
Nasal 0.9729 1.084 7.633 
Inferior 0.9960 0.9932 12.13 
* Meridians refer to visual field locations 
 
This formula is based on histologic data by Curcio and Allen (1990) and Drasdo 
et al (2007), and on a method of converting retinal dimensions in millimetres to 
visual angle in degrees using a wide angle schematic eye (Drasdo and Fowler, 
1974). The formula provides RGCf densities for each of four meridians. Since a 
circular stimulus centred on the fovea was used in this study, the mean density 
of the four meridians was calculated and used to plot Figure 4.2A. Note that the 
meridians refer to visual field locations (not retinal locations) and thus the blind 
spot appears in the temporal meridian. In the data provided by Watson (2014), 
the blind spot was 7o wide and started at an eccentricity of 11o in the temporal 
meridian and thus the RGCfs in this area (blind spot) was zero. Accordingly, the 
area of the blind spot (38.48 deg2) was subtracted from the areas covered by 
𝑑𝑔𝑓 (𝑟, 𝑘) = 𝑑𝑔𝑓(0) ∗  [𝑎𝑘 (1 +
𝑟
𝑟2,𝑘
)
−2
+ (1 − 𝑎𝑘) exp (−
𝑟
𝑟𝑒,𝑘
)] 
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stimuli greater than 20o. The mean cumulative counts of RGCf as a function of 
eccentricity (Figure 4.2B), was calculated by integrating the mean density at 
eccentricity, r, (using the trapezoid rule) and multiplying this by 2πr to account 
for the increasing area, as required by Watson (2014).   
 
 
Figure 4.2. (A) Mean density of midget ganglion cell receptive fields as a function of 
eccentricity computed from the formula provided by Watson (2014). The “valley” in the 
curve corresponds to the blind spot. (B) Cumulative number of midget ganglion cell 
receptive fields as a function of eccentricity. Graphs are plotted on a log scale. 
 
For the long duration stimulus, the densities and cumulative counts of the 
receptive fields of ON and OFF RGCs were required in order to compare them 
respectively to the PhNR-ON and PhNR-OFF parameters. For this, the 
distributions of ON and OFF cells of all RGC types were needed. As there are 
many different RGC types in the retina, the two major morphological types, the 
midget and parasol RGCs, were chosen. A third group, which was called 
“others” was added to include all the other RGCs in the retina. Computations 
regarding the midget RGCs, which constitute the most numerous type of RGCs, 
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were based on the published results of Dacey (1993) and Drasdo (2007) in 
which mRGCs make up ~90% of the population of RGCs near the fovea 
reducing to ~40% in retinal periphery. Calculations for ON and OFF mRGCs 
were based on the ratio of ON:OFF mRGCs from 0 – 5o = 1:1; from 5 – 25o = 
1:1 to 1:1.69; and beyond 25o = 1:1.69 (Drasdo et al., 2007). Explicit details of 
the distribution of the parasol RGCs (pRGCs) in humans were not available in 
the searched literature. Therefore, they were assumed to constitute 10% of the 
RGC population at all eccentricities based on the 8 – 12% reported by Silveiro 
et al (2004) for macaque. The ON:OFF ratio of parasol RGCs was then 
computed to be 0.4:0.6 based on the dendritic field size differences between 
ON and OFF pRGCs (Dacey and Petersen, 1992). The proportion of RGCs in 
the “others” group was calculated by subtracting the sum of the midget and 
parasol RGCs from the total number of RGCs at each eccentricity. The ON:OFF 
ratio for the others group was assumed to be 1:1. (Please see Appendix II for 
the calculation tables). 
 
4.2.7 Statistical Analysis 
The changes in response density and response per RGC with eccentricity as 
well as the relationship between the PhNR density and the RGCf density were 
determined by linear regression. Comparisons were considered significant 
when p <0.05. As the sample size was less than 30, 95% confidence intervals 
were calculated using the Student’s t-distribution (Altman, 1991). 
 
 
4.3 Results 
4.3.1 Participants 
In Experiment 1, six participants made up of four females and two males, were 
recruited. They were aged between 24 and 37 years (average 29.33 + 4.23 
years). In Experiment 2, sixteen participants aged between 21 and 50 years 
(average 27.5 + 6.88 years) and comprising seven females and nine males 
were recruited. Two participants from Experiment 1 were included in 
Experiment 2. Data for the oldest participant were excluded because the age 
fell two standard deviations outside the mean of the data set. Data for five more 
participants were excluded for the following reasons: 
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1. The ERG amplitudes did not increase systematically with increasing 
stimulus size and participant was not available for re-test (n =1) 
2. incomplete data set for all tested sizes (n = 2) 
3. systematic difference in waveform due to poor fixation, drift or 
decompensated heterophoria at near (n = 2) 
 
4.3.2 Experiment 1 
The traces from individual participants are shown in Figure 4.3A. All the ERGs 
recorded with the various stimulus sizes, with the exception of the 5.5o stimulus, 
had clearly identifiable a-wave, b-wave, PhNR-ON, d-wave and PhNR-OFF 
components in all participants. The components were not clearly identifiable in 
two of the participants in the 5.5o ERG. The average value of the amplitudes of 
the components determined for the remaining four participants were therefore 
assigned to these two participants and used for analysis. This was done so that 
the amplitude difference between for the 5.5o and 10o stimuli could be 
calculated.  
 
The group-averaged traces (Figure 4.3A) and the mean amplitudes of 
components as a function of eccentricity (Figure 4.4A, Table 4.3) demonstrated 
that the amplitudes of the ERG components increased with the stimulus size. 
The mean time-to-peak, however, appeared to decrease slightly except for the 
PhNR-OFF (Figure 4.4B).  
 
The group-averaged ERGs for each stimulus size were normalised to their 
respective b-wave amplitudes to allow for comparison of the waveforms (Figure 
4.3B). The waveforms of the normalised ERGs in response to the smaller 
stimulus sizes (5.5o – 30o) were different from those in response to the larger 
sizes (45o – full-field). The proportion of the PhNR-ON and PhNR-OFF 
amplitude was greater in the ERGs of the smaller stimulus sizes than in the 
larger stimulus sizes. A ledge on the rising limb of the d-wave (arrowed), first 
seen on the 15o ERGs become progressively prominent and developed into a 
separate peak in the 60o and full-field ERGs.  
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Figure 4.3. (A) Group-averaged long duration ERGs (thick black lines) recorded from 
participants in response to increasing stimulus size (bottom to top). Thin coloured lines 
are the individual traces and dotted lines show the 95% confidence interval. (B) The same 
group-averaged ERGs for each stimulus size which have been normalised to their 
respective b-wave amplitudes. Arrows indicate an emerging additional positive peak on 
rising phase of the d-wave. 
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Figure 4.4. (A) Amplitudes of components of the long duration ERG as a function of 
stimulus area. For clarity, error bars are shown for only the PhNR-ON and PhNR-OFF. B – 
Time-to-peak of the long duration ERG components. The legend in A applies to B. Error 
bars represent 95% confidence intervals.  
 
Table 4.3. Mean values of amplitudes and times-to-peak of ERG components recorded for 
the different stimulus sizes.  
Stim
Size, 
deg 
a-wave b-wave 
 
PhNR-ON d-wave 
 
PhNR-OFF 
Amp, 
µV 
Time, 
msec 
Amp, 
µV 
Time, 
msec 
Amp, 
µV 
Time, 
msec 
Amp, 
µV 
Time, 
msec 
Amp, 
µV 
Time, 
msec 
5.5 
0.35 
+0.12 
25.13 
+6.33 
1.31 
+0.30 
56.75 
+3.71 
2.61 
+0.27 
118.4 
+9.7 
1.31 
+0.49 
309.5 
+9.4 
1.77 
+0.39 
359.3 
+18.4 
10 
0.69 
+0.43 
23.92 
+1.36 
2.86 
+0.52 
55.50 
+2.85 
4.50 
+0.41 
110.5 
+5.6 
1.89 
+0.70 
303.8 
+7.1 
3.03 
+1.00 
361.8 
+11.0 
15 
1.46 
+0.59 
23.58 
+1.36 
4.23 
+0.69 
52.25 
+2.21 
6.02 
+1.38 
101.5 
+5.5 
2.41 
+1.03 
306.5 
+5.3 
3.41 
+1.09 
368.5 
11.6 
20 
1.89 
+0.80 
23.33 
+0.88 
5.93 
+1.31 
49.75 
+4.63 
9.00 
+2.04 
109.3 
+4.7 
3.08 
+2.16 
297.7 
+12.0 
4.88 
+1.12 
377.0 
+13.7 
30 
3.08 
+0.80 
22.92 
+0.58 
8.77 
+1.52 
46.92 
+4.22 
11.50 
+1.66 
108.0 
+4.2 
4.40 
+2.16 
304.0 
+7.1 
6.42 
+1.80 
363.3 
+9.2 
45 
4.41 
+1.36 
23.08 
+0.58 
13.52 
+3.12 
45.17 
+2.94 
16.53 
+2.52 
105.0 
+5.1 
5.92 
+3.62 
300.7 
+5.5 
9.15 
+2.70 
368.8 
+6.0 
60 
7.43 
+2.74 
23.67 
+0.26 
19.60 
+5.59 
45.00 
+2.51 
21.47 
+5.29 
105.9 
+6.4 
7.88 
+3.50 
298.3 
+4.5 
10.79 
+2.72 
378.8 
+13.5 
110 
18.12 
+4.48 
22.83 
+0.82 
36.87 
+11.43 
41.25 
+9.44 
36.57 
+9.96 
88.5 
+6.9 
13.16 
+4.53 
295.5 
+9.4 
20.38 
+4.44 
377.5 
+21.8 
Values are given as mean + standard deviation. 
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The response density plot in Figure 4.5A showed that both PhNR-ON and 
PhNR-OFF were maximal at the fovea and decreased towards the periphery. 
The density plots of the PhNR-ON and PhNR-OFF were qualitatively similar to 
that of the ON (blue dashed line) and OFF (grey-dashed lines) RGCf densities 
respectively. A cone density plot derived from the data provided by Curcio et al 
(1990) is also shown as a dashed orange line in Figure 4.5A. It may be seen 
that although cone density drops with eccentricity, the profile unlike that of the 
RCGf profile, deviates from that of the PhNR data from an eccentricity of about 
4o. 
 
Linear regression analysis showed a strong relationship between the PhNR-ON 
and ON-RGCf (R2 = 0.99, p < 0.0001) and between the PhNR-OFF and OFF-
RGCf (R2 = 0.99, p < 0.0001) (Figure 4.5B). The response per RGC (response 
in annulus/number of RGCf in annulus) of the PhNR-ON and PhNR-OFF both 
showed a significant increase with eccentricity (PhNR-ON: R2 = 0.89, p = 
0.0001; PhNR-OFF: R2 = 0.50, p = 0.0489) (Figure 4.5C). The mean values of 
the response density and response per cell are reported in Table 4.4. 
 
Table 4.4. Mean values of the response density and response per RGC of the PhNR-ON 
and PhNR-OFF as a function of eccentricity. 
Eccentricity, 
deg 
Response Density, 
µV/deg2 (x10-2) 
Response per RCG, 
µV/RGC (x10-5) 
RGCf Density 
PhNR-
ON 
PhNR-
OFF 
PhNR-ON PhNR-
OFF 
ON-RGCf OFF-RGCf 
1.38 11.00 
+1.15 
7.45 
+1.58 
3.98 
+0.42 
2.60 
+0.55 
3180.99 3310.83 
3.88 3.45 
+0.85 
2.35 
+1.25 
4.05 
+0.10 
2.63 
+1.40 
871.95 907.54 
6.25 1.55 
+1.11 
0.74 
+0.34 
3.61 
+2.45 
1.58 
+0.73 
444.08 473.64 
8.75 2.17 
+1.34 
1.07 
+0.13 
8.43 
+5.20 
3.61 
+0.45 
270.70 302.59 
12.50 0.85 
+0.33 
0.52 
+0.26 
7.18 
+2.80 
3.53 
+1.77 
102.97 121.91 
18.75 0.57 
+0.27 
0.31 
+0.14 
9.22 
+4.42 
3.55 
+1.55 
81.45 105.96 
26.25 0.40 
+0.31 
0.13 
+0.06 
9.99 
+7.66 
2.15 
+1.01 
45.19 62.24 
42.50 0.23 
+0.09 
0.14 
+0.06 
14.01 
+5.82 
5.90 
+2.55 
18.46 24.31 
Values are given in mean + standard deviation. NB – the RGC receptive field (RGCf) density 
provided in the last two columns were derived using formulas from Watson 2014. 
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Figure 4.5. (A) Amplitude densities of the PhNR-ON and PhNR-OFF components as a 
function of eccentricity. For comparison, the receptive field densities of ON-RGCs (ON-
RGCf) and OFF-RGCs (OFF-RGCf) plotted from the data provided by Watson (2014) are 
shown as blue and grey dashed lines respectively. Cone densities plotted from Curcio et 
al (1990) are also shown as the orange dotted line. (B) Linear regression analysis of 
PhNR density and RGCf density. The equation for the PhNR-ON line is y = 3.0 x 10-5x + 
0.0046; R2 = 0.99, p < 0.0001. The equation for the PhNR-OFF line is y = 2.0 x 10-5x + 
0.0011; R2 = 0.99, p < 0.0001. (C) Estimated response of the PhNR-ON and PhNR-OFF 
contributed by each ON-RGC and OFF-RGC respectively as a function of eccentricity. 
The equation of the PhNR-ON line is y = 0.25x + 3.7161; R2 = 0.86, p = 0.0001. The 
equation of the PhNR-OFF line is y = 0.07x + 2.1377; R2 = 0.50, p = 0.0486. Error bars 
represent 95% confidence intervals. 
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4.3.3 Experiment 2 
The traces of the brief flash ERGs from individual participants are shown in 
Figure 4.6A. All the ERGs recorded with the various stimulus sizes had clearly 
identifiable a-wave, b-wave and PhNR components. The amplitudes of all the 
components increased with stimulus area (Figure 4.7A, Table 4.5) while the 
time-to-peak for the components, except the a-wave, decreased (Figure 4.7B). 
The waveforms of the normalised brief flash ERGs were similar for all stimulus 
sizes except for the full-field, which had a positive going component interrupting 
the descending limb of the b-wave (the i-wave, arrowed) (Figure 4.6B). Similar 
to observations made in the long duration ERG, the proportion of the PhNR 
amplitude to the b-wave amplitude reduced as stimulus area increased. 
 
As observed in the long duration PhNRs, the brief PhNR density was maximal 
at the fovea and declined rapidly towards the periphery (Figure 4.8A). The 
results nearly overlap with Watson’s data in Figure 4.8A. Once again, the cone 
density profile shows poor overlap with the PhNR density profile (Figure 4.8A). 
Linear regression analysis demonstrated a strong relationship between the two 
quantities (R2 = 1.00, p < 0.0001) (Figure 4.8B). The calculated response per 
RGC increased with eccentricity as previously observed for the long duration 
PhNRs. The mean values of the density and response per RGC of the PhNR 
are provided in Table 4.6. 
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Figure 4.6. (A) Group-averaged brief flash ERGs (thick black lines) recorded from 
participants in response to increasing stimulus size (bottom to top). Thin coloured lines 
are the individual traces and dotted lines show the 95% confidence interval. (B) The same 
group-averaged ERGs for each stimulus size which have been normalised to their 
respective b-wave amplitudes. Arrow indicates the positive wavelet (i-wave) on the falling 
phase of the b-wave. 
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Figure 4.7. (A) The amplitudes of the brief flash a-wave, b-wave and PhNR plotted as a 
function of the log of stimulus area. (B) Time-to-peak of the components plotted as a 
function of the stimulus area. The legend in A applies to B. Error bars represent 95% 
confidence intervals. 
 
Table 4.5. Mean values of amplitudes and times-to-peak of brief flash ERG component 
recorded for the different stimulus sizes. 
Stimulus 
Size, deg 
a-wave b-wave PhNR 
Amp, µV Time, msec Amp, µV Time, msec Amp, µV Time, msec 
5 0.59 
+0.34 
21.63 
+3.91 
1.59 
+0.48 
47.80 
+2.71 
2.38 
+0.51 
84.65 
+7.08 
10 0.78 
+0.46 
20.25 
+1.38 
3.24 
+0.95 
44.30 
+2.93 
4.46 
+0.70 
81.53 
+4.73 
15 1.28 
+0.61 
19.58 
+0.80 
5.14 
+1.22 
42.03 
+1.41 
6.81 
+1.03 
77.00 
+4.76 
20 1.44 
+0.59 
19.35 
+0.64 
7.12 
+1.59 
40.15 
+2.19 
9.25 
+1.17 
76.08 
+4.77 
30 2.54 
+0.62 
19.15 
+0.69 
10.39 
+2.54 
38.73 
+2.34 
12.75 
+2.41 
74.13 
+3.16 
60 5.97 
+1.32 
20.60 
+0.68 
23.62 
+4.22 
37.83 
+1.80 
26.51 
+4.18 
74.68 
+4.71 
110 11.60 
+1.38 
20.65 
+0.98 
42.78 
+4.52 
37.03 
+1.92 
46.92 
+5.27 
74.30 
+4.40 
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Figure 4.8. (A) Amplitude density of the brief flash PhNR plotted as a function of 
eccentricity. For comparison, RGCf density plotted from the data provided by Watson 
2014 is shown as the grey dashed line and cone density plotted from Curcio 1990 is 
shown the orange dotted line. (B) Linear regression analysis of the PhNR density and 
RGCf density. The equation of the line is y = 2.0*10-5x + 0.0059, R2 = 0.9965, p < 0.0001. 
(C) Estimated PhNR amplitude contributed by each RGC as a function of eccentricity. 
The equation of the regression line (dotted line) is given by y = 0.128x + 1.8062, R2 = 0.98, 
p < 0.0001. Error bars represent 95% confidence intervals. 
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Table 4.6. Mean values of the response density and response per RGC of the brief flash 
PhNR as a function of eccentricity. 
Eccentricity, deg 
Response Density, 
µV/deg2 (x10-2) 
Response per RCG, 
µV/RGC (x10-5) 
RGCf Density 
1.25 12.01 
+2.63 
1.91 
+0.42 
7211.95 
3.75 3.56 
+0.77 
1.90 
+0.41 
1857.47 
6.25 2.39 
+0.57 
2.60 
+0.61 
917.72 
8.75 1.77 
+0.63 
3.09 
+1.09 
573.29 
12.50 0.99 
+0.42 
3.56 
+1.51 
224.88 
22.50 0.65 
+0.11 
5.06 
+0.90 
139.60 
42.50 0.31 
+0.06 
7.01 
+1.39 
42.77 
Values are given in mean + standardard deviation. NB – the RGC receptive field (RGCf) density 
provided in the last two columns were derived using formulas from Watson 2014. 
 
 
4.4 Discussion 
4.4.1 Changes to ERG Components with Stimulus Size 
This study demonstrated that all the ERG components of the long duration and 
brief flash ERG increased in amplitude with increasing stimulus area. This is 
because the cumulative count of the retinal cells from which these components 
arise increases with retinal area (Osterberg, 1935; Curcio and Allen, 1990; 
Curcio et al., 1990; Drasdo et al., 2007). Previous studies have reported a 
similar increase in the amplitudes of other ERG components (a-wave, b-wave, 
d-wave, flicker ERG) with stimulus size as more neurons are stimulated (Seiple 
et al., 1988; Errico et al., 1990; Junghardt et al., 1993; Murray et al., 2004; 
Jacob et al., 2015). However, the extent of increase was not uniform across 
ERG components (Brindley and Westheimer, 1965; Errico et al., 1990). This 
lack of uniformity was reflected in this study and demonstrated by the changes 
in the waveform and ratios of the ERG components to each other with 
increasing stimulus area. This may be explained by the changes in the relative 
proportions of retinal cells which occur with increasing eccentricity (Curcio and 
Allen, 1990; Curcio et al., 1990; Kolb, 2003; Drasdo et al., 2007; Kolb, 2011). 
For example, in Figure 4.3B, the increase of the b-wave, a bipolar cell 
response, in proportion to the PhNR-ON (or brief PhNR in Figure 4.6B), which 
arises from the RGCs may be explained by the increasing proportion of the 
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bipolar cells to RGCs (or decreasing proportion of RGCs to bipolar cells) with 
eccentricity. This suggests that individual variation in the topography of retinal 
cells in the normal population contributes to the inter-individual variability in 
ERG recordings.  
 
In the long duration ERGs, the emergence of two distinct positive peaks after 
stimulus offset in the 60o and full-field ERGs, not seen in the ERGs produced by 
smaller stimuli, was notable. These peaks are often seen in full-field long 
duration ERGs (Sieving et al., 1994; Viswanathan et al., 1999; Sustar et al., 
2006; Ueno et al., 2006b; Horn et al., 2011). Pharmacological evidence 
attributes the first positive peak to the depolarisation of OFF-bipolar cells after 
stimulus offset while the second positive peak is attributed to depolarisation of 
cones after stimulus offset (Sieving et al., 1994; Ueno et al., 2006b). As the 
timing of the d-wave peak of the smaller stimuli (5.5o – 45o) more closely 
matched the timing of the second peak in the larger stimuli (60o and full-field), it 
suggested that the cellular origins of the focal d-wave and those of the full-field 
d-wave (i.e. the first peak) were not the same; the focal d-wave may be 
dominated more by cone responses than OFF-bipolar cells. This implies that 
the cellular contributions to the focal ERG components are not the same for full-
field ERGs. In other words, the focal ERG is not necessarily a scaled down 
version of the full-field ERG. 
 
It was further observed that the times-to-peak of the ERG components generally 
tended to decrease with increasing stimulus sizes. The exceptions were the a-
wave time-to-peak which appeared constant and the PhNR-OFF which 
appeared to increase. The decrease in the time-to-peak of the ERG 
components could be due to increasing amplitude of the ERG components and 
convergence of first order neurons onto second and third order neurons; 
however, the exact mechanism could not be ascertained. It was also not clear 
why the PhNR-OFF peak time showed an increase with stimulus size, however, 
it appeared the additional positive peak after stimulus offset seen to emerge as 
the stimulus size got bigger (Figure 4.3B) may have contributed to this.  
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4.4.2 PhNR Density and Retinal Eccentricity 
Another key finding in this study was the strong relationship between the 
distribution of the response densities of the PhNRs (PhNR-ON, PhNR-OFF and 
brief PhNR) and the reported RGCf density (Watson, 2014) with increasing 
eccentricity. The mean densities of all the PhNRs were highest at the fovea and 
declined with eccentricity similar to the pattern reported for the RGCf. This 
result in itself is insufficient to link the PhNR to the RGCs since it is possible to 
obtain similarly strong relationships between the RGCf density and the other 
photopic ERG components. This is essentially because the neurons eliciting 
these responses are all denser in the central than peripheral retina. In fact, 
Errico et al (1990), compared the density profile of the negative going so-called 
“PIII” following the b-wave (now identified as the PhNR-ON) to cone density 
profile and erroneously attributed the component to cones. However, the results 
in Figure 4.5A and 4.8A, showed that the cone density profile derived from data 
from Curcio et al (1990), unlike the RGCf profile, was a poor fit for the long and 
brief PhNRs density profiles. This deviation lends support to the notion that the 
PhNR primarily arises from RGCs rather than cone photoreceptors. 
Furthermore, pharmacological evidence and diseases that selectively impinge 
on RGC function show that the PhNR is essentially an RGC response 
(Viswanathan et al., 1999; Viswanathan et al., 2000; Gotoh et al., 2004; 
Rangaswamy et al., 2004; Ueno et al., 2006a; Miyata et al., 2007; Machida et 
al., 2008b; North et al., 2010).  
 
Finally, this study attempted to estimate the PhNR amplitude produced by a 
single RGC on the basis of ERG recordings. The results suggested that the 
response of an RGC increases with eccentricity. In the long duration ERG, the 
ON-RGC response (PhNR-ON) showed about a threefold increase from 
approximately 4 x 10-5µV per cell at the fovea to 14 x 10-5uV per cell in the 
periphery, while the OFF-RGC response (PhNR-OFF) per cell for the PhNR-
OFF showed a twofold increase from approximately 3 x 10-5µV per cell to 6 x 
10-5µV per cell. The brief PhNR (assumed to be the response from the total 
RGC population) showed about a threefold increase from 2 x 10-5µV to 7 x 10-5 
µV.  
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The increase in response per cell with eccentricity, may be directly related to 
the increase in the dendritic field and/or cell size of the RGCs which also 
increases with eccentricity (Rodieck et al., 1985; Watanabe and Rodieck, 1989; 
Silveira and Perry, 1991; Dacey and Petersen, 1992; Dacey, 1993b; Yamada et 
al., 1996). For the range of eccentricities examined in this study (i.e. 1o – 45o ~ 
0.3 mm – 12 mm), morphometric data from previous studies showed that the 
soma sizes of midget and parasol ganglion cells each increase approximately 
by a factor of two (Rodieck et al., 1985; Watanabe and Rodieck, 1989). 
Dendritic field diameter, on the other hand, increases about 20 to 40 fold for 
midget ganglion cells and 10 fold for parasol ganglion cells (Rodieck et al., 
1985; Watanabe and Rodieck, 1989; Dacey and Petersen, 1992; Dacey, 
1993b). The increase in PhNR amplitude per RGC with eccentricity therefore 
appears to be more closely related to soma size than to dendritic field size. 
 
Although the increase in response per cell was statistically significant, the 
graphs (Figure 4.5C and 4.8C) showed considerable variations between 
individuals suggesting that large differences may exist in the output of cells 
among individuals. While this may be the case, it is possible that some of the 
variation in the data may be an artefact of the method of calculation used in this 
study as explained below. There are wide variations in the topography of RGCs 
in the normal population (Curcio and Allen, 1990; Drasdo et al., 2007). These 
variations are closely linked to the axial length and size of the eye, which both 
vary in the normal population (Grosvenor, 2007; Read et al., 2008; Hashemi et 
al., 2012). In this study, these individual variations in RGC distribution were not 
accounted for. Instead the mean values of RGC distribution reported by one 
study were used. In Experiment 1, the dichotomy of ON and OFF RGCs in 
addition to the low number of participants could therefore artificially increase the 
variability. A similar argument would apply in Experiment 2, however, the effect 
of the artefact is expected to be less since the ON/OFF dichotomy was avoided 
and a larger sample size was used. 
 
Another possible explanation for the observed increase in the response per cell 
with eccentricity is related to the generation of the PhNR component. The RGCs 
are considered as the primary generators of the PhNR, however, there is 
evidence to show that the photoreceptors, amacrine cells, Muller and other glial 
Chapter 4 
147 
 
cells contribute to the PhNR amplitude (Bush and Sieving, 1994; Viswanathan 
et al., 1999; Machida et al., 2008a; Luo and Frishman, 2011; Thompson et al., 
2011). Therefore, it may well be that all RGCs generate the same magnitude of 
response regardless of location, but that the larger amplitudes recorded with the 
larger stimuli (from which response per cell was highest) may have been 
boosted by other eccentricity based factors such as increasing convergence 
(e.g. more photoreceptors than RGCs) and lateral interaction of RGCs. This 
study was however, not designed to assess the impact of these confounding 
factors and further research is required to address them. Nevertheless, as 
previously mentioned, RGCs exhibit central to peripheral asymmetries in both 
structure and function. The findings from this study therefore appear to be in 
consonance with this characteristic of RGCs.  
 
4.4.3 PhNR-ON and PhNR-OFF Asymmetry 
With regards to the long duration ERG, the mean amplitude of the PhNR-ON 
was larger than that of the PhNR-OFF for all the stimulus sizes tested (Table 
4.3). The PhNR-ON amplitude was ~50% greater than the PhNR-OFF 
amplitude for the 5.5o and 10o stimulus sizes. For the remaining sizes, the 
PhNR-ON amplitude was 75 – 100% greater than the PhNR-OFF amplitude. 
Ganglion cell counts in the human retina, however, show that ON- and OFF-
centre RGCs are equal up to 5o eccentricity, from which point OFF-centre 
RGCs gradually outnumber ON-centre RGCs (ON: OFF ratio from 0 – 5o = 1:1; 
from 5 – 25o = 1:1 to 1:1.69; and beyond 25o = 1:1.69) (Dacey, 1993b; Drasdo 
et al., 2007) (See also Table II.4 in Appendix II). Since ERG responses are 
proportional to cell numbers, this appears to contradict the fact that there are 
more OFF-centre RGCs than ON-centre RGCs in the human retina (Dacey, 
1993b; Drasdo et al., 2007). It may, however, be argued that ON-centre RGCs 
have certain larger anatomical features (e.g. soma size, dendritic field, axon 
diameter) (Dacey and Petersen, 1992; Dacey, 1993b) and larger physiological 
responses (Chichilnisky and Kalmar, 2002; Maturana et al., 2014) than their 
OFF-centre counterparts that predict greater electrophysiological responses 
from ON-centre RGCs. Yet, the anatomical and functional data from the above 
listed previous studies predict ON-OFF asymmetries of 10 – 50% in favour of 
ON-centre RGCs. Since the asymmetries in this study exceed this prediction, 
other factors have to be considered and are addressed later in this section. 
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The results from this study further suggested that the PhNR-ON amplitude per 
cell was ~50% larger than the PhNR-OFF for the 5.5 and 10o annuli (computed 
from Table 4.4). However, for annuli >15o the PhNR-ON response per cell was 
larger by 100% or more than the PhNR-OFF response. In comparison, 
anatomical data shows that soma sizes of human ON midget ganglion cells are 
no more than 10% greater than that of their OFF midget counterparts (Dacey, 
1993b). (Data for parasol ganglion cell not available, but expected to be similar). 
The dendritic fields of human ON-centre parasol and midget cells are 30-50% 
larger in diameter than their OFF-centre counterparts (Dacey and Petersen, 
1992). As noted previously, the known anatomical and/or functional differences 
between ON- and OFF-centre RGCs may therefore not account completely for 
the larger asymmetry in the PhNR-ON to PhNR-OFF response per cell at 
eccentricities greater than 5o. 
 
It is presently difficult to account for the larger asymmetry recorded between the 
PhNR-ON and –OFF recorded in this study in comparison to the known 
anatomical and functional asymmetry between ON and OFF-centre RGCs. A 
possible factor however, may be related to the generation of the PhNR-ON and 
PhNR-OFF components. As mentioned earlier, other retinal cells apart from the 
RGCs are known to contribute to the components. It is possible that these non-
RGC cells do not contribute equally to the PhNR-ON and PhNR-OFF 
components thus enhancing the asymmetries in the PhNR-ON and PhNR-OFF 
components.  
 
4.4.4 Clinical and Research Implications 
The findings of this study have clinical and research implications. Currently, 
ISCEV recommends the full-field brief ERG as the standard for clinical use. This 
study, however, suggests that the use of the full-field stimulus may not be the 
best since the degree to which the PhNR amplitude is reduced is dependent on 
the location of the lesion. The functional loss in peripheral RGCs would have a 
greater impact on the PhNR amplitude than a functional loss of similar 
magnitude in the central RGCs. In other words, retinal lesions affecting the 
central RGCs need to be large or extensive to produce significant reductions in 
the full-field PhNR amplitudes. This has been noted in other studies (Tamada et 
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al., 2009; Machida et al., 2011; Kiszkielis et al., 2012). ERGs should therefore 
be recorded with consideration to the locus of the disease.  
 
 
4.5 Conclusion 
This study showed that the PhNR of the brief flash ERG, as well as the PhNR 
ON and PhNR-OFF of the long duration ERG, increased in amplitude with 
increasing stimulus area reflecting the number of RGCs stimulated. The strong 
relationship between PhNR density and RGCf density supports previous 
findings that the PhNR reflects activity of RGCs and that it is possible to use 
ERG PhNR recordings to determine RGC distribution within the retina. Finally, 
this study suggests that the contribution of a single RGC to the PhNR amplitude 
depends on its eccentricity as well as its morphological and intrinsic 
physiological characteristics.  
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 CHAPTER FIVE – ELECTROPHYSIOLOGICAL 
ASSESSMENT OF RETINAL FUNCTION IN 
AUTOSOMAL DOMINANT OPTIC ATROPHY – I: 
GENERAL METHODOLOGY AND RESULTS OF 
BASELINE TESTS 
 
 
5.1 Preamble 
The next three chapters (Chapters 5 – 7) constitute the main study of this PhD. 
This chapter reiterates the rationale and aims of the main study. The participant 
selection criteria, general methodology and results of baseline tests (i.e. visual 
acuity, contrast sensitivity, visual field sensitivity, peripapillary retinal nerve fibre 
layer thickness and macula thickness) are also described. In Chapter 6, the 
results of the electrophysiological assessment are presented and discussed. 
Finally, the correlations between the baseline tests and the electrophysiological 
assessments are presented and discussed in Chapter 7. Part of the data 
presented in Chapters 5 and 6 have been published (see Morny, et al., 2015 in 
Appendix VI 
 
 
5.2 Introduction 
Autosomal dominant optic atrophy (ADOA) is a hereditary optic neuropathy 
presenting in the first or second decade of life and characterised by bilateral 
optic nerve head pallor and loss of visual function including reduced visual 
acuity, centro-coecal visual field loss and colour vision defects (Votruba et al., 
1998a; Votruba et al., 1998b; Votruba et al., 2003b; Newman and Biousse, 
2004; Yu-Wai-Man et al., 2009). It is the commonest hereditary optic 
neuropathy with a prevalence between 1 in 50,000 to 1 in 8,000 (Krill et al., 
1970; Kjer et al., 1996; Votruba et al., 2003a; Yu-Wai-Man et al., 2010a; Gallus 
et al., 2012; Lenaers et al., 2012). ADOA is caused primarily by mutations in the 
autosomal nuclear gene, OPA1 (Alexander et al., 2000; Delettre et al., 2000; 
Ferre et al., 2005; Ferre et al., 2009; Yu-Wai-Man et al., 2010a), a key player in 
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mitochondrial dynamics, controlling mitochondrial fusion, amongst other key 
roles.  
 
Figure 5.1. Selective dendritic pruning of ON-centre RGCs in Opa1 deficiency. Examples 
of ON- and OFF-centre RGCs from an adult (10-month-old) wild-type mouse showing 
their normal dendritic arbours (A and B respectively). Scale bar = 25 µm. The dendrites of 
ON-centre RGCs ramify in sublamina b (close to the level of the cell body) and the 
dendrites of OFF-centre RGCs ramify in sublamina a (close to the inner nuclear layer). 
Total dendritic length is reduced in the ON-centre RGCs of 10- to 15-month-old and >20-
month-old mice (C) while remaining statistically unchanged in OFF-centre RGCs. 
P = Student’s t-test, %Δ = percentage change from wild-type. GCL = ganglion cell layer; 
IPL = inner plexiform layer (Williams et al. 2010). (This figure is the same as Figure 1.13) 
 
Histopathological studies in humans (Johnston et al., 1979; Kjer et al., 1983) 
and mouse models (Alavi et al., 2007; Davies et al., 2007; Williams et al., 2010; 
Sarzi et al., 2012) show that ADOA is principally characterised by the 
degeneration of the retinal ganglion cells (RGC). In a mouse model of ADOA, 
previously generated in our laboratory of this (Davies et al., 2007), the defect 
was first evident as a dendritic pruning of RGCs in B6:C3-Opa1Q285STOP Opa1 
mutant mouse which appears to be ON-centre specific (Williams et al., 2010; 
Williams et al., 2012). The mean dendritic field area and mean dendritic length 
was reduced in ON-centre RGCs, but not OFF-centre RGCs, of 10- to 20-month 
mutant mice compared with age-matched wild-type controls (Figure 5.1).  This 
selective vulnerability of ON-centre RGCs may reflect their higher energy 
demands in comparison to their OFF-centre counterparts, since OPA1 
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mutations are thought to curtail mitochondrial energy output (Williams et al., 
2010; Williams et al., 2012). This new finding has, however, not been 
investigated in humans with ADOA. 
 
The functional integrity of RGCs can be evaluated by assessing the photopic 
negative response (PhNR) of the flash ERG. The PhNR is a negative potential 
seen after the b-wave in a photopic ERG elicited by a brief flash. The PhNR is 
believed to originate from spiking activity in RGCs and their axons, with 
contributions from amacrine cells and associated glial cells like the astrocytes 
and Muller cells (Viswanathan et al., 1999; Viswanathan et al., 2000; 
Viswanathan et al., 2001; Rangaswamy et al., 2007; Thompson et al., 2011). 
When a long duration flash (>50 msec) is used to evoke the ERG, the PhNR is 
seen once after the b-wave (PhNR-ON) and again as a negative going potential 
after the d-wave (PhNR-OFF).  
 
The brief flash PhNR is attenuated in patients with ADOA (Miyata et al., 2007) 
and in the Opa1Q285STOP mutant mouse (Barnard et al., 2011). In the mouse 
model, the defect is seen prior to reduction in optokinetic visual acuity and to 
dendritic pruning which suggests that retinal connectivity may be affected 
before currently identifiable morphological abnormalities occur (Williams et al., 
2012). Miyata et al (2007) and Barnard et al (2011) highlight the diagnostic 
potential of the PhNR in ADOA, however, the investigators used a brief white 
flash (broadband stimulus) to evoke the PhNR, which provides a poor signal to 
noise ratio compared to monochromatic stimuli (Rangaswamy et al., 2007), and 
cannot distinguish ON and OFF components (Viswanathan et al., 1999; Sustar 
et al., 2006; Rangaswamy et al., 2007). Furthermore, the studies elicited full-
field (global) PhNRs which, in contrast to the focal PhNR, are less sensitive in 
detecting focal retinal lesions such as those seen in early to moderate 
glaucoma (Tamada et al., 2009; Machida et al., 2011).  
 
Clearly, the delineation of the PhNR-ON and PhNR-OFF components by long 
duration red flash provides an opportunity to test the functional integrity of these 
two classes of RGCs in ADOA. In addition, the use of a focal ERG, rather than 
the full field ERG might be more appropriate in ADOA given the focal nature of 
the abnormality (Votruba et al., 1998a). It is possible that the focal PhNR-ON 
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deficit could serve as a bio-marker for the early onset of ADOA. If such early 
changes in RGC function are reversible, they need to be defined as markers for 
targeted therapies in any forthcoming therapeutic trials.  
 
The main aim of this study, therefore, was to assess the effect of ADOA on the 
PhNR-ON and PhNR-OFF components elicited using focal and full-field long 
duration red flashes on a rod supressing blue background. On the basis of the 
evidence in mice, it was hypothesised that a selective reduction of the PhNR-
ON in humans would be seen early in the disease with a progressive decrease 
in the PhNR-ON amplitude as the disease progressed. Hence, the ratio of the 
PhNR-ON to PhNR-OFF would also decrease with disease progression. 
 
The specific objectives and their respective hypotheses are presented below.  
1. To record focal long duration ERGs and PERGs from the central, nasal 
and temporal macula in order to assess regional differences in the focal 
PhNRs and PERG components between and within the ADOA and 
control cohorts.  
 
Hypotheses: In healthy individuals, RGC density is greatest in the central 
macula and in addition, greater in the nasal macula than in the temporal 
macula at equal eccentricities. This led to the hypothesis that in controls, 
the amplitudes of the focal PhNRs and N95 would be greatest in the 
central macula, followed by the nasal macula and least in the temporal 
macula.  
 
ADOA is typically characterised by central and centrocoecal scotomas. 
This supported the hypothesis that a greater difference in ERG 
parameters between participants with ADOA and controls would be seen 
in the central and nasal macula than in the temporal macula. A further 
hypothesis was that, as the disease progressed in participants with 
ADOA, the PhNR and N95 amplitudes would decrease more in the 
central and nasal macula than in the temporal macula, resulting in the 
loss of the asymmetry between the locations (found in controls) or a 
reversal of this asymmetry (i.e. focal PhNR and N95 amplitudes would be 
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greater in the temporal than in the central and nasal macula) in the 
ADOA cohort. This would be clinically useful since the temporal macula 
of an individual could serve the control. 
 
2. To compare the focal long duration ERG to the full-field long duration 
ERG which have been recorded using the same stimulus parameters.  
 
Hypothesis: The distribution of RGCs in the normal retina is densest in 
the macula and progressively sparse with increasing eccentricity. In 
Chapter 4, the results showed that the contribution of the PhNR-ON and 
–OFF components to the long duration ERG decreased with increasing 
eccentricity. It was therefore hypothesised that there would be a greater 
contribution of PhNR-ON and –OFF components in the focal ERG than in 
the full-field ERG. In addition, it was hypothesised that the amplitude loss 
of the PhNRs in the focal ERG would be greater than in the full-field ERG 
due to the localised/centro-coecal nature of visual field defects in ADOA. 
 
3. To compare the diagnostic potential of the long duration PhNR to 
responses which have previously been shown to be affected by ADOA; 
the full-field brief flash PhNR (Miyata et al., 2007; Barnard et al., 2011) 
and the N95 amplitude of the pattern electroretinogram (PERG) (Holder 
et al., 1998),  
 
Hypothesis: It was hypothesised that the diagnostic power of the long 
duration PhNRs would be similar to that of the brief flash PhNR and the 
N95 of the PERG as all of these responses reflect the spiking activity of 
the RGCs (Viswanathan et al., 1999; Viswanathan et al., 2000; Luo and 
Frishman, 2011). 
 
4. To assess the effect of ADOA on retinal thickness measured using the 
OCT. 
 
Hypothesis: A reduction in the retinal thickness especially of the inner 
retina was predicted in ADOA 
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5. To assess the relationship between the results of the 
electrophysiological, psychophysical and structural tests obtained in this 
study. 
 
Hypothesis: It was hypothesised that tests that provide similar 
information about the retina would be well correlated e.g. RGC layer 
thickness and PhNR amplitude.  
 
6. To assess the effect of age on the electrophysiological parameters 
measured in this study in ADOA and controls. 
 
Hypothesis: Previous studies have shown that the rate of RGC loss with 
age appears constant in both ADOA and controls (Barboni et al., 2011). 
However, it has also been suggested that individuals with ADOA may 
have a reduced complement of RGCs from birth (Barboni et al., 2010). It 
was therefore hypothesised that due to the reduced redundancy of 
neurones in ADOA, the age related changes would have a greater effect 
on function in participants with ADOA than in controls. This is important 
since previous attempts to correlate disease severity (visual dysfunction 
using VA) with age have been equivocal. Some studies (Berninger et al. 
1991; Yu-Wai-Man et al. 2010a; Reis et al. 2013) have reported a 
progressive visual loss with age, while other studies (Votruba et al. 
1998a; Cohn et al. 2008; Almind et al. 2012; Ronnback et al. 2013) did 
not find a significant change in VA with age.    
 
 
5.3 Methods 
5.3.1 Ethical Approval 
This cross-sectional study had a multi-centre ethics approval from the National 
Health Service Research Ethics Committee for Wales. The study was carried 
out mainly at the School of Optometry and Vision Sciences, Cardiff University, 
Cardiff (Cardiff site), however, a second site was later set up at the Division of 
Optometry and Visual Science, City University, London (City site). Ethical 
approval was therefore obtained from the ethics committees of the School of 
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Optometry and Vision Sciences, Cardiff University, and the Division of 
Optometry and Visual Science, City University, London. All participants 
provided their written consent after receiving a participant information sheet and 
having the opportunity to ask questions. This study conformed to the 
Declaration of Helsinki. 
 
5.3.2 Sample Size and Power Calculations 
Miyata et al (2007) observed a difference in PhNR amplitude of 13.3µV between 
people with ADOA and healthy controls and a standard deviation of 9µV within 
healthy controls. Hence the computed standardised difference was 1.48. Using 
the nomogram provided by Altman (Altman, 1991), to detect this difference with 
80% power at a significance level of 0.05 required a total sample size of 14 
participants (7 per group) (See Appendix III).  
 
This sample size was small and as a substantial body of data was collected 
requiring a full day of attendance, the aim was to recruit as many participants as 
possible. The additional participants allowed the sample size requirements to be 
met in the case of incomplete datasets or participant dropout.  
 
5.3.3 Inclusion and Exclusion Criteria 
The inclusion and exclusion criteria used to select participants with ADOA and 
controls for this study are summarised in Table 5.1 and 5.2. 
 
Table 5.1. Inclusion criteria for participants 
CRITERION ADOA CONTROLS 
Age Adults 18 years and above Same as for ADOA 
Gender Male and female Same as for ADOA 
Visual acuity Better than or equal to 2.0 
logMAR (1/100 Snellen) in better 
seeing eye 
Better than or equal to 0.1 
logMAR (6/7.5 Snellen) in better 
seeing eye 
Mutation OPA1 mutation confirmed or 
member of family with confirmed 
OPA1 mutation 
Not applicable 
 
  
Chapter 5 
157 
 
Table 5.2. Exclusion criteria for participants  
CRITERION ADOA CONTROLS 
Medications  Medications that affect visual 
function 
Medications that affect visual 
function 
Pre-existing 
systemic 
condition 
Photosensitive epilepsy and any 
systemic disease affecting vision 
(e.g. uncontrolled diabetes) 
Photosensitive epilepsy and any 
systemic disease affecting vision 
(e.g. uncontrolled diabetes) 
Pre-existing 
ocular 
condition 
Significant ocular conditions 
except ADOA (e.g. glaucoma, 
age related macular 
degeneration with 1 or more risk 
factors on Age Related Eye 
Disease Study (AREDS) Scale 
(Ferris et al., 2005)) 
Significant ocular conditions 
(e.g. glaucoma, age related 
macular degeneration with 1 or 
more risk factors on Age 
Related Eye Disease Study 
(AREDS) Scale (Ferris et al., 
2005)) 
 
 
5.3.4 Participant Recruitment 
Twelve participants from six families with documented OPA1 mutations (Table 
5.4) and sixteen healthy age matched controls were recruited for the study. All 
participants with ADOA, except Patient 1021, were recruited from a database of 
patients nationwide who had been formally diagnosed by a single consultant 
ophthalmologist (MV). Participants were first contacted over the telephone in 
cases where a telephone number was available. A recruitment letter and 
participant information sheet were then sent out if the participant showed 
interest. In cases where a telephone contact was not available, the letters were 
sent out to the last known address of the participants.  
 
Patient 1021 contacted this research group and agreed to participate in the 
study after he had been diagnosed with subclinical ADOA by a different 
consultant ophthalmologist at a different facility. Patient 1021 had been 
diagnosed after his 8 year old daughter was diagnosed with classical signs of 
ADOA. Genetic testing at the same facility confirmed he and his daughter both 
carried the same OPA1 mutation. The data from the five members of Family E 
were first obtained at the City Site, however, two members (1018 and 1020) 
later travelled to Cardiff to re-record their ERGs.  
 
The participants who acted as controls were recruited from staff and students of 
the School of Optometry and Vision Sciences, including their friends and family. 
All the data from controls were obtained at the Cardiff Site.  
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5.3.5 Visual Acuity 
The best corrected visual acuity (BCVA) of participants was recorded 
monocularly using an ETDRS chart at 4m (Ferris et al., 1982; Ferris and Bailey, 
1996). The distance was reduced when necessary. The ETDRS charts are 
based on the design principles of Bailey and Lovie (Bailey and Lovie, 1976) and 
are the recommended standard in clinical research (Ferris and Bailey, 1996).  
Patients were encouraged to guess letters they could not see clearly until they 
made three or more errors on a line (Carkeet, 2001; Elliot, 2007). In all cases, 
the right eye was assessed before the left eye.  
 
5.3.6 Contrast Sensitivity 
Contrast sensitivity (CS) was measured monocularly using the Pelli-Robson CS 
chart at 1m (Pelli et al., 1988; Elliot, 2006; Elliot, 2007). The mean luminance of 
the chart was 477 cd/m2 and participants wore their habitual distance correction 
as required for this test.  
 
5.3.7 Autorefraction 
Refraction was assessed objectively for each eye using an auto-refractor (KR-
7500 Auto-kerato-refractometer, Topcon, Tokyo). At least three individual 
objective refractions for each eye were obtained and mean sphero-cylinder 
refraction was recorded. 
 
5.3.8 Visual field Assessment 
Visual field sensitivity (VFS) was assessed using the 24-2 SITA fast protocol of 
the Humphrey Visual Analyser (24-2 SITA-FAST, Humphrey Visual Field 
Analyser, Carl Zeiss Meditec, Inc., Dublin, CA, USA). This protocol assesses 
VFS 24o either side of the fovea and provides the mean deviation scores, in 
decibels (dB) on a 54 point grid (Figure 5.2). However, only the 16 points on the 
total deviation plot (boxed area of Figure 5.2) corresponding to an 18o x 18o 
area on the retina were used for the analysis described in this study. The total 
deviation score at each point on the visual field test report is expressed on a 
logarithmic scale (10dB = 1 log unit). Therefore, to calculate the mean deviation 
(i.e. average of the total deviation scores) of the 16 locations, total deviation 
scores were first converted into a linear scale and averaged (Hood and Kardon, 
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2007; Hood et al., 2009). The mean deviation value was then obtained by 
converting the linear average back to a dB value.  
  
 
Figure 5.2. The total deviation plot of one of the control participants in this study. The 
mean deviation of visual field sensitivity was calculated from the central 16 points (boxed 
area). 
 
5.3.9 Colour Vision 
Colour vision was assessed monocularly using the L’Anthony desaturated D15 
(DS-D15) test. All colour vison tests were performed in a light box with artificial 
daylight bulb of illumination 615 Lux (Artificial Daylight Bulb, 20 W, Thorn). The 
order in which the coloured caps were arranged was recorded on the D-15 
score sheet to determine the axis of confusion as recommended (Elliot, 2007). 
The pass criterion was a circular diagram and no more than a single 
transformation between adjacent caps (Birch, 2008).  
  
5.3.10 Imaging 
OCT images were obtained using a Topcon 3D-1000 OCT machine (Topcon 
Medical Systems, Inc., Tokyo, Japan) at the Cardiff site and a Topcon 3D-2000 
machine (Topcon Medical Systems, Inc., Tokyo, Japan) at the City University 
site. Cube scans (6mm x 6 mm = 512 horizontal x 128 vertical scans) were 
recorded from both optic nerve head and macula of participants. These were 
exported and analysed offline using the Iowa Reference Algorithm OCT 
Explorer Version 3.6 (Garvin et al., 2008; Garvin et al., 2009; Lee et al., 2010).  
 
The OCT Explorer is able to analyse scans from the Topcon 3D OCT which are 
recorded in an *.fds format. This setting was not activated on the Topcon at the 
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London site at the time the OCT images were recorded for this study. Attempts 
were made to segment the images from City using an alternative third party 
software (ImageJ), however, this proved unsuccessful. As such only the images 
recorded from the Cardiff site (n = 6) could be used in this analysis.  
 
5.3.11 Image Segmentation and Analysis 
The Iowa Reference Algorithm OCT Explorer, hereafter referred to as “OCT 
Explorer”, is a suite of algorithms for quantitative analysis of human and murine 
3-D retinal OCT images. The OCT Explorer is compatible with OCT image data 
obtained from all widely-available clinical OCT machines including Heidelberg 
Spectralis and Topcon 1000 and 2000. The OCT Explorer is capable of 
automatically identifying up to 11 surfaces on retinal images as well as 
providing thickness and volume measurements for each identified layer (Figure 
5.3).  
 
 
Figure 5.3. (A) A screenshot of the macula of a participant in this study showing the 
layers segmented by the OCT Explorer (coloured lines). (B) An enlarged section of the 
macula in (A) above showing the labelled layers. (C) The enface view of the macula. The 
macula was divided into three circular zones using an ETDRS grid (superimposed). The 
diameters of the circles (innermost to outermost) are 1, 3 and 6mm. S – superior, N – 
nasal, I – inferior, T - temporal 
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In this study, macula scans were segmented into the nine layers: retinal nerve 
fibre layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner 
nuclear layer (INL), outer plexiform layer (OPL), photoreceptor layer and retinal 
pigment epithelium (RPE) (Figure 5.3B). Each layer was then divided into nine 
sectors using the Early Treatment Diabetic Retinopathy Study (ETDRS) grid. 
The mean thickness was calculated for each sector. Measurements from the 
innermost ring for RNFL and GCL were not included in the analysis since RGCs 
and their cell bodies in this area are displaced centrifugally.  
 
The thickness of the peripapillary RNFL was measured using a circular scan 
(1.73mm diameter) centred on the optic nerve head (Figure 5.4). The circle was 
divided into four quadrants to assess the superior, temporal, inferior and nasal 
quadrants.  
 
 
Figure 5.4. A screenshot of the optic nerve head (right eye) of a control participant as 
seen on the OCT Explorer. The peripapillary thickness was measured along the blue 
circle and divided into quadrants as shown by the red dashed lines. S – superior, N – 
nasal, I – inferior, T - temporal 
5.3.12 Electroretinography  
All ERGs were recorded monocularly using DTL fibre electrodes as the active 
electrode (Unimed Electrode Supplies, Ltd, Surrey, UK) and contralateral 
reference electrode. The DTL fibre was placed in the lower fornix to maximise 
stability during recording and the loose end fastened using medical tape at the 
inner canthus (Blenderm, Viasys Healthcare Ltd., Warwick, UK). A silver-silver 
chloride 10mm diameter touch-proof skin electrode (Unimed Electrode 
Supplies, Ltd, Surrey, UK), placed at the mid-frontal forehead position was used 
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as ground electrode. (The procedure for preparing participants for ERG 
recordings and the details of the equipment for recording the focal ERG have 
been presented in section 2.2.2 – 2.2.6) 
 
All ERG responses were obtained using an evoked potential monitoring system 
(Medelec EP, Oxford Instruments PLC, Surrey, UK [Cardiff site]; Espion, 
Diagnosys LLC, Cambridge, UK [City site]). Responses were bandpass filtered 
from 1 – 100 Hz and digitally averaged. Signals were recorded in blocks of 10 - 
20 responses, with a total of 40 – 60 averaged per trace. Between 4 and 6 
traces were obtained for each stimulus condition. The traces were 
superimposed to confirm signal repeatability and averaged off-line into a single 
averaged trace containing 160 – 300 responses. An automatic artefact rejection 
system removed signals contaminated by large eye movements and blinks.  
 
Transient PERG stimuli (4 reversals per second; check size = 1o) were 
generated on a computer monitor at 98% contrast. The screen was masked 
with a black opaque cardboard with a 13 x 13 cm square cut-out at the centre 
so that it produced a 20o x 20o field at a viewing distance of 36cm.  
 
Long duration ERGs were recorded at both sites using a red flash stimulus 
(peak output 660nm, 250msec duration, 55 cd/m2, 2Hz) on a rod saturating blue 
background (peak output 469nm, 80 scot cd/m2) produced by a hand-held 
miniature Ganzfeld light emitting diode (LED) stimulator (CH Electronics, Kent, 
UK).  Focal stimulation was produced by mounting the miniature Ganzfeld LED 
tube into the middle of a light box (44 cm x 44 cm x 10 cm) such that the circular 
stimulus subtended 20o diameter at a viewing distance of 15.6 cm. In order to 
minimise the effect of stray light stimulating the peripheral retina, the light box 
contained a strip of white LEDs (Super Bright InGan) passed through a blue 
filter (Lee Filter 068 Sky Blue, Lee Filters, Hampshire, UK) to produce a 
desensitising blue surround of 140 scot cd/m2 (field size = 109o x 109o field). 
The stimulus configuration for recording from the central, nasal and temporal 
macula was described in section 2.6.2. To test the central macula, the 
participant fixated on the cross hairs in the middle of the stimulus; to test the 
nasal macula, the stimulus was moved temporally until the nasal edge of the 
stimulus was aligned to the participant’s line of sight gaze; to record from the 
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temporal macula, the procedure for nasal macula was reversed. Full-field ERGs 
were recorded by holding the stimulator head, fitted with a diffusing cap, directly 
to the eye. 
 
Full-field brief (flash) ERGs were elicited at the Cardiff site by a Ganzfeld 
stimulator (GS2000, LACE Elettronica, Italy) presenting a xenon flash stimulus 
(1.51 cd.s/m2, 300 µsec maximum flash duration, 4Hz). Filters were used to 
obtain a red stimulus (Lee Filter “Terry Red”, Lee Filters, Hampshire, UK, 
transmittance <5% at wavelengths shorter than 575 nm, and above 85% from 
625–700 nm) over a continuous rod saturating 64 scot cd/m2 blue background 
(Schott Glass filter BG28, Schott AG, Mainz, Germany, peak transmittance 454 
nm).  
 
All ERGs were recorded by the same investigator using the same protocol at 
both sites. PERGs were always recorded first and as recommended, with 
natural pupils and appropriate near refractive correction when necessary (Bach 
et al., 2013). Pupils were then dilated using 1% tropicamide to a minimum of 
7mm and flash ERGs were recorded in the following order: focal long-duration, 
full-field long duration and full-field brief flash ERG. The entire session for 
collecting data from each participant was between 4 – 5 hours including breaks 
which were incorporated to relieve fatigue. The recording protocol is provided in 
Appendix IV. 
 
The long duration ERGs (focal and full-field) were generated by the same 
miniature Ganzfeld LED stimulator at both sites. However, the computer monitor 
for generating the PERG stimuli and the stimulator for the full-field brief flash 
available at the City site were different. They produced waveforms which were 
different to the ones obtained at the Cardiff site. As such, these recordings were 
not analysed.  
 
All stimulus backgrounds were of sufficient scotopic illuminance (> 2000 scot td) 
to saturate the rods (Aguilar and Stiles, 1954). All stimuli were calibrated using 
an ILT 1700 radiometer with SED033/Y/R luminance detector (Able Instruments 
and Controls, Reading, UK) assuming a 7 mm pupil with no correction for the 
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Stiles-Crawford effect. The wavelength of the light sources was measured using 
a Specbos 1201 spectro-radiometer (Horiba Jobin Yvon Ltd, Middlesex, UK). 
 
5.3.13 Signal Analysis 
The method for measuring the amplitude of the various ERG sub-components is 
described in Figure 5.5. PERGs and focal ERGs were Fourier analysed to 
remove high frequency noise above 30Hz and 50Hz respectively.  
 
 
Figure 5.5. Representative traces of the (A) PERG, (B) full-field long-duration ERG and (C) 
full-field brief flash ERGs showing their components and how their amplitudes were 
measured (double headed arrows). The amplitudes of the P50, N95 (A) and b-wave (B-C) 
were measured as recommended by the International Society of Clinical 
Electrophysiology of Vision (ISCEV) (Marmor et al., 2009; Bach et al., 2013). The a-wave 
was measured from the point of light onset to the trough of the a-wave while the d-wave 
amplitude was measured from the point of light offset to the peak of the d-wave. The 
PhNR-ON (PhNR in brief flash) and PhNR-OFF amplitudes were measured from the 
voltage at stimulus onset and offset respectively to a fixed time point in their respective 
troughs (see main text for details). The focal long duration ERG had the same profile as 
the full-field long duration except that in the focal ERG there was only one prominent 
positive peak after light offset, the d-wave. 
 
The PhNR-ON (PhNR for brief flash ERG) and PhNR-OFF amplitudes were 
measured from the voltage at stimulus onset and offset respectively to a fixed 
time point in their respective troughs. When determining the most appropriate 
C 
A B 
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fixed time point at which to measure the PhNR-ON and PhNR-OFF responses, 
the group averaged ERG of ADOA participants was subtracted from the group 
averaged ERG of the controls to obtain a difference ERG. The time-to-peak of 
the greatest discrepancy between the two was identified for the PhNR-ON and 
PhNR-OFF responses and was used as the fixed time point for all 
measurements. This method of measuring the PhNR was adapted from a 
previous study by Viswanathan et al (Viswanathan et al., 2001). The fixed times 
at which the PhNR amplitudes were measured are shown in Table 5.3. When 
assessing the other components of the flash and pattern ERGs, the 
identification of all peaks and troughs was determined objectively using 
Microsoft Excel i.e. as the minimum/maximum voltage within a fixed time 
window. 
 
Table 5.3. Fixed time points for measuring the PhNR components 
ERG Type PhNR-ON, msec PhNR-OFF, msec 
Focal long duration 
 Central macula 
 Nasal macula 
 Temporal macula 
 
95 
122 
98 
 
347 
395 
354 
Full-field long duration  83 352 
Brief flash 72 NA 
NA – not applicable 
 
5.3.14 Statistical Analysis 
The distribution of the ERG data was checked for normality using the Shapiro-
Wilk test. Where data were normally distributed, independent samples t-tests 
(2-tailed) were used to compare controls and participants with ADOA; the 
Mann-Whitney U test was used where data were non-normally distributed. In 
order to minimise Type 1 errors due to the number of comparisons made, 
observations were reported as significant when p < 0.01, unless otherwise 
specified. Where data were normally distributed, comparisons between ERGs 
recorded from the central, nasal and temporal macula from each participant in 
either the ADOA or control cohort were conducted using one-way repeated 
measures analysis of variance (ANOVA) with Bonferonni adjustment for multiple 
comparisons; otherwise a Friedman test (with post-hoc Wilcoxon Signed 
Ranked tests for post-hoc pairwise comparisons) was conducted. Receiver 
Operating Characteristic (ROC) curve analysis was used to calculate the area 
under the curve (AUC) to assess the discriminatory ability of the various ERG 
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components. The comparisons between AUCs were made using the method 
described by Hanley and McNeil (Hanley and McNeil, 1983). 
 
5.4 Results 
5.4.1 Demographical Results of Participants 
The twelve participants recruited for this study comprised nine females and 
three males aged 18 to 61 years (mean = 43.75 + 14.03 years) from five 
families (see Table 5.4 for characteristics of all 12 participants). Detailed 
information about the clinical characteristics of nine of the participants with 
ADOA (1010 – 1015, 1018 and 1019) have been reported elsewhere (Votruba 
et al., 1998a). The control group was made up sixteen participants comprising 
seven females and nine males aged 19 to 61 years (mean = 39.13 + 14.06 
years). The difference in the mean ages of the groups was not statistically 
significant (p = 0.40). The range of refractive errors for all participants (control 
and ADOA) included in the study ranged from +4.00 to -7.00 D with cylinders of 
up to -2.00 D. 
 
5.4.2 Psychophysical Assessment 
The BCVA, CS and VFS results were significantly worse in the participants with 
ADOA compared to controls (p < 0.05) (Figure 5.6). The BCVA for participants 
with ADOA ranged from 0.00 logMAR (normal) to 1.64 logMAR (severe visual 
impairment) with a median of 0.88 logMAR (Figure 5.6A). Contrast sensitivity 
was also reduced in participants with ADOA. CS scores ranged from 1.65 (near 
normal) to 0.00 (severe loss) log units. The median CS score was 1.15 log 
units. (Figure 5.7B). 
 
All participants with ADOA presented with various visual field defects (Figure 
5.7) except one participant (EM-1021) who had normal visual fields (Figure 
5.7B). The mean deviation scores of the central 18o x 18o field ranged from -
1.35 dB (normal) to -15.52 dB (severe visual loss) with a median value of -6.56 
dB. Colour vision was abnormal in all participants with ADOA who were tested. 
The colour vision defects were variable, but participants from the same family 
had similar defects (Table 5.4). 
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Table 5.4. Characteristics of Participants with ADOA 
Participant 
ID/Gender 
Family Age 
Visual Acuity, 
logMAR 
Contrast 
Sensitivity, log 
units 
Mean 
Deviation, dB 
Mean Deviation  
(18o x 18o), dB Color Vision 
OPA1 
Mutation 
ADOA+ 
RE LE RE LE RE LE Test Eye   
1010/F A 49 1.34 1.32 0.35 0.40 -27.03 -25.15 -15.52 Mixed c.1202G>A Atx, Df, Myp 
1011/F B 55 1.64 1.62 0.00 0.00 -17.65 -19.58 -15.51 Mixed C1508A Df 
1012/F C 58 0.80 1.00 1.15 1.05 -8.68 -10.39 -5.39 Mixed IVS8+5G>A None 
1013/F C 61 1.10 0.64 NA NA -12.47 -9.06 -7.05 Mixed IVS8+5G>A None 
1014/M D 33 1.40 1.32 0.30 0.45 -13.84 -11.89 -11.40 Protan/Deutan NA Nystagmus 
1015/F D 31 1.02 0.98 1.05 1.05 -13.98 -13.20 -13.78 Protan/Deutan NA KD 
1016/F E 18 0.80 0.80 1.65 1.35 -7.08 -8.15 -6.45 Tritan IVS9+3A>T None 
1017/F E 27 0.82 0.80 1.65 1.65 -5.14 -5.82 -3.70 Tritan IVS9+3A>T None 
1018/F E 59 0.86 0.96 0.90 0.75 -9.55 -7.03 -6.21 Tritan IVS9+3A>T Df, Myp 
1019/F E 49 0.72 1.20 1.50 1.50 -5.99 -6.79 -6.67 Tritan IVS9+3A>T None 
1020/M E 46 0.98 1.20 1.65 1.20 -10.15 -8.21 -5.35 Tritan IVS9+3A>T None 
1021/M F 39 0.02 0.00 1.65 1.65 -1.31 -2.25 -1.35 NA c.357delT None  
NA – not available. Atx – Ataxia (poor gait). Df – Deafness. Myp – Myopathy. KD – Kidney disease. 
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Figure 5.6. Comparison of results for controls and participants with ADOA for (A) BCVA, 
(B) CS and (C) mean deviation of VFS. The p-values are displayed on top of each plot. * - 
data were not normally distributed  
 
 
 
Figure 5.7. Visual field plots from study participants Displayed plots are from one control 
participant EM-241 (A) and three participants with ADOA (B - D). B = 1021; C = 1012 and D 
= 1010 
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5.4.3 Effect of Age on Psychophysical Measures 
In participants with ADOA, VA, CS and mean deviation worsened with age, 
however, this trend was not significant (Figure 5.8, Table 5.5). In controls, VA 
and CS declined with age (significant for CS) while mean deviation improved 
significantly with age (Table 5.5).  
 
Table 5.5. Regression analysis for the effect of age on the psychophysical measures  
Parameter Equation R2 p-value 
Visual Acuity ADOA 0.0038x + 0.7684 0.0163 0.6928 
Control -0.0036x – 0.0822 0.2215 0.0658 
Contrast Sensitivity ADOA -0.0205x + 1.9061 0.2353 0.1305 
Control -0.0037x + 1.9169 0.2632 0.0421 
Mean Deviation ADOA -0.0152x – 7.5311 0.0021 0.8881 
Control 0.0316x – 1.3863 0.3885 0.0099 
Regressions significant at p< 0.05 are shown in bold fonts in shaded cells 
 
 
Figure 5.8. Scatter plots showing the relationship between age and (A) BCVA, (B) CS, and 
(C) mean deviation score. Data for participants with ADOA are shown as red dots and 
controls as open black circles. The dotted lines represent the lines of regression. The 
equation of the regression lines are provided in Table 5.5. 
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5.4.4 Macular Retinal Thickness 
Figure 5.9 shows the horizontal OCT scans taken from the six participants with 
ADOA and one control. The foveal pits are shallower in the participants with 
ADOA, especially in 1011, 1013 and 1020, compared to the control, which 
indicates a reduction in the thickness of the inner retinal layers of the OCT scan. 
The mean thicknesses of each retinal layer in the macula are shown for each 
patient in Table 5.6. The total retinal thicknesses, i.e. from the RNFL to the 
RPE, are also shown. There was a significant reduction in the RNFL, GCL and 
IPL in the ADOA group compared to controls. There was however no significant 
difference between the two groups for the INL, OPL and photoreceptor layers. 
The RNFL and IPL in participants with ADOA were reduced to about 60% of the 
mean thickness in controls while the GCL was reduced to about 35% of the 
mean thickness in controls, making the GCL the most severely affected layer of 
the retina in ADOA participants.  
 
5.4.5 Peripapillary RNFL Thickness 
The thicknesses of the peripapillary RNFL in each quadrant at the optic nerve 
head for the participants with ADOA and controls are displayed in Table 5.6. 
The mean total thickness was 44.03 + 13.50 µm in participants with ADOA and 
95.86 + 12.26 µm in controls (Table 5.6). The comparison of the mean RNFL 
thicknesses between participants with ADOA and controls are provided in Table 
5.7. The RNFL thickness was significantly reduced in all four quadrants in 
ADOA participants. The average RNFL in ADOA participants was significantly 
reduced by nearly 50% in comparison with controls. The greatest loss in RNFL 
thickness in ADOA was recorded in the temporal sector (~70% loss) and the 
least in the superior quadrant (~30% loss). 
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Figure 5.9. OCT images showing horizontal scans of the macula of the six participants 
with ADOA (numbered) and one control. Each scan was centred at the fovea. The foveal 
pit is notably shallow for patients 1011, 1013 and 1020. 
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Table 5.6. Thicknesses of the retinal layers at the macula and the peripapillary RNFL in participants with ADOA 
Participant 
ID/Gender 
Age 
Macula Thickness Peripapillary RNFL 
RNFL GCL IPL INL OPL Photo RPE 
Total 
Meana 
Sup Tem Inf Nas 
Total 
Mean 
1010/F 49 18.48 14.86 25.39 35.77 30.07 153.49 17.86 295.92 42.41 20.18 60.12 29.34 38.01 
1011/F 55 21.42 8.70 21.01 29.63 22.93 146.71 15.38 265.77 44.67 18.13 47.31 48.69 39.70 
1013/F 61 21.47 10.98 24.95 34.62 32.93 126.25 17.30 268.50 86.14 24.54 51.09 34.11 48.97 
1015/F 31 23.51 10.02 20.92 17.37 23.37 122.65 15.74 233.59 23.10 14.31 35.14 24.50 24.26 
1017/F 27 25.55 7.00 18.81 21.69 25.53 115.34 18.92 232.85 87.05 14.99 55.4 37.65 48.77 
1021/M 39 21.26 18.35 28.12 28.05 26.21 133.00 18.08 273.07 100.21 28.52 85.21 44.06 64.50 
a – Total mean macula thickness includes RPE thickness 
 
Table 5.7. Comparison of mean retinal layer thickness at the macula for ADOA participants and controls 
 
Macula Peripapillary RNFL 
RNFLa GCLa IPL INL OPL Photo RPE Totalb Sup Tem Inf Nas Total 
ADOA Group Mean 
+Standard Deviation 
21.95 
+2.38 
11.65 
+4.21 
23.20 
+3.50 
27.86 
+7.20 
26.84 
+3.92 
132.91 
+14.64 
17.22 
+1.39 
261.62 
+24.44 
63.93 
+31.13 
20.11 
+5.55 
55.71 
+16.76 
36.39 
+9.03 
44.04 
+13.50 
Control Group Mean 
+Standard Deviation 
33.95 
+3.46 
35.08 
+4.74 
37.59 
+2.58 
29.16 
+2.46 
28.00 
+2.38 
129.81 
+7.67 
18.67 
+1.52 
312.26 
+15.18 
116.51 
+14.42 
70.16 
+26.19 
121.90 
+27.30 
74.86 
+19.22 
95.86 
+12.96 
p-value 0.0000* 0.0000* 0.0000* 0.6805 0.4025 0.6393 0.1048 0.0000* 0.0006* 0.0005* 0.0006* 0.0011* 0.0005* 
a - RNFL and GCL thicknesses exclude central zone. b - Total mean macula thickness includes RPE thickness. * - significant difference at p < 0.05
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5.4.6 Effect of Age on OCT measures 
To assess the effect of age on the retinal structure, regression analysis were 
conducted for age and periparilary RNFL (Figure 5.10A) and age and total 
macula thickness (Figure 5.10B). The layers of the macula were further grouped 
into the RNFL – IPL layer and the INL – RPE layer and their respective 
relationship with age determined (Figure 5.10C-D). This grouping of the retina 
was employed to separate the ganglion cell rich layers from the rest of the 
retina. There were no significant relationships between age and any of these 
parameters in either the ADOA or control group. However, in the ADOA group 
the R2 values for age and total macula thickness was 0.47 while that for age 
and outer macula thickness was 0.55. All other R2 values were below 0.1. 
 
 
Figure 5.10. Scatter plots showing the relationship between age and OCT measures. (A) 
peripapillary RNFL, (B) total macula thickness, (C) RNFL – IPL layers and (D) INL – RPE 
layers.  
 
 
  
Chapter 5 
 174 
 
Table 5.8. Regression analysis for the effect of age on OCT measures 
Parameter Equation R2 p-value 
RNFL (ONH) ADOA 0.0876x + 40.2107 0.0077 0.8686 
Control 0.0652x + 93.2596 0.0051 0.7999 
Total Macula 
Thickness 
ADOA 1.2326x + 207.7898 0.4667 0.1347 
Control 0.0973x + 308.4475 0.0081 0.7400 
Macula RNFL – IPL 
Thickness 
ADOA 0.0282x + 55.5690 0.0038 0.9074 
Control 0.0291x + 105.4675 0.0021 0.8678 
Macula INL – RPE 
Thickness 
ADOA 1.2044x + 152.2208 0.5571 0.0883 
Control 0.0683x + 202.9771 0.0104 0.7071 
 
 
5.5 Discussion 
5.5.1 Psychophysical Tests 
The results of the psychophysical tests showed that visual function in 
participants with ADOA was significantly poorer than in controls. However, there 
was a wide variation in the results of in the ADOA cohort. For example, visual 
acuity results ranged from normal to severe visual impairment (Table 5.4; 
Figure 5.6 and 5.7). The wide range of visual acuities seen in this study follows 
similar previous reports in which visual acuities ranged from -0.1 logMAR to 
hand-motion (Holder et al., 1998; Votruba et al., 1998a; Cohn et al., 2007; Yu-
Wai-Man et al., 2010a; Yu-Wai-Man et al., 2010b). The median BCVA in 
participants with ADOA of 0.88 logMAR (~6/48 on the Snellen chart) in this 
study is similar to results obtained in other studies (Eliott et al., 1993; Votruba et 
al., 1998a; Yu-Wai-Man et al., 2010a; Yu-Wai-Man et al., 2010b). These wide 
variations were also reflected in the results for CS, VFS and colour vision tests 
and are consistent with results from other studies which reported variable 
degrees of visual field loss in ADOA (Berninger et al., 1991; Votruba et al., 
1998a).  
 
Although genotype-phenotype correlations are difficult to establish, disease 
severity appears linked to the type and site of the mutation on the OPA1 gene 
(Thiselton et al., 2002; Barboni et al., 2010; Yu-Wai-Man et al., 2010b). For 
example, missense mutations are often associated with worse visual 
dysfunction and carry greater odd ratios for developing ADOA+ phenotypes 
(Table 5.9) (Yu-Wai-Man et al., 2010b; Barboni et al., 2014). The type and 
location of mutations in the ADOA cohort in this study is provided in Table 5.10. 
Due to the inadequate number of members in each family, a reliable association 
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between the mutation and severity of visual impairment could not be computed. 
However, an observation of Table 5.4 shows that as may be predicted by Yu-
Wai Man et al (2010b), Patient 1021 with a deletion occurring in the basic 
domain had only mild visual impairment (VA = 0.02 logMAR, VFS = -1.35), 
while Patient 1011, who carried a missense mutation occurring in the GTPase 
domain, had severe visual impairment (VA = 1.64 logMAR, VFS = -15.51). This 
patient also self-reported a 30% loss in hearing.  
 
Nonetheless, other studies have shown that wide phenotype variations exist in 
homogenous ADOA populations, which, are not correlated with age (Almind et 
al., 2012; Ronnback et al., 2013). For example, Ronnback et al. (2013) reported 
a two-fold variation in GCL-IPL thickness as well as variations in visual acuity 
from 20/20 – 20/700 in a homogeneous ADOA population (n = 49) carrying the 
2826delT OPA1 mutation. The phenotype variations were not correlated with 
age, thus suggesting that other environmental or genetic factors other than the 
patient’s specific mutation may impact largely on the phenotype (Ronnback et 
al., 2013; Bonifert et al., 2014).  
 
Table 5.9. Odd ratios for developing ADOA+ phenotype based on OPA1 mutation type 
and domain. (Yu-Wai-Man et al., 2010b) 
OPA1 mutations Odd ratio 95% CI p-value 
Type Missense 3.06 1.44 – 6.49 0.0027* 
Nonsense 0.31 0.07 – 1.34 0.0975 
Substitution 0.81 0.35 – 1.92 0.6378 
Deletion 0.50 0.18 – 1.38 0.1745 
Domain GTPase 2.29 1.08 – 4.82 0.0271* 
Dynamin 0.28 0.10 – 0.84 0.0159* 
Others 1.02 0.46 – 2.27 0.9628 
CI = confidence interval; * significant p value at 0.05 
 
Table 5.10. Type and location of OPA1 mutations in the cohort of participants with ADOA 
Family (no. of members) OPA1 mutation Type Location (Domain) 
A (n = 1) c.1202G>A Substitution Exon 12, GTPase 
B (n = 1) C1508A Missense Exon 15, GTPase 
C (n = 2) IVS8+5G>A Substitution Intron 8; GTPase 
E (n = 5) IVS9+3A>T Substitution Intron 9, GTPase 
F (n = 1) c.357delT Deletion Exon 3; Basic 
 
There were variable colour vision defects in participants with ADOA, however 
members of the same family had similar colour vision defects (Table 5.4). 
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Tritanopic defects were the commonest finding in the ADOA cohort, similar to 
some previous studies (Kjer, 1959; Holder et al., 1998; Almind et al., 2012). It 
has been suggested that the preponderance of tritanopic defects is related to 
the fewer cells of the short-wavelength (S)-cone pathway compared to the long 
(L-) and medium (M-) cone pathways in the retina (Jaeger, 1988; Johnston et 
al., 1997). In this hypothesis, the different pathways are equally vulnerable, but 
the loss of RGCs in the S-cone pathway has a greater effect due to their 
scarcity. Tritanopic defects are therefore seen early in the course of the 
disease, but progress to protanopic and/or mixed defects at later stages.  
 
Although the percentage of tritanopic defects in the ADOA cohort was the 
highest and may appear to support this notion, all these participants belonged 
to one family and were therefore associated with one OPA1 mutation. 
Therefore, while the S-cone pathway scarcity theory remained probable, the 
findings of this study raised the possibility that the colour vision defects may be 
mutation specific. Earlier studies have however reported variable colour vision 
defects between and within families with the same mutations (Holder et al., 
1998; Simunovic et al., 1998; Votruba et al., 1998a; Johnston et al., 1999), thus 
implying that the heterogeneity in colour vision is not fully explained by genetic 
heterogeneity (Simunovic et al., 1998).  
 
5.5.2 Retinal Thickness Measures  
At the outset, it was hypothesised that the peripapillary RNFL thickness and 
retinal thickness would be significantly reduced in participants with ADOA 
compared to controls. The results of this study confirm this hypothesis. The 
peripapillary RNFL thickness was significantly reduced in all quadrants with the 
temporal quadrant being the most affected. This is consistent with previous 
studies showing that the papillomacular bundle subserving central vision is the 
most affected part of the retina in ADOA (Johnston et al., 1979; Kjer et al., 
1983; Milea et al., 2010; Barboni et al., 2011; Carbonelli et al., 2015). Total 
macular thickness was significantly reduced in participants with ADOA 
compared to controls. This was caused by a selective reduction in the RNFL - 
IPL layer with a relative sparing of the INL - RPE layer. This agrees with other 
studies which show that ADOA is essentially a disease that targets RGC and 
their axons (Ito et al., 2007; Milea et al., 2010; Ronnback et al., 2013).  
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It is not clear why RGCs are the primary target of ADOA since OPA1 is present 
in all body tissues (Aijaz et al., 2004; Davies and Votruba, 2006; Sarzi et al., 
2012). Several hypotheses have been advanced for this super-selectivity of the 
RGCs and the major views are summarised in Section 1.2.5 (See also Carelli et 
al. 2009 and Yu Wai Man et al. 2011). The most supported explanation, 
however, relates to the peculiar distribution of mitochondria in RGCs (Yu Wai 
Man et al., 2005; Carelli et al., 2009; Yu-Wai-Man et al., 2009; Yu-Wai-Man et 
al., 2011b). They are accumulated in the cell bodies and in the intra retinal 
unmyelinated axons to support the higher energy demands of unmyelinated 
nerve conduction, but scarce in the myelinated part of axons after the lamina 
cribosa. It is therefore likely that a delicate cytoskeletal architecture is needed to 
maintain this sharp mitochondrial gradient (Bristow et al., 2002; Barron et al., 
2004). Since the majority of the macula RGCs have small, unmyelinated fibres 
and with high firing rates, pathological mechanisms which disrupt this unique 
structural feature would lead to impaired axonal transport and set up a vicious 
cycle with fragmentation of the mitochondrial network at the lamina cribrosa 
exacerbating even subtle mitochondrial energy deficits and eventually 
precipitating apoptotic cell death of RGCs (Yu-Wai-Man et al., 2009). 
 
The changes in the RNFL corresponds to those in the inner macula. Although 
macula thickness is significantly reduced in ADOA participants, there was a 
tendency towards increasing thickness. 
 
5.5.3 Effect of Age on Psychophysical and Structural Measures 
In this study, there were no significant relationships between age and any of the 
psychophysical tests in the ADOA cohort. This agrees with previous studies 
which did not find a significant effect of age on disease severity or progression 
(Votruba et al. 1998a; Cohn et al. 2008; Almind et al. 2012; Ronnback et al. 
2013) and may suggest that disease severity is determined by a combination of 
factors such as the type of OPA1 mutation (Yu-Wai-Man et al., 2010b; Barboni 
et al., 2014), environmental and genetic factors (Almind et al., 2012; Ronnback 
et al., 2013; Bonifert et al., 2014). In comparison, there was a significant effect 
of age on contrast sensitivity and mean deviation in the control group. While 
contrast sensitivity in the control group decreased with age as expected 
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(Owsley, 2011), mean deviation improved with age contrary to previous reports 
(Johnson et al., 1989). Since the majority of participants in the control group 
were staff and students of the School of Optometry, it is possible that the older 
participants having more experience with the test performed better than the 
younger participants.  
 
The results from the six participants with ADOA in this study showed that there 
was no significant correlation between age and periparpillary RNFL or macula 
thickness. This was also the case in the control cohort. It was observed that 
while the variances were similar in the ADOA and control groups for the 
peripapillary RNFL (<1%), the variances of the total macular thickness in the 
ADOA and control group differed substantially, i.e. 47% in ADOA compared to 
<1% in controls. When the macula was segregated into the RNFL – IPL and INL 
– RPE layers, it was noted that the INL – RPE layer was the major contributor 
for this variance (Figure 5.10D, Table 5.8). An increase in the INL was recently 
reported in a group of ADOA participants (Carbonelli et al., 2015) They 
proposed that the firm vitreo-retinal adhesions holding the retina in place most 
likely caused the retina to expand or split to form empty cystic spaces as the 
RNFL and GCL become thinner in ADOA. Furthermore, rod inner segments are 
known to increase with age (Gao and Hollyfield, 1992; Curcio et al., 1993) while 
the INL is relatively preserved in ageing (Lei et al., 2011). These factors may 
contribute to the observation of thickening of the INL – RPE layer with age in 
this study.  
 
 
5.6 Conclusion 
The results of the baseline tests showed that the participants with ADOA 
recruited in this study exhibited features which were consistent with those 
reported in previous studies. The participants with ADOA typically presented 
with reduced visual acuity and contrast sensitivity as well as visual field 
scotomas and colour vision defects. Participants with ADOA also showed 
significant reduction in the peripapillary RNFL thickness as well as a selective 
reduction in the thickness of the RNFL – IPL layer, pointing to the RGCs and 
their axons as the primary site of assault in ADOA.  
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 CHAPTER SIX – ELECTROPHYSIOLOGICAL 
ASSESSMENT OF RETINAL FUNCTION IN 
AUTOSOMAL DOMINANT OPTIC ATROPHY - II: 
RESULTS OF ELECTROPHYSIOLOGICAL TESTS 
 
6.1 Preamble 
This chapter is a continuation of the previous chapter. The methods, participant 
characteristics and baseline results were presented in the previous chapter. 
Here the results of the electrophysiological assessment of participants with 
ADOA are presented and discussed. 
 
6.2 Electrophysiological Results 
6.2.1 Pattern ERGs 
PERGs were successfully recorded from the central, nasal and temporal 
macula of participants with ADOA and controls. The individual PERG responses 
for the nine participants with ADOA are displayed in Figure 6.1. The PERGs for 
three participants (1016, 107 and 1019) which were recorded at the City site 
were not included as they were contaminated by extraneous noise arising from 
construction works outside the recording room. In participants with ADOA, the 
P50 component was typically more discernible than the N95 component in all 
three retinal locations. However, in two participants (1014 and 1015), the PERG 
responses were nearly flat.  
 
The PERG responses from the nasal macula of participants with ADOA and 
controls (middle columns of Figures 6.1 and 6.2) were different in waveform 
compared to those from the central and temporal macula. In participants with 
ADOA, the N95 component could not be determined for nearly half the 
participants, and even where it was present, the N95 had a shallow trough. In 
controls, the N95 had a wide and shallow trough. 
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Figure 6.1. Individual PERGs 
recorded from participants with 
ADOA from the central, nasal and 
temporal macula.  
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Figure 6.2. (A) Individual PERG responses (thin coloured lines) recorded from the central, nasal and temporal macula of participants with ADOA and 
superimposed on group-averaged PERG traces of controls. (B) Comparison between group-averaged PERGs of participants with ADOA (thick red line) 
and controls (thick black lines) recorded from the central, nasal and temporal retina. Dotted lines represent 95% confidence intervals. Grey line 
represents the difference ERG for each paired comparison. * - Significant difference, p < 0.01. 
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In Figure 6.2A, the individual PERG responses from the ADOA cohort are 
superimposed on the corresponding group-averaged PERG response for 
controls for each location. Notably, the P50 and N95 components in the central 
(left column) and temporal (right column) macula were reduced in amplitude for 
nearly all participants with ADOA beyond the 95% confidence intervals for the 
control data. 
 
There was evidence of a significant P50 and N95 loss in people with ADOA 
compared to controls in all locations (Figure 6.2B, Table 6.1). However, the 
difference plot of the central retina (grey line in Figure 6.2B, left column) was 
dominated by a negative going signal corresponding to the loss of the N95 
component. The difference between the groups was greatest in the central 
macula (2.97 µV) and approximately equal in the nasal (1.75µV) and temporal 
macula (1.91 µV). 
 
Table 6.1. Mean values of amplitudes and times-to-peak of PERG components in 
participants with ADOA and in controls. 
Location Component ADOA Control P-value 
Central 
P50 
A, µV 1.90 + 0.79 3.11 + 0.88 0.0020* 
T, msec 48.83 + 3.95 53.41 + 3.16 0.0042* 
N95 
A, µV 2.13 + 1.13 5.10 + 0.96 0.0000* 
T, msec 102.00  + 11.53 101.95 + 7.44 0.4788† 
N95:P50 Ratio 1.07 + 0.32 1.73 + 0.47 0.0008*† 
 
Nasal PERG 
P50 
A, µV 1.60 + 0.52 2.62 + 0.63 0.0010* 
T, msec 53.11 + 5.82 53.23 + 4.06 0.9574 
N95 
A, µV 1.55 + 0.52 3.30 + 1.04 0.0001* 
T, msec 108.89 + 6.56 97.05 + 9.62 0.0041* 
N95:P50 Ratio 1.12 + 0.57 1.27 + 0.28 0.4034 
 
Temporal 
P50 
A, µV 1.02 + 0.73 2.08 + 0.53 0.0016*† 
T, msec 48.89 + 4.62 52.21 + 3.17 0.0528 
N95 
A, µV 1.83 + 0.87 3.74 + 0.94 0.0001* 
T, msec 103.08 + 10.06 102.11 + 7.32 0.7899 
N95:P50 Ratio 2.28 + 1.14 1.84 + 0.40 0.3049 
Data are expressed as mean + standard deviation. A – Amplitude; T – Time-to-peak from 
stimulus onset. * – Value is significant at p < 0.01 level; † – data was non-uniformly distributed 
and Mann-Whitney U test was used for statistical comparison. 
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Figure 6.3. A pair-wise comparison of group-averaged PERGs recorded from the central, nasal and temporal retina for participants with (A) ADOA and (B) 
controls. The legend in A applies to B. Dotted lines represent 95% confidence intervals. Grey line represents the difference ERG for each paired 
comparison. Cen/C – Central retina; Nas/N – Nasal retina; Tem/T – Temporal. * - Significant difference, p < 0.01. 
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The PERGs recorded from the different locations were also compared within 
individuals in each cohort to determine regional variations in the PERG (Figure 
6.3; Table 6.2).  In both the ADOA and control groups, there was a significant 
effect of location on the P50 amplitudes. The mean P50 amplitude was greatest 
in the central retina, followed by the nasal and temporal macula in decreasing 
order. However this difference was significant (p < 0.01) for comparisons 
between the central and temporal macula (ADOA and control group) and 
between the nasal and temporal macula (control group only).  
 
The mean N95 amplitudes in both groups were greatest in the central macula, 
followed by the temporal and nasal macula. However, the difference was only 
significant between the central and nasal macula and between the temporal and 
nasal macula (Figure 6.2). There was no significant difference in mean time-to-
peak of either the P50 or N95 component across the three locations.  
 
Table 6.2. Summary of results for intra-individual comparisons (repeated measures) 
Component ADOA Controls 
P50 Amp Significant† 
(p = 0.0124) 
Pairwise: Cen > Tem (p = 0.0065) 
Significant  
(p = 0.0002; P.Eta2 = 0.76) 
Pairwise: Cen > Tem (p=0.0003); 
Nas > Tem (p = 0.0013) 
Time Not significant 
(p = 0.3950; P.Eta2 = 0.23) 
Not significant  
(p = 0.2446; P.Eta2 = 0.21) 
N95 Amp Not significant  
(p = 0.1650; P.Eta2 = 0.40) 
Significant 
(p = 0.0000; P.Eta2 = 0.83) 
Pairwise: Cen > Nas (p = 0.0010); 
Cen > Tem (p = 0.0000) 
Time Not significant† 
(p = 0.4594)  
Not significant  
(p = 0.3783; P.Eta2 = 0.15) 
N95:P50 Significant† 
(p = 0.0131) 
Pairwise: Cen > Tem (p = 0.0109) 
Significant† 
(p = 0.0025) 
Pairwise: Cen > Nas (p = 0.0028) 
Nas < Tem (p = 0.0015) 
† – data were non-normally distributed and Friedman test was used. P.Eta2 = partial Eta2 are 
given for parametric tests. Pairwise comparisons are given only for significant comparisons. The 
significant value of p < 0.05 is Bonferroni adjusted 
 
6.2.2 Focal Long Duration Cone ERGs 
Focal long duration cone ERGs were successfully recorded from the central, 
nasal and temporal retina of 12 participants with ADOA and are displayed for 
each participant in Figure 6.4. The typical ERG responses were characterised 
by the a-wave, b-wave, PhNR-ON, d-wave and PhNR-OFF. In Figure 6.5A, the 
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individual traces of ADOA participants are superimposed on the group-
averaged traces of controls for each location. These showed that in the central 
and temporal macula, the PhNR-ON and PhNR-OFF amplitudes were 
significantly reduced in amplitude below the 95% confidence limit of control data 
in most ADOA participants.  This was reflected in the difference plots in Figure 
6.5B (left and right columns) which were dominated by two negative going 
waves representing the PhNR-ON and PhNR-OFF components affected by 
ADOA.  There was however no significant difference between ADOA and 
control participants in the PhNR-ON or PhNR-OFF amplitudes recorded from 
the nasal macula (Figure 6.5, middle column; Table 6.3).  
 
Notably, the waveform after stimulus offset varied considerably between ADOA 
participants for the central and temporal macula (Figure 6.5B). For instance, in 
participants with ADOA, the most prominent positive peak after stimulus offset, 
assumed to be the d-wave, was delayed and had a broad peak whose 
maximum amplitude occurred at highly variable times (Figure 6.5B, left and right 
column). In comparison, this prominent peak was highly consistent among 
control participants with respect to time-to-peak and was reflected in the much 
smaller SD of the d-wave time-to-peak in contrast to data from participants with 
ADOA (Table 6.3). In addition, the PhNR-OFF components of the central and 
temporal group-averaged traces of the ADOA group were practically eliminated 
and the d-wave peak extended over the place where the PhNR-OFF trough was 
expected to be when compared to the control traces.  
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Figure 6.4. Focal long-duration ERGs 
recorded from (left to right) the 
central, nasal and temporal macula in 
participants with ADOA. Traces in the 
same row were recorded from the 
same participant 
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Figure 6.5. (A) Individual focal long duration ERGs responses (thin coloured lines) recorded from the central, nasal and temporal macula of participants 
with ADOA and superimposed on group-averaged traces of controls (thick lines). (B) Comparison between group-averaged focal ERGs of participants 
with ADOA (thick red lines) and controls (thick black lines) recorded from the three retinal locations. Dotted lines represent 95% confidence intervals. 
Grey lines represent the difference ERG for each paired comparison. 
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Table 6.3. Mean values of amplitude and time-to-peak of long duration focal ERGs 
recorded from central, nasal and temporal macula in ADOA and control participants. 
Location Component ADOA Control p-value 
Central Focal 
ERG 
a-wave A, µV 1.76 + 0.94 2.22 + 0.61 0.0069* 
T, msec 23.00 + 1.72 23.75 + 1.74 0.2454 
b-wave A, µV 5.29 + 2.08 6.76 + 1.74 0.0529 
T, msec 46.25 + 3.14 49.81 + 4.88 0.0349 
PhNR-ON A, µV 1.02 + 0.97 3.81 + 1.74 0.0000* 
T, msec 109.25 + 7.16 104.50 + 8.49 0.0554 
d-wave A, µV 2.81 + 1.52 3.12 + 1.04 0.2045 
T, msec 321.92 + 13.80 302.41 + 5.92 0.0000* 
PhNR-OFF A, µV -1.97 + 1.52 0.93 + 1.23 0.0000* 
T, msec 422.08 + 26.51 369.00 + 21.29 0.0000* 
Nasal Focal 
ERG 
a-wave A, µV 1.31 + 0.97 1.40 + 0.76 0.7715 
 T, msec 23.08 + 1.88 23.33 + 1.67 0.7339 
b-wave A, µV 4.44 + 1.69 5.55 + 1.16 0.1488† 
 T, msec 46.25 + 3.60 50.00 + 4.16 0.0273 
PhNR-ON A, µV 2.03 + 1.55 2.21 + 1.31 0.4529† 
 T, msec 112.67 + 8.82 111.83 + 9.80 0.9763† 
d-wave A, µV 2.23 + 1.70 2.44 + 0.69 0.8847 
 T, msec 317.67 + 8.81 306.42 + 10.27 0.0087* 
PhNR-OFF A, µV -0.55 + 2.75 -1.07 + 1.29 0.3026 
 T, msec 396.08 + 39.73 403.50 + 19.75 0.7948† 
Temporal 
Focal ERG 
a-wave A, µV 1.05 + 0.57 1.44 + 0.64 0.1460 
 T, msec 22.50 + 2.71 22.83 + 1.64 0.3592† 
b-wave A, µV 3.59 + 1.06 4.23 + 0.82 0.1060† 
 T, msec 43. 75 + 8.73 43.75 + 4.05 0.9073† 
PhNR-ON A, µV 1.18 + 1.09 3.57 + 1.33 0.0001* 
 T, msec 101.17 + 26.73 103.17 + 5.80 0.1741† 
d-wave A, µV 1.74 + 1.03 1.59 + 0.84 0.5371 
 T, msec 288.92 + 84.78 298.58 + 5.40 0.0426† 
PhNR-OFF A, µV -1.48 + 1.14 1.58 + 0.93 0.0000* 
 T, msec 410.67 + 50.62 361.92 + 11.66 0.0372† 
Data are expressed as mean + standard deviation. A – Amplitude; T – Time-to-peak from 
stimulus onset. * – Value is significant at p < 0.01 level; † – data were non-normally distributed. 
 
The focal ERGs recorded from the different locations were again compared 
within individuals in each cohort (Figure 6.6). In participants with ADOA, there 
was no observable difference when the group-averaged ERGs were compared 
pairwise between the locations. On the other hand, in controls, there difference 
plots showed prominent differences in the negative components (PhNR-ON and 
PhNR-OFF) for comparisons between the central and nasal macula and 
between the temporal and nasal macula. The comparison between the central 
and temporal macula showed a prominent difference in the positive components 
(b-wave and d-wave). A summary of the statistical comparisons is shown in 
Table 6.4. 
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Figure 6.6. A pair-wise comparison of group-averaged focal ERGs recorded from the central, nasal and temporal retina for participants with (A) ADOA 
and (B) controls. The legend in A applies to B. Dotted lines represent 95% confidence intervals. Grey line represents the difference ERG for each paired 
comparison. Cen/C – Central retina; Nas/N – Nasal retina; Tem/T - Temporal 
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Table 6.4. Summary of comparisons between ERGs recorded from different locations 
within individual (repeated measures comparisons)  
Component ADOA Controls 
a-wave Amp Not significant 
(p = 0.4924; P.Eta2 = 0.13) 
Significant  
(p = 0.0001); P.Eta2 = 0.86 
Pairwise: Cen > Nas (p = 0.0001); 
Cen > Tem (p = 0.0014) 
Time Not significant† 
(p = 0.4966)  
Not significant † 
(p = 0.1870) 
b-wave Amp Significant† 
(p = 0.0087) 
Pairwise: Cen > Tem (p = 0.0037) 
Significant  
(p = 0.0003; P.Eta2 = 0.81 
Pairwise: Cen > Nas (p = 0.0002) 
Cen > Tem (p = 0.0001) 
Time Not significant  
(p = 0.6547; P.Eta2 = 0.08) 
Significant†  
(p = 0.0000) 
Pairwise: Cen > Tem (p = 0.0022); 
Nas > Tem (p = 0.0022) 
PhNR-ON Amp Not significant  
(p = 0.2328; P.Eta2 = 0.25) 
Significant†  
(p = 0.0003) 
Pairwise: Cen >Nas (p = 0.0022); 
Tem > Nas (p = 0.0022) 
Time Not significant† 
(p = 0.4723)  
Significant† 
(p = 0.0077) 
Pairwise: Cen < Nas (p = 0.0183); 
Nas > Tem (p = 0.0150) 
d-wave Amp Not significant  
(p = 0.2531; P.Eta2 = 0.24) 
Significant  
(p = 0.0028; P.Eta2 = 0.69) 
Pairwise: Cen > Nas (p = 0.0183); 
Cen > Tem (p = 0.0016); Nas > 
Tem (p = 0.0018) 
Time Not significant† 
(p = 0.3878) 
Significant  
(p = 0.0338; P.Eta2 = 0.49) 
Pairwise: Nas > Tem (p = 0.0099) 
PhNR-
OFF 
Amp Significant  
(p = 0.0319; P.Eta2 = 0.50) 
Pairwise: Cen > Nas (p = 0.0500) 
Significant  
(p = 0.0336; P.Eta2 = 0.49) 
Tem > Nas (p = 0.0242) 
Time Not significant†  
(p = 0.2636) 
Significant† 
(p = 0.0005) 
Pairwise: Cen > Nas (p = 0.0120); 
Tem > Nas (p = 0.0022) 
† – data were non-normally distributed. P.Eta2 = partial Eta2 are given for parametric tests. 
Pairwise comparisons are given only for significant comparisons. The significant value of p < 
0.05 is Bonferonni adjusted 
 
6.2.3 Long Duration Full-field Cone ERG 
The individual long duration full-field cone ERGs recorded from the twelve 
participants with ADOA are displayed in Figure 6.7A and again in Figure 6.7B, 
where they (thin coloured lines) are superimposed on the group-averaged trace 
of the 16 age matched controls (thick black line).  
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Figure 6.7. (A) Individual long duration full-field ERG recorded from the ADOA 
participants. (B) Individual ERGs (thin coloured lines) superimposed on group averaged 
ERG of controls (black line). (C) Comparison of group-averaged traces of ADOA 
participants (red thick line) and controls (thick black line). Thick grey line represents the 
difference ERG between the ADOA and control trace. Red arrow shows a third positive 
peak (3PP) after light offset in ADOA participants. Dotted lines represent 95% CI. * - 
Significant difference at p < 0.01 
 
Table 6.5. Mean values of amplitudes and times-to-peak of long full-field long duration 
ERG 
Component ADOA Controls p-value 
a-wave A, µV 15.87 + 4.44 18.84 + 4.45 0.0927 
T, msec 22.50 + 1.09 23.16 + 1.70 0.2537 
b-wave A, µV 33.57 + 10.67 41.29 + 11.18 0.0768 
T, msec 41.83 + 2.86 42.16 + 2.47 0.7515 
PhNR-ON A, µV 12.26 + 3.95 15.68 + 4.36 0.0430 
T, msec 96.18 + 9.16 92.72 + 4.15 0.2472 
d-wave A, µV 15.11 + 6.20 12.84 + 4.89 0.2866 
T, msec 274.67 + 1.15 273.47 + 1.02 0.0172† 
2nd positive 
peak 
A, µV 15.48 + 4.87 16.10 + 7.55 0.8064 
T, msec 302.50 + 8.35 298.19 + 2.00 0.1360† 
PhNR-OFF A, µV -8.31 + 5.69 0.45 + 5.74 0.0005* 
T, msec 178.33 + 27.02 132.19 + 17.30 0.0000*† 
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The form of the long duration ERG was similar under focal and full-field 
conditions with one exception. There were at least two positive peaks 
immediately after light offset in the full-field ERG; the first being the d-wave 
(Evers and Gouras, 1986; Viswanathan et al., 1999). The mean amplitude of 
the PhNR-OFF, but not the PhNR-ON, was significantly reduced in participants 
with ADOA (Table 6.5). On the difference plot (Figure 6.7C) the amplitude of the 
PhNR-OFF difference (8.76 µV) was more than twice the amplitude of the 
PhNR-ON difference (3.42 µV) when measured. 
 
Once again, the OFF components showed greater variability than ON 
components for participants with ADOA. In fact, in at least 6 participants with 
ADOA, there was a third positive peak (3PP) after light offset not seen in 
controls (Figure 6.7C, arrowed). There was no obvious pattern to the presence 
or absence of the 3PP in ADOA participants. The amplitude and time-to-peak of 
the 3PP measured from the ADOA group averaged trace was 13.34 µV and 75 
msec after light offset respectively. Comparatively, none of the control traces 
displayed the 3PP prominently, although on close visual inspection, a kink 
corresponding in time with the 3PP was observed in some individual control 
traces. 
 
6.2.4 Comparison of Focal and Full-field Long Duration ERGs 
The waveforms of the central retina focal and full-field long duration ERGs were 
further compared by normalising the group averaged ERGs to their respective 
b-wave amplitudes (Figure 6.8). The focal and full-field ERGs of controls (Figure 
6.8A) and participants with ADOA (Figure 6.8B) had similar profiles although 
times-to-peak of the b-wave, PhNR-ON and d-wave were significantly delayed 
in the focal ERG (p <0.01, data not shown). The most prominent positive peak 
of the focal ERG after light offset coincided with the 2PP of the full-field ERG in 
the control traces while in the ADOA group, the broad peak of the focal ERG 
after offset described a curve that roughly matched the profile of the 2PP and 
3PP of the full-field ERG. 
 
In controls, the PhNRs were proportionally greater in the focal ERG than in the 
full-field ERG (Figure 6.8A). The losses in amplitudes of the PhNRs were also 
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greater in the focal ERG than the full-field ERG in participants with ADOA 
(Figure 6.8B and 6.8C).  
 
 
Figure 6.8. A comparison of the focal (dashed lines) and full field (solid lines) long 
duration group-averaged ERGs for (A) controls, (B) participants with ADOA and (C) 
difference plots (i.e. Control – ADOA).  ERGs have been normalised to the b-wave 
amplitude of their respective control group-averaged ERG. 
 
6.2.5 The Brief Full-field ERG 
Brief full-field ERGs recorded from 7 ADOA participants are shown in Figure 
6.9A. Typical ERG responses had a-wave, b-wave, i-wave and PhNR 
components. The PhNR amplitude was reduced significantly in people with 
ADOA compared to controls (Figure 6.9B and Table 6.6). The difference plot in 
Figure 6.9C indicates that the greatest deficit in ADOA corresponds to the 
timing of the b-wave and the PhNR. An i-wave was recorded for all participants 
(controls and ADOA). Although it appeared more prominent in ADOA 
participants, there was no statistical difference in amplitude or time-to-peak 
between control and ADOA participants (Table 6.6).  
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Figure 6.9. (A) Individual full-field brief ERGs recorded from 7 participants with ADOA. (B) 
Individual ERGs (thin coloured lines) superimposed on group averaged ERG of controls 
(black line). (C) Comparison of group-averaged traces of ADOA participants (red thick 
line) and controls (thick black line). Thick grey line represents the difference ERG 
between the ADOA and control trace. Dotted lines represent 95% CI. * - Significant 
difference at p < 0.01 
 
Table 6.6. Mean amplitude and implicit values for the full-field brief ERG 
Component ADOA Controls p-value 
a-wave A, µV 20.60 + 3.79 25.73 + 5.91 0.0422† 
T, msec 17.50 + 0.69 17.22 + 0.76 0.4133 
b-wave A, µV 59.75 + 14.58 77.88 + 18.17 0.0302 
T, msec 35.39 + 1.51 35.38 + 1.26 0.9768 
i-wave A, µV 14.00 + 8.37 16.19 + 7.58 0.5420 
T, msec 58.04 + 2.04 57.61 + 2.37 0.6844 
PhNR A, µV 12.93  + 3.38 22.39 + 6.17 0.0001* 
T, msec 72.75 + 4.13 70.59 + 6.40 0.6390† 
 
6.2.6 Specificity and Sensitivity of the Different ERGs 
Receiver operating characteristics (ROC) curves were used to determine the 
effectiveness of the N95 and long duration focal and full-field PhNRs at 
discriminating participants with ADOA from controls for 9 participants with 
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ADOA and 16 controls for whom PERG and long duration focal and full-field 
ERG data were available. The AUC, sensitivity, specificity and cut off value 
which produced an optimal sensitivity while maintaining minimum specificity of 
~90% are shown in Table 6.7. The N95 amplitude had the greatest diagnostic 
power. However, a comparison of the AUCs of the focal and full field PhNRs 
with the N95 amplitude, using the method described by Hanley and McNeil 
(1983)(Hanley and McNeil, 1983) showed that the N95 amplitude was only 
significantly more sensitive than the full-field PhNR-ON amplitude (z = 2.12). 
Therefore, considered in terms of their diagnostic ability, the focal PhNRs were 
equivalent to the N95 amplitude.  
 
 
Figure 6.10. Receiver Operating Characteristic (ROC) curves for ERG components. (A) 
N95 component and N95:P50 ratio of the PERG, (B) focal PhNR-ON and PhNR-OFF 
amplitudes and (C) full-field PhNR-ON and PhNR-OFF amplitudes. 
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Table 6.7. Sensitivity, specificity and Area Under Curve of ROC analysis for ERG 
components 
Test Variable Area (95% CI) Sensitivity Specificity Cut Off 
Value 
N95 0.993 (0.971 – 1.000) 93.8 100 4.12 µV 
N95:P50 0.920 (0.809 – 1.000) 81.3 89.9 1.44 
Focal PhNR-ON 0.920 (0.834 – 1. 000) 81.3 100 2.62 µV 
Focal PhNR-OFF 0.951 (0.871 – 1.000) 81.3 100 0.24 µV 
Full-field PhNR-ON 0.785 (0.599 – 0.970) 50.0 100 16.99 µV 
Full-field PhNR-OFF 0.833 (0.731 – 0.995) 62.5 89.9 0.35 µV 
 
 
 
Figure 6.11 Scatter plot of long duration focal (A – B) and full-field (C – D) PhNRs as a 
function of age for participants with ADOA (red dots) and controls (grey dots). The dotted 
lines represent the regression line. Equations and R2 of the lines are provided in Table 
6.8. 
 
6.2.7 Effect of Age on Electrophysiological Measures 
Separate regression analyses were carried out for focal PhNR-ON and PhNR-
OFF and full-field PhNR-ON and PhNR-OFF, each as a function of age, within 
ADOA and control groups. Their scatter plots are shown in Figure 6.11.. These 
were selected since they were the parameters for which data were available for 
all participants. There was no significant relationship between age (independent 
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variable) and any of the dependent variables except the full-field PhNR-OFF 
amplitude in the ADOA group, which declined with age (Table 6.8). The R2 
values were low for each parameter’s comparison with age (R2 < 0.3) except for 
the PhNR-OFF which had an R2 of 0.52 in the ADOA participants.  
 
Table 6.8. Linear regression equations for the relationship between age (independent 
variable) and selected parameters (dependent variables) 
Parameter Equation R2 p-value 
Focal PhNR-ON ADOA 0.0199x + 0.3198 0.16 0.1912 
Control -0.0057x + 4.0293 0.00 0.8655 
Focal PhNR-OFF ADOA -0.0452x – 0.0193 0.18 0.1728 
Control -0.0300x + 2.0995 0.11 0.2057 
Full-field PhNR-ON ADOA 0.1530x + 5.5611 0.30 0.0674 
Control -0.0716x + 18.4777 0.05 0.3925 
Full-field PhNR-OFF ADOA -0.2938x + 4.5390 0.52 0.0078* 
Control -0.1524x + 6.4139 0.14 0.1540 
* - Significant at p < 0.05 
 
 
6.3 Discussion 
6.3.1 Effect of ADOA on ON and OFF RGCs 
In this section and section 6.3.3, only the focal ERG from the central retina is 
considered. This study sought to determine whether the PhNR-ON was 
preferentially affected in ADOA as might be predicted based on the study by 
Williams et al (2010). The findings of the present study, however, suggested 
that in patients with ADOA the PhNR-ON and PhNR-OFF amplitudes were 
equally reduced in the focal ERG, while in the full-field ERG, there was a 
greater reduction in the PhNR-OFF amplitude than the PhNR-ON amplitude. 
What then might explain this apparent contradiction? 
 
In the study by William et al (2010), evidence for the preferential loss of ON-
RGCs was based on mouse retinal flat mounts showing significant dendritic 
pruning of ON-, but not OFF-centre RGCs. The experiment reported here, 
however, assessed the effect of ADOA on the ON and OFF RGCs by evaluating 
the PhNR amplitude of the human ERG, a functional measure. The role of the 
RGCs as primary originators of the PhNR has been demonstrated in previous 
studies (Viswanathan et al., 1999; Viswanathan et al., 2000; Viswanathan et al., 
2001; Rangaswamy et al., 2007; Luo and Frishman, 2011). In experiments 
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using long duration full-field ERGs, they showed that that PhNR-ON and PhNR-
OFF components were both reduced or eliminated after experimental glaucoma 
and intravitreal injection of tetrodotoxin (TTX) (an agent that blocks generation 
of sodium dependent spikes in retinal neurons) in macaque, as well as in 
patients with glaucoma. Furthermore, Luo and Frishman (Luo and Frishman, 
2011) showed that the PhNR-ON (and b-wave) component, but not the PhNR-
OFF (or d-wave) was eliminated after injecting 2-amino-4-phosphonobutyric 
acid (APB) into the macaque retina to block synaptic transmission from 
photoreceptors to ON-bipolar cells and hence ON-RGCs. Injecting TTX after 
APB then removed the PhNR-OFF thereby linking the PhNR-ON and PhNR-
OFF components to the ON and OFF pathways respectively (Figure 6.12). 
 
Previous human (Gotoh et al., 2004; Machida et al., 2011; Nakamura et al., 
2011b) and animal (Viswanathan et al., 1999; Barnard et al., 2011) studies 
(including our mouse model) have shown that the PhNR amplitude is very 
susceptible to RGC damage with severe attenuation of PhNR amplitude 
recorded even when morphologic and other functional parameters were within 
normal range i.e. in early stage disease. It is possible that the PhNR-ON 
pathways may be selectively compromised at an earlier stage of the disease 
process than that studied here. In addition, it is important to consider the timing 
of the onset of ON-RGC dendropathy and visual loss in mice in relation to the 
age at which symptoms are reported in ADOA patients. In the mouse model, 
preferential ON-RGC dendropathy was detected in 10 – 15-month-old mutant 
mice and become pronounced in >20-month mutant old mice (Williams et al., 
2010; Williams et al., 2012). One human year is equivalent to 9 mouse days 
(Dutta and Sengupta, 2016); hence the equivalent human age of the 10 – 15-
month and 20-month old mice would be 33.3 – 50 years and 66.6 years 
respectively. Furthermore, a decline in visual function was detected in 12-
month-old mutant mice (~ 40 human years) (Davies et al., 2007) and a 
significant reduction in the PhNR amplitude was detected in 11-month-old 
mutant mice (~ 37 human years) (Barnard et al., 2011).   
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Figure 6.12. Full-field long duration ERGs (200 msec white-on-white flash) recorded from a macaque monkey before and after serial injection of APB, TTX 
and PDA showing the contributions of the various retinal cells to the long duration ERG. The top row shows ERG traces recorded before (A) and after 
drug administration (B – D), while the bottom row (E – G) shows the ERG components lost as a result of the drug administration. (A) Control ERG 
showing the sum of all retinal cells. (B) Photoreceptor, OFF-bipolar and OFF inner retinal cell (RGC and amacrine) activity. (C) Photoreceptor and OFF 
bipolar cell activity. (D) Photoreceptor activity. (E) Contribution from ON-Bipolar, and ON inner retinal cells (RGCs and amacrine). (F) Contribution from 
OFF inner retinal cells (OFF RGC and amacrine). (G) Contribution of OFF-bipolar cells. After APB, the ERG trace represents the photoreceptors and OFF 
responses. (Digitised and modified from Luo and Frishman 2011, Figure 4, using ImageJ 1.49u). 
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Per these estimates, the mean age of the ADOA cohort in this study (44 + 14 
years) fell within the predicted age range in which a selective effect of ON-RGC 
dendropathy would be detected in humans (i.e. 10 – 15 month mice = 33.3 – 50 
year humans). However, the onset of a decline in visual function in ADOA 
patients is much earlier (usually before 10 years) (Votruba et al., 1998a; 
Johnston et al., 1999; Yu-Wai-Man et al., 2010a) than was predicted by the 
mouse model.  Therefore, if as suggested by the mouse model, the selective 
ON-RGC dendropathy preceded or coincided with the decline in visual signs, 
then in humans such a selective effect of ON-RGC would be detected before 
the first decade of life and with time, the OFF-RGCs may also be compromised 
by the disease. Thus, the age range of the ADOA cohort in this study may have 
precluded the detection of a selective effect of ON-RGC dysfunction. A similar 
study in pre-symptomatic people with the OPA1 mutations or in people with 
ADOA at a much earlier stage of the disease (e.g. <10-year-old children with 
ADOA) could provide additional insights.  
 
The findings of this study may also be a reflection of the heterogeneous nature 
of ADOA (Votruba et al., 1998a; Votruba et al., 1998b; Ferre et al., 2005; Amati-
Bonneau et al., 2009; Ferre et al., 2009; Yu-Wai-Man et al., 2010a; Yu-Wai-Man 
et al., 2010b). There are over 200 OPA1 mutations (Ferre et al., 2005; Ferre et 
al., 2009) which cause ADOA with wide phenotypic variations both within and 
between affected families (Votruba et al., 1998a; Granse et al., 2003). In the 
mouse model, the mutant mice (>10 months old) were genetically homogenous 
and disease severity correlated with age. Participants studied here were from 6 
families, with a different mutation in each family, and at different stages of the 
disease. This may have diluted observations that would have been made from a 
homogenous cohort. 
 
6.3.2 Comparison of ERGs from Different Retinal Locations in ADOA and 
Control Participants 
PERGs and focal ERGs were recorded from the central, nasal and temporal 
retinas in both participants with ADOA and controls to assess whether ADOA 
showed a preferential locus of damage to the retina. The amplitude of the N95 
was significantly reduced in the ADOA group compared to controls in all 
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locations while in the case of the focal PhNRs, the difference between the 
ADOA and control group was significant in the central and temporal macula, but 
not the nasal macula. In cases of both the N95 and focal PhNR amplitudes, the 
greatest difference between the ADOA and control group was recorded in the 
central macula. This was consistent with the hypothesis that the greatest 
difference between participants with ADOA and controls would be recorded 
from the central macula since ADOA was characterised by central scotomas.  
 
It was also expected that the difference in the nasal macula would be greater 
than that in the temporal macula since centrocoecal scotomas also characterise 
ADOA. However, the amplitude difference between the ADOA and control 
groups for the N95 amplitude was approximately equal for the nasal and 
temporal macula while the focal PhNRs reported a significant difference in the 
temporal, but not the nasal. This could be explained by the variable visual field 
defects present in the ADOA cohort in this study. Centrocoecal scotomas are 
frequently reported in ADOA, however scotomas in other locations are also 
common (Votruba et al., 1998a). With regards to the focal PhNRs, the lack of 
statistical difference between the ADOA and control groups in the nasal macula 
could be related to the factors that caused the waveform of the ERGs from the 
nasal macula to be different to those recorded from the central and temporal 
retina. These factors are discussed below where the ERGs recorded from the 
three locations within each cohort are compared.  
 
In healthy individuals, the nasal retina has a greater RGC density than the 
temporal retina at similar eccentricities (Curcio and Allen, 1990; Silveira and 
Perry, 1991; Dacey, 1993b). It was therefore expected that in controls, the N95 
and focal PhNR amplitudes from the nasal retina would be greater than those 
from the temporal retina as shown in previous studies (Kurimoto et al., 2009). 
However, in both the focal PERG and focal ERG, responses initially recorded 
from the nasal macula had smaller N95 and PhNR amplitudes than those from 
the temporal macula. It was assumed that this reduction in the nasal retina was 
due to the optic nerve head being present within the stimulated area when the 
20o stimulus was moved to the nasal side of the fovea. Since ERGs amplitudes 
are directly proportional to retinal cell numbers (Murray et al., 2004), the nasal 
ERG were multiplied by a factor of 1.11 (for PERGs) and 1.14 (for focal ERG) to 
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account for the loss in signal due to the optic nerve head (assuming an angular 
radius of 3.5o (Curcio and Allen, 1990)). This however did not result in the nasal 
N95 and focal PhNRs becoming significantly greater than their counterparts 
from the temporal macula. The temporal PhNR-ON, for example, remained 
significantly greater than the nasal PhNR-ON (Figure 6.6, right column). 
 
In both the PERG and focal ERGs, the control group-averaged traces from the 
nasal macula were different in waveform compared to those from the central 
and temporal retina (Figure 6.3B and 6.6B) as observed previously in Chapter 3 
(compare Figure 3.2). As explained in section 3.4, the reasons for this could be 
due to the luminance imbalance caused by the presence of the ONH when the 
nasal retina was stimulated and/or the intrusion of components associated with 
the optic nerve head (Sutter and Bearse Jr, 1999).  
 
Interestingly, the ADOA group-averaged waveforms of the PERG and focal 
ERGs from the three locations (Figure 6.3A and 6.6B) were more similar to 
each other than the control group-averaged waveforms (Figure 6.3B and 6.6B); 
the difference plots (grey traces) for comparisons in the ADOA group were less 
remarkable (appeared flatter) than for comparisons in the control group. This 
suggested that the factors contributing to the waveform differences in the 
control ERGs recorded from the three retinal locations may have been removed 
or diminished by the disease. It was further observed that the waveforms of the 
ADOA group-averaged focal ERGs from all three locations (red traces in Figure 
6.5B) were closely similar in shape to the control group-averaged trace from the 
nasal retina. The waveform similarity is shown for the comparison between the 
nasal records of the ADOA and control group-averaged traces in the middle 
column of Figure 6.5B. In addition, the waveform difference between the nasal 
trace and the central/temporal trace in controls was most obviously observed in 
the OFF responses. This particular difference in the OFF responses in controls 
was similar to the differences observed in the OFF responses between the 
ADOA and control group for the central and temporal macula (Figure 6.5B). 
These observations suggested that the ERGs recorded from controls may have 
contained a component whose amplitude and/or time-to-peak were/was 
influenced by proximity to the optic nerve head (or eccentricity away from the 
fovea). This potential will be called the late-potential (LP).  
Chapter 6 
203 
 
 
In light of the fact that the ERG recorded at the cornea is the resultant wave 
produced by the superimposition of several component waves arising from 
different retinal cells (as explained for example by Granit’s classical analysis 
(Granit, 1933) or Sieving’s push-pull model (Sieving, 1993; Sieving et al., 
1994)), it was difficult to establish the true nature of the LP without further 
evidence. Such evidence could have been procured from a pharmacological 
study into the nature and origin of the LP, however, this was beyond the scope 
of this study. Nevertheless, the following inferences may be made about the LP. 
1.  It was a slow component with a time-to-peak either coinciding with or 
occurring close to the time-to-peak of the PhNR-OFF component 
2. Its amplitude and/or time-to-peak were/was influenced by proximity to the 
optic nerve head (or eccentricity away from the fovea) 
3. It was susceptible to the dysfunction of RGC bodies, RGC axons or the 
optic nerve, and further suggesting that it may have been generated by 
or related to these elements. 
 
Although the proposal about the LP is drawn from the results of the focal ERGs, 
the results of the transient PERG are also consistent with the submission. The 
transient PERG generated in this study (using ISCEV standards) does not 
discriminate between ON and OFF components, they overlap. However, 
pharmacological interventions which selectively block ON or OFF pathways 
have shown that the P50 component of the transient PERG originates from both 
spiking and non-spiking activity of ON and OFF pathways, while the N95 
originates solely from the spiking activity of the two pathways (Viswanathan et 
al., 2000; Luo and Frishman, 2011). If as proposed, the LP exerts its greatest 
influence in the nasal macula and at a time coinciding with the activities of the 
OFF-RGCs, then one would expect that, at least in the control group, any 
differences in the PERG waveforms between the nasal and central/temporal 
macula would be seen prominently in the N95 component. This was the case as 
seen in Figure 6.3, thereby lending credence to the LP theory. It was earlier 
suggested that luminance imbalance may be responsible for the difference in 
the nasal PERG. The current proposal about the LP is not necessarily in 
contradiction with that since both luminance imbalance and the LP may together 
be responsible for the differences observed.  
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A discrepancy was noticed between the quantitative comparison of the ERG 
components and the qualitative (graphical) comparisons of the group-averaged 
ERGs in the comparison of ERGs from different locations within the groups 
(repeated measures comparisons). For example, in Figure 6.3B (middle 
column), the most negative point of the N95 trough for both central and 
temporal PERGs occur at the same point (~ -2uV) and an overlap of the 95% 
confidence intervals may be observed. However, since the N95 amplitude was 
quantitatively measured from the peak of P50 (as recommended by ISCEV), 
which was reduced in the temporal macula, the N95 amplitude of the temporal 
macula was also reported to be significantly reduced when analysed with SPSS 
(Table 6.2). Conversely, in Figure 6.3 (right column), a separation of the 95% 
confidence intervals for the N95 components of the nasal and temporal macula 
was observed, yet quantitative analysis reported no significant difference 
between the two locations. The presence of the discrepancy between the 
quantitative and graphical comparisons therefore supports a different approach 
for measuring the N95 amplitude (e.g. from baseline). 
 
A similar phenomenon was observed for the focal ERGs (Figure 6.6A, left 
column). The PhNR-OFF components in the graph overlap, yet quantitative 
analysis showed them to be significantly different. This was also due to the 
method of measuring the PhNR components. The PhNR-OFF was measured 
from the d-wave to a fixed time point which was determined as the time point 
marking the greatest difference between the ADOA and control groups. This 
fixed time point was different for the two locations (Table 5.3) and hence the 
amplitudes for the two locations were also different. This discrepancy again 
supports alternative methods of measuring the ERG components which do not 
rely solely on peaks and troughs (Gauvin et al., 2014; Wood et al., 2014).  
 
6.3.3 Comparison of Focal and Full-field PhNRs  
The long duration focal and full-field ERGs in this study were recorded using the 
same stimulus parameters, which were comparable to the parameters 
recommended by Kondo et al (Kondo et al., 2008a) for eliciting focal responses. 
This enabled a comparison of the long duration focal (central macula only) and 
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the full-field ERG to determine the effect of ADOA on them. Although the 
waveforms of the focal and full field ERGs were similar within the ADOA and 
control groups, they were not identical (Figure 6.8A-B). In the control group, 
there was a greater contribution of PhNR-ON and PhNR-OFF components to 
the focal ERG than to the full-field ERG (Figure 6.8A) which reflects the 
decreasing proportion of RGCs with eccentricity (Curcio and Allen, 1990). The 
focal PhNRs were more severely affected than their full-field counterparts by 
ADOA and this was reflected in the larger normalised difference plot (Figure 
6.8C) and AUCs (Table 6.8) found for the focal signals. In addition, whereas the 
focal ON- and OFF-PhNRs were both significantly reduced (p<0.001), only the 
full-field PhNR-OFF was significantly reduced in the full-field ERG (Table 2). 
These findings were consistent with the central field defects recorded in ADOA 
participants in this study and in others (Votruba et al., 1998a; Votruba et al., 
1998b; Fuhrmann et al., 2010).  
 
The symmetrical loss in the focal PhNR-ON and PhNR-OFF amplitudes (Figure 
6.5B, left column and 6.8C) may reflect the 1:1 ratio of ON- to OFF-RGCs in the 
macula, while the greater loss in the full-field PhNR-OFF amplitude than the 
PhNR-ON amplitude (Figure 6.7C and 6.8C) reflects the nearly 1:2 (Dacey and 
Petersen, 1992; Dacey, 1993b; Drasdo et al., 2007) ratio of ON- to OFF- RGCs 
in the peripheral retina. The broadening of the d-wave peak in the focal ERG 
and the presence of the 3PP in the full-field long ERG in participants with ADOA 
may be due to contributions from the cone receptor potential (CRP) and/or 
depolarising OFF-bipolar cell responses after light offset which were unmasked 
in the relative absence of the negative going PhNR-OFF (Bush and Sieving, 
1994; Sieving et al., 1994). The 3PP in the full-field ERG could also be due to 
the unmasking of the late positive potential originating from the optic nerve as 
proposed earlier. The 2PP may be the iOFF-wave described by Horn et al (2011), 
although in contrast to their results, this study did not record a significant 
difference in amplitude between controls and participants with ADOA in this 
component. 
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6.3.4 Comparison to other Electrophysiological Studies in ADOA 
Miyata et al (2007) reported a significant reduction in the full-field brief PhNR, 
but none in the a- or b-wave amplitude, in ADOA patients using white-on-white 
stimulus. Similar results were obtained by Barnard et al (Barnard et al., 2011) in 
the mouse model. This present study found similar results using a red on blue 
stimulus. The flash luminance used in this study was adopted from a previous 
study in this laboratory (Mortlock et al., 2010) and was comparable to the flash 
luminance used by Miyata et al (2007). This supports findings that the red-on 
blue stimulus is effective for clinical evaluation of RGC function.   
 
Holder et al reported a significant reduction in N95 amplitude and the N95:P50 
ratio of the PERG participants with ADOA (Holder et al., 1998). Similar results 
were obtained and showed that the performance of the focal PhNRs and N95 
amplitude at discriminating controls from participants with ADOA were not 
significantly different. The focal ERG could therefore be used as an alternative 
to the PERG, and has the advantage of not relying on clear optical media or 
refractive error correction (as is the case for the PERG). Although the N95 and 
focal PhNR amplitudes were highly diagnostic for ADOA, it should be noted that 
the participants in this study had relatively late stage disease. The better 
performance of the N95 (although not significant) could therefore imply an 
advantage of the PERG over the focal PhNRs in the detection of early or 
subclinical stages of the disease as has been reported for comparisons 
between the PERG and full-field PhNRs (North et al., 2010; Preiser et al., 
2013). 
 
In this study, as well as in the study by Holder et al (1998), the P50 amplitude 
was significantly reduced. Since bipolar cells are involved in generating the 
P50, this may indicate that bipolar cell function is compromised as well in 
ADOA.  In fact, Reis et al reported a significant reduction in the N1 and P1 of 
the multifocal ERG in participants with ADOA indicating bipolar cell dysfunction 
which they attributed to retrograde degeneration of bipolar cells subsequent to 
RGC dysfunction in ADOA (Reis et al., 2013). However, a significant reduction 
in the amplitudes of the b- or d-wave, which also originate from ON- and OFF-
bipolar cells respectively, was not found.  
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6.3.5 Effect of Age of Long Duration PhNR 
One of the objectives of this study was to find out whether age significantly 
affected the amplitudes of the PhNR components. Some previous studies had 
found that visual function in ADOA measured by VA or VFS deteriorated with 
age (Berninger et al. 1991; Yu-Wai-Man et al. 2010a; Reis et al. 2013). Some 
other studies, however, did not find any significant decline in visual function with 
age in ADOA patients (Votruba et al. 1998a; Cohn et al. 2008; Almind et al. 
2012; Ronnback et al. 2013). In this study, there was no significant effect of age 
on the ERG amplitudes except for the PhNR-OFF amplitude which decreased 
with age (Table 6.8). Age accounted for ~50% of the variance observed in the 
PhNR-OFF amplitude in participants with ADOA compared to 14% in controls. 
This finding could imply that the full-field PhNR-OFF amplitude may be a better 
indicator of disease progression (or severity) than the other ERG parameters, 
although the reason for this could not be determined. Alternatively, it could be 
due to an interaction of other OFF components; e.g. an age-related delay in d-
wave time-to-peak may be impacting on the PhNR-OFF component.  
 
Apart from the heightened effect of age on the PhNR-OFF amplitude in 
participants with ADOA, the results presented here and the earlier results of no 
significant effect of age on the psychophysical or structural defects in ADOA 
(section 5.4.3 and 5.4.6), agree with the proposal other environmental 
and/genetic factors other than age impact largely on the severity of visual 
dysfunction (Ronnback et al., 2013).  
 
 
6.4 Conclusion 
The following conclusions are drawn from this study. 
1. The ON- and OFF-RGCs are equally affected in patients with 
symptomatic ADOA, as evidenced by the symmetrical reduction in 
amplitude of the focal PhNR-ON and PhNR-OFF in participants with 
ADOA across a range of disease severity.  
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2. The central retina is primarily affected in ADOA as demonstrated by the 
fact that the central macula produced the greatest differences in the focal 
PhNR and N95 amplitudes between the ADOA and control groups. In 
addition, the focal PhNRs were superior to the full-field responses at 
discriminating participants with ADOA from controls.  
3. The focal PhNR and N95 components have similar diagnostic power and 
are similarly effective at discriminating between participants with ADOA 
and controls. 
4. With the exception of the full-field PhNR-OFF amplitude, disease severity 
determined by electrophysiology was not significantly affected by age in 
ADOA. 
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 CHAPTER SEVEN - ELECTROPHYSIOLOGICAL 
ASSESSMENT OF RETINAL FUNCTION IN 
AUTOSOMAL DOMINANT OPTIC ATROPHY – III: 
RELATIONSHIP BETWEEN 
ELECTROPHYSIOLOGICAL, PSYCHOPHYSICAL 
AND STRUCTURAL MEASURES 
 
7.1 Preamble 
The results of the baseline tests and the electrophysiological assessment of the 
participants were presented in Chapters 5 and 6 respectively. This chapter 
explores the relationship between the psychophysical, structural and 
electrophysiological results using correlation coefficients and linear regression 
analysis. 
 
7.2 Introduction 
ADOA causes losses in visual function which have been measured using a 
variety of psychophysical tests namely visual acuity, visual fields, contrast 
sensitivity and colour vision tests (Kjer, 1959; Krill et al., 1970; Kline and Glaser, 
1979; Hoyt, 1980; Kjer et al., 1983; Berninger et al., 1991; Eliott et al., 1993; 
Kjer et al., 1996; Brown et al., 1997; Johnston et al., 1997; Simunovic et al., 
1998; Votruba et al., 1998a; Votruba et al., 1998b; Johnston et al., 1999; 
Thiselton et al., 2002; Votruba et al., 2003a; Nakamura et al., 2006; Walters et 
al., 2006; Cohn et al., 2008; Yu-Wai-Man et al., 2010a; Yu-Wai-Man et al., 
2010b; Almind et al., 2012; Reis et al., 2013; Ronnback et al., 2013). These 
studies showed that visual dysfunction in participants with ADOA was 
characterised by reduced visual acuity and contrast sensitivity as well as visual 
field defects and colour vision anomalies. They also reported however, wide 
inter- and intra-family variations in the results of these tests, which ranged from 
normal to severe loss. 
 
Histological examination of post-mortem tissue in humans and murine models 
shows that the RGCs and their axons are selectively affected in ADOA 
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(Johnston et al., 1979; Kjer et al., 1983; Williams et al., 2010; Sarzi et al., 2012; 
Williams et al., 2012). These findings have been confirmed in studies using 
optical coherence tomography (OCT) which provides a means of measuring the 
thickness of the retina in-vivo (Ito et al., 2007; Barboni et al., 2010; Milea et al., 
2010; Barboni et al., 2011; Gocho et al., 2013; Russo et al., 2013; Carbonelli et 
al., 2015). The parapapillary retinal nerve fibre layer (RNFL), especially the 
temporal quadrant, is significantly reduced in ADOA compared to healthy 
controls or mutation-free first degree relatives of patients with ADOA (Ronnback 
et al., 2013). The macula is also thinner in people with ADOA than healthy 
controls (Ito et al., 2007). Current advances in OCT technology which allow 
layer by layer segmentation of the retina and analysis have been used in a 
number of studies (Ito et al., 2007; Gocho et al., 2013; Ronnback et al., 2013; 
Russo et al., 2013; Carbonelli et al., 2015) and show that the thickness of the 
inner retina comprising the RNFL, ganglion cell layer (GCL), and inner plexiform 
layer (IPL), is significantly reduced in participants with ADOA compared to 
controls, while the outer retinal layers are spared. 
 
Electrophysiological tests of retinal function in participants with ADOA also 
show a reduction in the amplitude of the photopic negative response (PhNR) 
component of the flash ERG (Miyata et al., 2007; Morny et al., 2015), the PERG 
and PVEP (Holder et al., 1998; Russo et al., 2013); findings which are 
consistent with RGC dysfunction.  
 
The psychophysical, structural and electrophysiological test results point to 
defects consistent with RGC damage. The purpose of this part of the study was 
therefore to determine the relationship between these tests in participants with 
ADOA and to find out whether the electrophysiological tests (the main 
instrument of this study) could be used to predict results of the psychophysical 
or structural tests. Since there were more than two measurement variables 
under consideration, it would have been ideal to perform multiple regression 
analysis. Multiple regressions provide an equation that best predicts the Y 
(dependent) variable as a linear function of the X (independent) variables. 
However, as a rule of thumb, there should be at least 10 observations per 
independent variable (Altman, 1991). This implied that for the six 
electrophysiological variables to be used as the independent variables, 60 
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cases per group would be required. As there were not enough cases in this 
study to satisfy this criteria, linear correlation and linear regression analysis 
were used instead.  
 
 
7.3 Methods 
The methods for recording the baseline measures and electrophysiological tests 
are described in Chapter 5.  
 
7.3.1 Statistical Analysis 
Correlations within the ADOA dataset were explored using Spearman’s rank 
correlation test (2 tailed) since the distribution of the data was not always 
normal. Statistical significance was set at p< 0.05 (with no Bonferroni 
correction). Linear regression analysis were later performed on comparisons for 
which the correlation coefficients were significant. With regards to the PERG 
and focal ERG data, only results from the central retina were used in these 
analyses. Cohen’s convention was adopted in categorising the strength of the 
correlation coefficient where 0 – 0.29 was classified as weak, 0.30 – 0.49 as 
moderate and >0.5 as strong (Cohen, 1988). 
 
 
7.4 Results 
The characteristics of the twelve participants with ADOA as well as the results 
of their baseline and electrophysiological assessments have been reported in 
Chapters 5 and 6.  
 
7.4.1 Correlation between Psychophysical and Electrophysiological 
Measures 
Figure 7.1 shows the scatter plots for comparisons between the 
electrophysiological (N95 of the PERG, focal and full-field PhNR-ON and PhNR-
OFF and brief flash PhNR) and the psychophysical (VA, CS, VFS) tests in 
participants with ADOA. The corresponding correlation coefficients for the 
comparisons are shown in Table 7.2 for participants with ADOA.  
 
Chapter 7 
212 
 
 
Figure 7.1. Scatter plots of ERG components and psychophysical measures in participants with ADOA. The amplitude of the ERG components (shown as 
headings on the columns) are plotted on the horizontal (x-) axis against the vertical (y-) axis of (A) visual acuity in logMAR; (B) contrast sensitivity (CS) in 
log units and (C) mean deviation in dB. 
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Table 7.1. Correlations between psychophysical (vertical axis) and electrophysiological 
(horizontal axis) assessments in participants with ADOA 
Parameter Cor  N95 
Focal 
PhNR-
ON 
Focal 
PhNR-
OFF 
Full-
field 
PhNR-
ON 
Full-
field 
PhNR-
OFF 
Brief 
PhNR  
VA, 
logMAR 
 r = 
 p = 
-0.65 
0.06 
-0.53 
0.08 
0.10 
0.75 
-0.55 
0.06 
-0.20 
0.53 
-0.06 
0.91 
CS, log 
units 
 r = 
 p = 
0.42 
0.30 
0.22 
0.52 
0.26 
0.45 
0.22 
0.52 
0.58 
0.06 
-0.41 
0.43 
VFS 
(18o x 18o), 
dB 
 r = 
 p = 
0.50 
0.17 
0.51 
0.09 
0.04 
0.90 
0.48 
0.12 
0.32 
0.31 
-0.07 
0.88 
Cor – Spearman’s correlations test (2-tailed); r – correlation value; p – p-value of significance. 
Size of ADOA group, n = 12, except for comparisons with N95 (n = 9) and brief PhNR (n = 7). 
None of the correlations were statistically significant (p>0.05). 
 
In participants with ADOA, there were moderate inverse correlations between 
VA and the N95, focal PhNR-ON and full-field PhNR-ON amplitudes; that is, 
better VA was associated with higher ERG amplitudes. The VFS showed a 
moderate correlation with the N95, focal and full field PhNR-ON amplitude. The 
correlations between the psychophysical tests and the focal or full-field PhNR-
OFF amplitudes were weak, except between CS and full-field PhNR-OFF 
amplitude. However, none of the correlations reached statistical significance. 
 
7.4.2 Correlation between Structural and Electrophysiological Measures 
The correlations between structural and the electrophysiological measures are 
shown in Table 7.2 and Figure 7.2. The peripapillary RNFL, inner macula layer 
and total retinal thickness were selected for analysis because they were the 
parameters which were significantly reduced in ADOA compared to controls. In 
participants with ADOA, the total peripapillary RNFL thickness showed strong 
correlations with the N95 (r = 0.94), focal PhNR-ON (r = 0.83) and full-field 
PhNR-ON (r = 0.66) as well as with the brief PhNR (r = 0.7). However, these 
correlations were significant only for the N95 and focal PhNR-ON amplitude. 
The equation of the regression analysis for N95 amplitude (x-axis) and 
peripapillary RNFL thickness (y-axis) was y = 13.80x + 16.09, R2 = 0.83, p = 
0.01, while that for the PhNR-ON amplitude (x-axis) and peripapillary RNFL 
thickness (y-axis) was y = 14.25x + 27.48, R2 = 0.64, p = 0.06. 
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Figure 7.2. Scatter plots of OCT measures and ERG amplitudes in participants with ADOA. The amplitude of the ERG components (shown as headings 
on the columns) are plotted on the horizontal (x-) axis against the vertical (y-) axis of (A) peripapillary RNFL; (B); inner macular (RNFL+GCL+IPL) 
thickness and (C) total macular thickness. * - Correlation was significant at p < 0.05. Dotted lines represent regression lines 
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Table 7.2 Correlations between structural (vertical axis) and electrophysiological 
(horizontal axis) assessments in participants with ADOA. 
Parameter Cor N95 
Focal 
PhNR-
ON 
Focal 
PhNR-
OFF 
Full-field 
PhNR-
ON 
Full-field 
PhNR-
OFF 
Brief 
PhNR  
Total 
peripapillary 
RNFL, um 
 r = 
 p = 
0.94 
0.01 
0.83 
0.04 
0.26 
0.62 
0.66 
0.16 
0.20 
0.70 
0.70 
0.19 
Inner Macula 
Thickness, um 
 r = 
 p = 
0.77 
0.07 
0.26 
0.62 
-0.14 
0.79 
0.09 
0.87 
0.09 
0.87 
-0.20 
0.75 
Total Macular 
Thickness, um 
 r = 
 p = 
0.66 
0.16 
-0.03 
0.96 
-0.26 
0.62 
0.03 
0.96 
-0.31 
0.54 
0.20 
0.75 
Par’t – participant type; AD – ADOA; C – Control; Cor – Spearman’s correlations test (2-tailed); r 
– correlation value; p – p-value of significance. Significant correlations at p< 0.05 are shown in 
bold fonts in shaded cells. Size of ADOA group, n = 6, except for comparisons with brief flash, 
where n = 5. 
 
 
7.5 Discussion 
This chapter explored the relationship between the electrophysiological, 
psychophysical and structural measures in participants with ADOA in order to 
determine whether the psychophysical and structural results could be predicted 
from the electrophysiological results. Correlations between the psychophysical 
and electrophysiological tests did not attain statistical significance in this study, 
although previous studies have shown correlations between psychophysical 
tests (VA and mean deviation) and ERG amplitudes (N95 and PhNR) in 
glaucoma studies (Colotto et al., 2000; Viswanathan et al., 2001; Garway-Heath 
et al., 2002; Harwerth et al., 2002). For example, Colotto et al. (2000) found a 
significant correlation (r = 0.60, p < 0.05) between the N95 amplitude and the 
mean deviation of the VFT in 11 glaucoma patients while Viswanathan et al. 
(2001) also found a significant correlation (r = 0.59, p < 0.01) between the brief 
PhNR amplitude and the mean deviation in 18 glaucoma patients. In this study, 
some of the correlations showing large effects approached statistical 
significance (e.g. VA vs N95, VA vs focal PhNR-ON and CS vs full-field PhNR-
OFF in Table 7.1) and a significant effect might have been found if a larger 
sample size had been used. Using Cohen’s convention (Cohen, 1988), the 
reported r values in the previous literature (Colotto et al. 2000; Viswanathan et 
al. 2001) suggested a large effect (r > 0.5) for the association between the ERG 
and psychophysical parameters. To detect such an effect at a significant value 
of 0.05 and power of 80% in the ADOA cohort, a minimum sample size of 29 
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was required for the bivariate correlation (Hulley et al., 2013) (see Appendix V 
for calculation). 
 
It is, however, important to note that though the psychophysical and 
electrophysiological tests both assess related aspects of visual function, and 
were expected to be significantly correlated, the two categories of tests differ in 
their nature (Garway-Heath et al., 2002). The ERGs are objective measures of 
massed retinal responses to a suprathreshold stimulus, whereas the 
psychophysical tests depend on subjective responses to a threshold stimulus. 
The fact that these sets of results were not correlated suggest that the 
information provided by the two types of test are independent and 
complementary. The combination of subjective and objective functional tests 
could thus improve disease detection and staging of progression (Garway-
Heath et al., 2002).   
 
Table 7.3. Comparison of the correlation coefficient between RNFL thickness and ERG 
(N95 and PhNR) amplitudes obtained in previous studies 
Study Variables Sample Size Correlation 
coefficient, r 
p-value 
Parisi et al. (2001) N95 vs RNFL 30 (OAG) 0.69 < 0.0001 
Toffoli et al (2002) N95 vs RNFL 112 (OAG+OHT+C) 0.31  < 0.05 
North et al. (2010) N95 vs RNFL 23 (OHT) 0.26 0.020 
Machida et al. (2008) PhNR vs RNFL 99 (OAG) 0.53 <0.001 
Horn et al. (2011) PhNR-ON vs RNFL  53 (OAG+OHT+C) -0.46# 0.001 
Initials in brackets indicate sample group used in analysis. POAG = open angle glaucoma; OHT 
= ocular hypertensive patients; ADOA = autosomal dominant optic atrophy; C = controls. # = 
The PhNR-ON amplitude was defined by the deepest negative point after following the b-wave.  
 
The correlations between the OCT and the electrophysiological results were 
mostly not significant (Table 7.2). Significant correlations were found only for 
the peripapillary RNFL and N95 amplitude (r = 0.94, p <0.01) and the 
peripapillary RNFL and focal PhNR-ON amplitude (r = 0.83, p <0.05). 
Regression analysis showed that the N95 amplitude accounted for more than 
80% of the variance in RNFL thickness, implying a good model fit for predicting 
peripapillary RNFL thickness. Similar significant relationships have been shown 
in previous studies (Table 7.3) (Parisi et al., 2001; Toffoli et al., 2002; Parisi, 
2003; Ventura et al., 2006; North et al., 2010), which, highlight the fact that the 
N95 of the PERG reflects the activities of the RGCs (Arden et al., 1982; Bach et 
al., 1992; Thompson and Drasdo, 1994; Holder et al., 1998; Holder, 2001; Bach 
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and Hoffmann, 2008). Although the correlation coefficient between the PhNR-
ON and RNFL was strong and significant (r = 0.83, p = 0.04), the relationship 
failed to reach statistical significance in regression analysis. Considering that 
the R2 value for the relationship was ~60%, it is possible that the lack of 
statistical significance was due to the small sample size in this study.  
 
In this study, the correlation between the PhNR-OFF amplitude and RNFL 
thickness was weak and not statistically significant. Only one previous study 
was found to have reported on the correlation between the PhNR-OFF 
amplitude and the RNFL thickness (Horn et al., 2011). They found a significant 
correlation between the PhNR-OFF and RNFL thickness (Figure 7.3). A critical 
appraisal of their data, however, showed that controls and glaucoma patients 
were analysed together, with the controls clustering to one side and the 
glaucoma patients to another side. If the data from the glaucoma patients (filled 
circles) were isolated, their reported significant relationship would likely 
breakdown.  
 
Figure 7.3. Correlation between the full-field PhNR-OFF amplitude and peripapillary RNFL 
thickness a combined group of participants with glaucoma (filled circles) and ocular 
hypertension (open circles) as well as controls (crosses). The diagonal line is the line of 
regression. r = Pearson’s correlation. p = p-value of significance. (Horn et al., 2011) 
 
The scarcity of such reports is due to the high variability in measuring the 
PhNR-OFF (Viswanathan et al., 1999; Colotto et al., 2000; Horn et al., 2011). 
Although the ADOA cohort in this study was comparatively small, the large 
variability was present in the control group as well. Furthermore, the experiment 
correlating the PhNR-ON and –OFF with RGC distribution (Chapter 4) showed 
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that the PhNR-OFF had the poorest fit to published OFF-centre RGC 
distributions.  
 
7.6 Conclusion  
In this study, there were no significant correlations between the 
electrophysiological and psychophysical tests of visual function in ADOA 
participants. This implies that the two classes of tests assess different aspect of 
visual function. In addition, the correlation between electrophysiological and 
structural measures assessed using the OCT were significant only for 
correlations between the N95 amplitude and the RNFL thickness as well as the 
PhNR-ON amplitude and RNFL thickness. The results of this study supports the 
view that disease detection and staging of disease progression may be 
improved when electrophysiological, psychophysical and structural tests are 
combined. However, given the small sample size included here the results 
should be treated cautiously. 
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 CHAPTER EIGHT – GENERAL DISCUSSION AND 
CONCLUSION 
 
 
8.1 Discussion and Conclusion 
The primary aim of this thesis was to assess the effect of ADOA on the PhNR-
ON and PhNR-OFF components of the photopic ERG in order to determine 
whether the ON pathway was selectively susceptible to the disease. In order to 
achieve the main aim of this study, a series of studies was conducted in 
Chapter 2 using control participants to develop a suitable protocol for recording 
the focal long duration PhNR. A 250 msec red flash of luminance 55cd/m2 with 
an angular diameter of 20o flashing at 2Hz on a rod saturating blue background 
of luminance 100 scot cd/m2 was found to be optimal for eliciting the PhNR-ON 
and –OFF components of the photopic ERG. Previous studies which recorded 
focal ERGs used stimulus sizes ranging from 5 – 15 degrees (Kondo et al., 
2008a; Machida et al., 2008b; Kurimoto et al., 2009; Tamada et al., 2009; 
Tamada et al., 2010; Nakamura et al., 2011a; Nakamura et al., 2011b). 
However, a 20o stimulus size was chosen for this study to encompass as much 
of the central field as possible while avoiding the optic disc, which starts 
approximately 12o to 15o nasal to the fovea. 
 
It has been hypothesised that the tritanopic defects often associated with ADOA 
may be due to preferential damage to the S-cone pathway caused by the 
disease (Johnston et al., 1999). Since the red-on-blue stimulus produces L and 
M cone dominated ERGs (Viswanathan et al., 1999; Rangaswamy et al., 2007; 
Sustar et al., 2009), it was initially desired to also assess the S-cone pathway 
by eliciting S-cone dominated ERGs using a blue flash (luminance = 55 cd/m2) 
on a rod saturating amber background (luminance = 115 scot cd/m2). Although 
the S-cone ERGs successfully recorded in some control participants and in two 
ADOA participants, this extended the entire duration of the experiments and 
increased patient fatigue. This aspect of the study was therefore discontinued. 
The parameters of the focal ERG were later used to record full field ERGs in 
order for the focal and full-field ERGs to be directly comparable.  
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As the PhNR of the flash ERG and the N95 of the PERG have been previously 
reported to share similar retinal origins (Viswanathan et al., 2000; Luo and 
Frishman, 2011), the retinotopic characteristics of the focal ERG and PERG 
were compared in Chapter 3. It was found that the focal ERG and PERG 
exhibited certain similar retinotopic characteristics. In both the focal ERG and 
PERG, the ERG waveforms recorded from the nasal macula were different from 
those recorded from the central and temporal macula. In addition, the 
amplitudes of their respective subcomponents recorded from the central macula 
were significantly larger than amplitudes from the nasal and temporal retinal. 
This agreed with histological data showing that neuronal densities in the central 
macula are greater than in the nasal or temporal macula (Curcio and Allen, 
1990; Curcio et al., 1990). However, while the positive components of the focal 
ERG (b- and d-waves) and PERG (P50) in the nasal macula were significantly 
greater than in the temporal retina, the negative going components of the focal 
ERG (a-wave, PhNR-ON and PhNR-OFF) and PERG (N95) did not show 
significant differences. This was contrary to expectations as histological data 
shows that the neuronal density is significantly greater in the nasal macula than 
in the temporal macula. The identification of a new ERG component, the late 
component (LC), in addition to other factors such as luminance imbalance of the 
PERG stimulus and the intrusion of the optic nerve head component may have 
contributed to this discrepancy.  
 
In spite of the similarities in the focal ERG and PERG, linear regression analysis 
found no significant relationship between the amplitudes of the focal long 
duration PhNRs (measured using peak-to-trough method) and the N95. This 
implied that the retinal origins of these components are not identical. This is a 
clinically relevant finding as it shows that the ERG subcomponents may assess 
different aspects of RGC function (Preiser et al. 2013) 
 
In Chapter 4, the relationship between the PhNR (elicited by brief and long 
stimuli) and RGC density obtained from published data (Curcio and Allen, 1990; 
Watson, 2014) was evaluated. Linear regression analysis established a 
significant relationship between the PhNRs and RGC density. This showed that 
the PhNR reflected the distribution of RGCs in the retina and could therefore be 
used as a reliable measure of RGC function. 
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Chapters 5 – 7 constituted the main study of this thesis where the main aims 
presented in section 1.7 were addressed. Retinal function in twelve participants 
with ADOA and sixteen healthy age matched controls was assessed using focal 
(20o) and full-field ERGs produced in response to a long duration red flash (55 
cd/m2, 2Hz) on a rod saturating blue background (100 scot cd/m2). Additional 
electrophysiological assessment included the PERG and the full-field ERG in 
response to a brief red flash on a rod saturating blue background. Baseline 
tests of visual function (VA, CS and VFT and colour vision) and structure (OCT) 
were also carried out.  
 
The results of the studies carried out in this thesis demonstrated that ADOA 
affects both the ON and OFF RGC pathways. There was no evidence of a 
preferential effect on ON-RGCs as had been hypothesised based on previous 
findings in a mouse model of the disease. As noted previously in section 6.3.1, 
the evidence for the preferential loss of ON-RGCs in the mouse model was 
based on histological data showing significant dendritic pruning of ON-, but not 
OFF-centre RGCs, while this study assessed the effect of ADOA on the ON- 
and OFF-RGCs using the PhNR amplitude of the human ERG, a functional 
measure. The susceptibility of the PhNR amplitude to functional damage even 
when other functional and morphologic parameters remain normal makes it 
plausible that the PhNR-ON amplitudes may be selectively compromised at an 
earlier stage of the disease process than that studied here. A longitudinal study 
in pre-symptomatic people with the OPA1 mutations or in people with ADOA at 
a much earlier stage of the disease (e.g. children with ADOA) could provide 
additional insights.  
 
This thesis further demonstrated that the largest difference between participants 
in ADOA and controls was recorded in the central macula, followed by the 
temporal macula with the least difference being in the nasal macula. This 
confirmed that the central macula is the most susceptible part of the retina to 
ADOA. If the paracentral areas of the retina are relatively spared in ADOA as 
suggested by the results of this study, patients with ADOA may benefit from 
vision rehabilitation strategies that enhance the use of eccentric viewing training 
(Gaffney et al. 2014).  
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Differences in the ERGs between ADOA and control groups were not only 
observed in the amplitudes and times-to-peak of subcomponents, but also in 
the waveform of the ERG. The broadening of the d-wave peak in the focal ERG 
and the emergence of the late positive peak (2PP) in the full field ERG seen in 
the ADOA are examples of these waveform changes. When the waveform 
differences between ADOA and control groups are coupled with the waveform 
differences of the nasal and central/temporal macula, the method of using 
amplitude and time-to-peak to evaluate ERG components prove inadequate. 
Other methods of waveform analysis (e.g. principal component analysis, Fourier 
analysis, are required in assessing the ERG waveform in order capture more of 
the information contained therein. Such novel approaches to evaluating the 
ERG are currently being tried (Gauvin et al., 2014; Wood et al., 2014). 
 
In light of ongoing studies to find a treatment for a number of hereditary optic 
neuropathies, of which ADOA is part (Yu-Wai-Man et al., 2014), the 
establishment of robust early biomarkers of disease and the quantification of 
RGC dysfunction is an essential prerequisite for human treatment trials. This 
thesis is important to the extent that it shows that the brief and long duration 
PhNRs are reliable and robust parameters for assessing RGC function in 
controls and dysfunction in diseases that compromise the integrity of RGCs. 
Furthermore, although the results of this study as well as a previous study in 
glaucoma (Preiser et al. 2014) indicated that the N95 amplitude of the PERG 
performed better than the PhNR amplitude at discriminating between disease 
and non-disease states, the difference was not statistically significant. The 
choice of one over the other can therefore be currently guided by practical 
considerations, namely PhNR requiring mydriasis and the PERG requiring an 
optimal retinal image (i.e., clear optics and adequate refractive correction) 
(Preiser et al 2014). 
 
 
8.2 Study Limitations  
A major limitation in this study was the small sample size of participants with 
ADOA and incomplete data for some participants. Nearly 70 individuals with 
known OPA1 mutations were contacted from a nationwide database of about 
200 patients who had been studied over the last 20 years by the primary 
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supervisor of this project (MV). However, many declined to participate in the 
study due to travel distance. Many of them were living between 100 – 200 miles 
of Cardiff. The group of five members in Family E expressed interest in the 
study, but were unwilling to come to Cardiff. This led to the setting up of a 
second site in City University, London. However, the use of an additional site 
led to the following technical challenges which prevented the collection of a 
complete dataset for some participants.   
1. The monitors used for generating the PERG stimuli at the Cardiff and 
City sites were different. Although the luminance and check sizes at the 
City site were calibrated to match that of the Cardiff site, the PERG 
traces from City were different in form to those from Cardiff. 
2. The Ganzfeld stimulator available at City was an Epsion Colour Dome 
while the one used at Cardiff, was an Electronica model. The properties 
of the brief flashes produced by the two systems were not identical.  
3. As explained in the methods, the Topcon 2000 OCT available at the City 
site did not have the same data storage settings as the Topcon 1000 
OCT in Cardiff. It was not, therefore, possible to analyse the data 
collected from the City site using the OCT Explorer. 
 
Another limitation to this study relates to the different methods of measuring the 
PhNR amplitudes (Mortlock et al., 2010). This study used the peak to trough 
(Chapter 2 and 4), peak to fixed time (Chapter 3) and the baseline to trough 
(Chapter 5, 6 and 7) methods. It is possible that using a different method of 
assessing the PhNR amplitude (e.g. PhNR/b-wave ratio) could have produced 
different outcomes.  
 
In spite of these limitations, the results of this research were consistent with 
previous reports indicating that the findings were not spurious. At the start of the 
study, an initial sample size of 14 participants (7 per group) was calculated 
based on the results reported by Miyata et al (2007). This gave a standardised 
difference of 1.48 with 80% power at a significance level of 0.05. The revised 
standardised difference calculated from the focal PhNR-ON amplitude in this 
present study is 1.60, giving a power of 98% at a significance level of 0.05 (or 
90% at p = 0.01).  
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Previous studies of visual acuity loss, visual field loss and colour vision changes 
(Kjer, 1959; Krill et al., 1970; Kline and Glaser, 1979; Hoyt, 1980; Kjer et al., 
1983; Berninger et al., 1991; Eliott et al., 1993; Kjer et al., 1996; Brown et al., 
1997; Johnston et al., 1997; Simunovic et al., 1998; Votruba et al., 1998a; 
Votruba et al., 1998b; Johnston et al., 1999; Thiselton et al., 2002; Votruba et 
al., 2003a; Nakamura et al., 2006; Walters et al., 2006; Cohn et al., 2008; Yu-
Wai-Man et al., 2010a; Yu-Wai-Man et al., 2010b; Almind et al., 2012; Reis et 
al., 2013; Ronnback et al., 2013) as well as thinning of the retina (Ito et al., 
2007; Barboni et al., 2010; Milea et al., 2010; Barboni et al., 2011; Gocho et al., 
2013; Russo et al., 2013; Carbonelli et al., 2015) have shown changes 
associated with ADOA which are in keeping with the findings of this research. 
Furthermore, these studies have shown a similar wide phenotypic variability 
between individuals, which may be attributable to genetic heterogeneity. This 
corroboration of previous studies again supports the validity of the findings of 
this PhD.  
 
 
8.3 Future Directions 
ERG components have been traditionally assessed by measuring their 
amplitudes and times-to-peak. However, the weaknesses in this approach are 
becoming increasingly evident. Further research into developing a new 
paradigm of evaluating the ERG response which does not rely on amplitude and 
time-to-peak would therefore be highly valuable in future.  
 
The ERG provides a reliable and robust objective assessment of retinal 
function. The long duration ERG especially provides the unique opportunity to 
dissect ON and OFF pathways in vivo and has been used in assessing 
diseases of the visual system that preferentially affect one pathway or the other 
(e.g. congenital stationary night blindness). However, its clinical use is limited 
by the longer recording times, especially for the low amplitude focal response. 
For example, it took an average of one hour to record focal ERGs from the 
central, nasal and temporal macula (i.e. at least 20 mins per location). It would 
therefore be of interest to develop recording protocols that cut recording times 
at least in half. This may involve improvements in the hardware for ERG 
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recordings; for example, developing better amplifiers or more sensitive 
electrodes to improve the signal to noise ratio so that fewer responses are 
required for averaging or the development of more sensitive electrodes. 
Alternatively, more cost-effective approaches which would look into optimising 
recording techniques could be investigated (e.g. investigations into optimum 
electrode placement and minimum duration of stimulus flash required to obtain 
an optimum separation of ON and OFF components).  
 
In Chapter 7, the significant relationship between the PhNR-OFF and ageing in 
participants with ADOA was interesting and would require further probing. A 
longitudinal study or a cross sectional study with sufficient numbers in 
appropriate age bins could be conducted in future to look into this. 
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APPENDIX I – CALIBRATION OF LIGHT SOURCES USED IN 
THIS STUDY 
The miniature Ganzfeld stimulator used in this study contained four LEDs which 
were individually controlled by an analogue dial. The change in luminance of the four 
LEDs with the dial settings are shown in Figure 1.  
 
At the start of the study, the maximum luminance of the red LED was 35.10 cd/m2, 
which was lower than required for this study. The original configuration of diffusers in 
the tube of the miniature Ganzfeld included a semi-spherical diffuser cap. In order to 
increase the luminance of the red LED, the diffuser cap removed and replaced with a 
series of diffusing sheets at different stages during the pilot studies. The LEDs were 
therefore re-calibrated (i.e. dial settings were changed) after each change of 
diffusers to ensure the required luminances were obtained. The dial settings and 
corresponding luminances of the light sources are provided in Tables A1 – A8.  Note 
however, that the configuration used at the start of the main study was maintained 
throughout the study.  
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Figure A.1. Graph showing the change in luminance of the four LEDs in the miniature Ganzfeld 
to the dial settings. Luminance were measured using Minolta CS-100 on 21/02/2013. 
 
 
Table A.1. Maximum luminance for the LEDs after diffuser cap was replaced with diffusion 
sheets (26-06-2016) 
LED Dial Setting Luminance 
Red 1000 61.93 
Green 1000 341.30 
Blue 1000 168.03 
Amber 1000 228.36 
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Table A.2. Settings used for experiment to determine optimum stimulus duration for eliciting 
the long duration focal PhNR in Section 2.3. (29/07/2013)  
Light Source Dial Settings Luminance, cd/m2 
Photopic Scotopic 
Red LED flash 710 55 NA 
Blue LED background 195 3.75 67.35 
Blue Surround 8.5V, 0.08 Amp 5.65 113.10 
 
 
Table A.3. Settings used for the red LED flash in experiment to determine optimum luminance 
for eliciting the long duration focal PhNR in Section 2.4. (12-04-2013) 
Luminance, cd/m2 
(Red LED flash) 
2 4 7 12 17 26 40 55 
Dial Setting 198 230 272 339 412 556 772 989 
 
 
Table A.4. Settings used for background light sources in experiment to determine optimal 
luminance for eliciting the long duration focal PhNR in Section 2.4. Date - 12-04-2013 
Light Source Dial Settings Luminance, cd/m2 
Photopic Scotopic 
Blue LED 199 3.75 67.35 
Blue Surround  8.5V, 0.08 Amp# 5.65 113.10 
# - The blue surround background was controlled by a voltage controller 
 
 
Table A.7. Settings for experiment to determine optimum stimulus wavelength for eliciting the 
long duration focal PhNR in section 2.5. (26/07/2013 to 09/08/2013) 
LED Type Dial Setting Luminance, cd/m2 
Photopic Scotopic 
Red Flash 710 57.18 NA 
Green Flash 385 53.12 NA 
Blue Flash 400 60.68 NA 
Amber Flash 310 56.86 NA 
Green Background 372 35.59 143.42 
Blue Background 198 3.75 67.35 
Amber  Background Max 300.58 104.70 
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Table A.8. Settings used for main study. Calibrated using ILT 1700 (Able Instruments and 
Controls, Reading, UK). (20/01/2014 to 24/01/2014) 
ERG Light 
Source 
Type Dial Setting Luminance, cd/m2 
Photopic Scotopic 
Focal  Red  Flash 600 55.10 NA 
Blue Flash 300 56.50 NA 
Blue Background 180 4.47 80.27 
Blue Surround 0.85 V, 0.09 amps 7.00 139.94 
Full-field Red Flash 870 53.00 NA 
Blue Background 186 4.31 77.40 
 
Table A.9. Ganzfeld bowl settings for brief full-field ERG. Calibrated using ILT1700 (Able 
Instruments and Controls, Reading, UK). (14/01/2014) 
Flash 
Settings 
Colour Red 
Flash Strength 20 
Measured luminance 1.51 cd.s/m2 
Neutral density filter 0.3 
Duration 300 
Flash frequency 2 Hz 
Background 
Settings 
Colour Blue 
Background luminance setting 300 
Measured luminance 2.92 cd/m2 (63.95 scot cd/m2) 
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APPENDIX II – CALCULATION OF DENSITIES AND 
CUMULATIVE COUNTS OF THE RECEPTIVE FIELDS OF 
RGCS 
1. The receptive field densities of all RGCs, dgf, in deg2, at a given eccentricity, 
rx, in each of the four meridians were calculated based on the formula Watson 
2014 (Equation I.1). A data table of receptive field densities was generated for 
values of r, ranging from 0 to 70o in 0.01o steps using Microsoft Excel.  
 
 
Equation II.1 
  
where dgf (r, k) is the density of RGCfs at eccentricity, r, in degrees along 
meridian, k; dgf(0) is the density receptive fields at the centre of the fovea 
(33,163.2 RGCf/deg2), ak is the weighting function of the first term, r2 is the 
eccentricity at which RGC receptive field density is reduced by a factor of 4 
(and spacing is doubled) and re,k is the scale factor by the index k. The values 
of the constants are provided in Table II.1. 
 
Table II.1. The values of constants for Equation 1 in four meridians (Watson, 2014) 
Meridian (k)* a r2 re 
Temporal 0.9851 1.058 22.14 
Superior 0.9935 1.035 16.35 
Nasal 0.9729 1.084 7.633 
Inferior 0.9960 0.9932 12.13 
* Meridians refer to visual field locations 
 
2. Since a circular stimulus was used in this study, the mean density, dav, in 
deg2, was calculated as the average of the densities of the four meridians and 
plotted as a function of eccentricity (Figure 1A). The dimensions of the stimuli 
used in the study are provided in Table 2. The mean receptive field densities 
are shown in Table 3 for the eccentricities used in this study. Note that the 
density in temporal visual field from 12o – 17o = 0 because of optic nerve 
head. 
𝑑𝑔𝑓 (𝑟, 𝑘) = 𝑑𝑔𝑓(0) ∗  [𝑎𝑘 (1 +
𝑟
𝑟2,𝑘
)
−2
+ (1 − 𝑎𝑘) exp (−
𝑟
𝑟𝑒,𝑘
)] 
Appendix II1 
265 
 
3. The number of all RGCfs, T, at a given eccentricity, rx, was calculated by 
integrating the mean density, dav, at eccentricity, rx, using the trapezoid rule 
and multiplying this by 2πr to account for the increasing area (Equation 2), as 
required by Watson (2014).  
 
𝑇 = (𝑟𝑥 − 𝑟0) ∗ (
𝑑𝑎𝑣𝑥 − 𝑑𝑎𝑣0
2
) ∗ 2𝜋𝑟𝑥 
Equation 2 
 
where T is the total number of RGC receptive fields, rx is the given 
eccentricity, ro is the previous adjacent eccentricity, davx and davo are the mean 
RGCf densities at rx and ro respectively. 
4. The cumulative count of all RGCfs at a given eccentricity, rx, was calculated 
as the cumulative sum of T from r = 0, to rx. This was plotted in Figure 1B. 
5. The number of RGCfs in each annulus was then calculated as the sum of T 
for from the inner radius to the outer radius of the annulus (see Table 4) 
 
 
Figure II.1. A – Mean density of midget ganglion cell receptive fields as a function of 
eccentricity computed from the formula provided by Watson (2014). The “valley” in the curve 
corresponds to the blind spot. B – Cumulative number of midget ganglion cell receptive fields 
as a function of eccentricity. Graphs are plotted on a log scale 
 
 
Calculation of densities and cumulative counts of the receptive fields of ON 
and OFF RGCs 
For the long duration stimulus, the densities and cumulative counts of the receptive 
fields of ON and OFF RGCs were required in order to compare them respectively to 
the PhNR-ON and PhNR-OFF parameters. For this, the distribution of ON and OFF 
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cell of all RGC types was needed. As there are many different RGC types in the 
retina, the two major morphological types, the midget and parasol RGCs, were 
settled on. A third group, which was called “others” was added to include all the other 
RGCs in the retina.  
 
The receptive field density of midget cells (mRGCf) at a given eccentricity, r, in a 
meridian, k, was given by Watson (2014) as,  
 
𝑑𝑚𝑓 (𝑟, 𝑘) = 2𝑑𝑐 (0)(1 +
𝑟
𝑟𝑚
)−1 ∗ [𝑎𝑘( +
𝑟
𝑟2,𝑘
)−2 + (1 − 𝑎𝑘)exp (−
𝑟
𝑟𝑒𝑘
) 
Equation II.3 
 
where dmf is the density of midget RGC receptive fields, dc is the density of foveal 
cones (= 14,804.6 cones/deg2); r is the eccentricity of interest, rm = 41.03o, r2 = 
eccentricity is the eccentricity at which RGC receptive field density is reduced by a 
factor of 4 (and spacing is doubled), ak is the weighting function of the first term, re,k 
is the scale factor by the index, k, and k is the index of the meridian. 
 
Calculations for ON and OFF mRGCs were based on the ratio of ON:OFF mRGCs 
from 0 – 5o = 1:1; from 5 – 25o = 1:1 to 1:1.69; and beyond 25o = 1:1.69 (Drasdo et 
al., 2007). Explicit details of the distribution of the parasol RGCs (pRGCs) in humans 
were not available in the searched literature. Therefore, they were assumed to 
constitute 10% of the RGC population at all eccentricities based on the 8 – 12% 
reported by Silveiro et al (2004) for macaque. The ON:OFF ratio of parasol RGCs 
was then computed to be 0.4:0.6 based on the dendritic field size differences 
between ON and OFF pRGCs (Dacey and Petersen, 1992). The proportion of RGCs 
in the “others” group was calculated by subtracting the sum of the midget and 
parasol RGCs from the total number of RGCs at each eccentricity. The ON:OFF ratio 
for the others group was assumed to be 1:1.  
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Table II.2. Dimensions of stimulus sizes used in the study. 
Stimulus Angular 
Size (Diameter), deg 
Viewing 
distance, cm 
Angular radius, 
deg 
Stimulus Angular 
Area, deg2 
Annulus Area, deg2 Annulus Dimension 
(Inner - outer radius), deg 
Eccentricity (midpoint 
of stimulus), mm 
5 66.42 2.5 19.63 19.63 0.00 – 2.5 1.25 
5.5 (60.37) 2.75 (23.76) (23.76) 0.00 – 2.75 (1.38) 
10 33.15 
 
5.00 78.54 
 
58.90 
(54.78) 
2.51 – 5.00 
(2.76 – 5.00) 
3.75 
(3.88) 
15 22.03 7.50 176.71 98.17 5.51 – 7.50 6.25 
20 16.45 10.00 314.16 137.44 7.51 – 10.00 8.75 
30 10.82 15.00 668.37 392.70 10.01 – 15.00 12.50 
(45) 7.00 (22.50) (1590.43) (883.57) (15.01 – 22.50) (18.75) 
60 5.02 
 
30.00 2788.95 
 
2120.58 
(1237.00) 
15.01 – 30.00 
(22.51 – 30.00) 
22.50 
(26.25) 
110 NA 55.00 9464.83 6675.88 30.01 – 55.00 42.50 
Values in brackets apply to long duration stimulus used in Experiment 1. NA – not applicable. NB – The area of the optic nerve head (38.48 deg2; assuming a 
diameter of 7o and beginning at 11o from the fovea (Watson, 2014)) has been subtracted from angular areas of stimuli >30o. 
 
Table II.3. Mean receptive field density and counts of RGCfs for eccentricities used in this study 
Stimulus Size, deg Eccentricity, deg RGCf Density, /deg2 RGCf Cumulative Count, n No. of RGCfs in Annulus 
5 1.25 7211.95 56245.41 123728.93 
(5.5) (1.38) 6491.82 63560.24 136063.34 
10 
 
3.75 
(3.88) 
1857.47 
(1779.49) 
182196.35 
(187425.19) 
110293.66 
(97959.25) 
15 6.25 917.72 281056.76 90485.39 
20 8.75 573.29 365148.74 78977.70 
30 12.50 224.88 460348.69 98368.63 
(45) (18.75) (187.41) (561932.51) (138541.34) 
60 
 
22.50 
(26.25) 
139.60 
(107.43) 
640198.36 
(710322.80) 
271687.79 
(133146.45) 
110 42.50 42.77 942631.07 291422.63 
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Table II.4. Table for calculating the proportion of receptive fields of ON and OFF cells of all RGC types, midget RGCs, parasol RGCs and other 
RGCs 
Stimulus 
Size 
(Diameter), 
deg 
Annulus  
(Inner - outer 
radius), deg 
No. of all 
RGCf in 
Annulus 
(A) 
No. of Midget RGCfs in Annulus# No. of Parasol RGCfs in Annulus No. of Other RGCfs in Annulus 
Total 
mRGCf 
(B) 
ON 
mRGCf 
(C) 
OFF 
mRGCf 
(D) 
Total pRGCf 
(E = A – B) 
ON pRGCf  
(F= E*0.4) 
OFF 
pRGCf  
(G= E*0.6)  
Total oRGCf  
(H = A – B – E) 
ON 
oRGCfs  
(I= H*0.5) 
OFF 
oRGCFs 
(J= H*0.5) 
5.5 0.00 – 2.75 136063.34 
117354.34 58677.17 58677.17 13606.33 5442.53 8163.80 5102.67 2551.33 2551.33 
10 2.76 – 5.00 97959.25 
80001.69 40000.85 40000.85 9795.92 3918.37 5877.55 8161.63 4080.82 4080.82 
15 5.51 – 7.50 90485.39 
70174.28 34534.80 35639.48 9048.54 3619.42 5429.12 11262.57 5631.29 5631.29 
20 7.51 – 10.00 78977.70 
58160.09 27673.66 30486.43 7897.77 3159.11 4738.66 12919.83 6459.92 6459.92 
30 10.01 – 15.00 98368.63 
67740.56 30712.75 37027.80 9836.86 3934.75 5902.12 20791.21 10395.61 10395.61 
45 15.01 – 22.50 138541.34 
84613.43 34631.23 49982.20 13854.13 5541.65 8312.48 40073.78 20036.89 20036.89 
60 22.51 – 30.00 133146.45 
72714.80 27126.28 45588.52 13314.65 5325.86 7988.79 47117.01 23558.50 23558.50 
110 30.01 – 55.00 291263.11 
130815.36 48401.68 82413.67 29126.31 11650.52 17475.79 131321.44 65660.72 65660.72 
Total 1064805.21 681574.54 301758.42 379816.12 106480.52 42592.21 63888.31 276750.15 138375.07 138375.07 
# - Total number of mRGCf was calculated from Equation 3. Calculations for ON and OFF mRGCs were based on the ratio of ON:OFF mRGCs from 0 – 5o = 
1:1; from 5 – 25o = 1:1 to 1:1.69; and beyond 25o = 1:1.69 (Drasdo et al., 2007) 
 
Table II.4. (continued) 
Stimulus 
Size 
(Diameter), 
deg 
Annulus 
(Inner - outer 
radius), deg 
No. of all 
RGCf in 
Annulus 
(A) 
Total No. of 
ON RGCfs 
(K = C + F + I) 
Total No. of 
OFF RGCfs 
(L = D + G + I) 
ON-RGCfs 
Fraction 
(M = K/A) 
OFF-RGCfs 
Fraction 
(N = L/A) 
RGC Density, 
/deg2 
(O) 
All ON-RGCf 
Density 
(P = M*O) 
All OFF-RGCf 
density 
(Q = N*O) 
5.5 0.00 – 2.75 136063.34 66671.04 69392.30 0.49 0.51 6491.82 3180.99 3310.83 
10 2.76 – 5.00 97959.25 48000.03 49959.22 0.49 0.51 1779.49 871.95 907.54 
15 5.51 – 7.50 90485.39 43785.50 46699.89 0.48 0.52 917.72 444.08 473.64 
20 7.51 – 10.00 78977.70 37292.69 41685.01 0.47 0.53 573.29 270.70 302.59 
30 10.01 – 15.00 98368.63 45043.10 53325.53 0.46 0.54 22.4.88 102.97 121.91 
45 15.01 – 22.50 138541.34 60209.77 78331.57 0.43 0.57 187.41 81.45 105.96 
60 22.51 – 30.00 133146.45 56010.64 77135.81 0.42 0.58 107.43 45.19 62.24 
110 30.01 – 55.00 291263.11 125712.93 165550.18 0.43 0.57 42.77 18.46 24.31 
Total 1064805.21 482725.70 582079.51 - - - - - 
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Table II.5. Table of values for number of RGCf in annuli used to calculate PhNR density using 
the brief flash 
Stimulus Angular 
Size (Diameter), 
deg 
Eccentricity 
(Midpoint of 
Annulus), deg 
Annulus 
Dimension (Inner 
- outer radius), 
deg 
Number of RGCf 
in Annulus 
5 1.25 0.00 – 2.50 123728.93 
10 3.75 2.51 – 5.00 110293.66 
15 6.25 5.51 – 7.50 90485.39 
20 8.75 7.51 – 10.00 78977.70 
30 12.50 10.01 – 15.00 98368.63 
60 22.50 15.01 – 30.00 271687.79 
110 42.50 30.01 – 55.00 291422.63 
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APPENDIX III – SAMPLE SIZE CALCULATION FOR 
INDEPENDENT SAMPLES T-TEST 
Sample size calculated using Altman Nomogram (Figure 1) based on standardised 
difference = 1.5 (see Equation III.1), power of the study = 80% and significance level 
of 5%. 
 
 
Figure III.1 Nomogram for calculating sample size, given Power = 80% and standardised 
difference = 1.5 (rounded up for simplicity). (Modified from Altman, 1991) 
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Equation III.1: 
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑𝑖𝑠𝑒𝑑 𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 =
𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑔𝑟𝑜𝑢𝑝𝑠 
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛
 
 
Based on Miyata et al. 2007: 
Mean PhNR amplitude in controls (+ standard deviation)  = 34.3 (+ 9.0) 
Mean PhNR amplitude in ADOA (+ standard deviation)  = 21.0 (+ 2.4) 
 
 
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑𝑖𝑠𝑒𝑑 𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 =
(34.3 − 21.0)µ𝑉 
(9.0)µ𝑉 
 
 
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑𝑖𝑠𝑒𝑑 𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = 1.48 
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APPENDIX IV – STUDY PROTOCOL 
PARAMETER EQUIPMENT IMPLEMENTATION  
OBJECTIVE REFRACTIVE ERROR  
 
Topcon KR – 7500 
Auto-kerato-refractometer  
Record mean of three readings 
If patient has uncorrected refractive error > +/- 0.50 DS, perform subjective 
refraction for best corrected visual acuity (BCVA) 
If objective prescription is within +/- 0.50 D (best vision sphere) of patient’s 
current spectacle prescription, then proceed; if not, then refract for BCVA 
BCVA should be better than or equal to 1.0 logMAR in the better seeing eye 
for inclusion into study 
PRESENTING DISTANCE VISUAL 
ACUITY  
 
Early treatment diabetic retinopathy 
study (ETDRS) Chart  
 
 
Test distance VA: 4m 
Room illumination: Well lit (60-120 cd/m2) 
Check VA with near addition if required 
Patient is encouraged to read/guess until more than half the letters on line 
are missed 
Record VA in logMAR 
PRESENTING READING ABILITY Near logMAR chart (N-notation) Test distance: 40 cm 
Room illumination: Well lit (60-120 cd/m2) 
Check VA with current prescription if available 
Record near VA in N-notation 
CONTRAST SENSITIVITY Pelli-Robson Chart Test distance: 1 metre 
Room Illumination: Well lit  
Record contrast sensitivity in log units (Score 0.05 log CS per letter. Per 
letter recording is more repeatable than the line recording (Elliot, 2006)  
VISUAL FIELDS Humphrey Field Analyzer – 720i  
 
Protocol: 24-2 SITA Fast  
Perform two sessions. First session is for training and second session 
results will be recorded for study  
Record the following indices 
Fixation losses (should be <30% for reliability) 
False negative (should be <20% for reliability)  
False positive (should be <20% for reliability) 
Appendix IV 
273 
 
Mean deviation (dB) 
If “a” AND either “b” or “c” are unreliable, repeat test to confirm 
Save and print out field plot data 
INTRAOCULAR PRESSURE  Nidek Auto non-contact tonometer, 
NT-2000 
Record the mean of 3 readings per eye (mmHg) 
COLOUR VISION Farnsworth-Munsell D-15 
desaturated colour vision kit 
 
Illumination: Well Lit  
Plot score (arrangement of discs) on score sheet 
Determine axis of defect if present (protanopia, deutranopia, tritanopia) 
otherwise record “Normal” 
ANTERIOR SEGMENT OCULAR 
HEALTH 
Keeler SL-16 Slit lamp 
biomicroscope 
Assess  
Eyelids*, Conjunctiva*, Sclera*, Cornea*, Anterior chamber angle#, Pupils 
(shape, size, reflex), Lens# 
*: Based on Efron Grading Scales for Contact Lens Complications (Efron, 
1998) 
#: Based on Optometric Grading Scales (Pearson, 2003) 
RETINAL GANGLION LAYER 
FUNCTION 
 
Electrodes: DTL fibre 
Electronic recording system: Medelec 
Synergy System 
Visual stimulation 
PERG: Computer monitor, ViewSonic 
G70fm 
Full field ERG: Ganzfeld full field 
stimulator, GS2000, LACE 
Elettronica, Italy 
Focal ERG: LED miniature Ganzfeld 
Stimulator, CH Electronics, Bromley, 
Kent, UK 
Pattern electroretinogram (PERG)   
Check size: 0.8o +0.2o (=5mm)* 
Repetition rate: 4 reversals per second* 
Field size: 20o x 20o 
Viewing distance: 36 cm 
Contrast = 98.5%* 
Mean luminance: 46.7 cd/m2 
Amplitude of P50: measured from trough of N35 to peak of P50* 
Amplitude of N95: measured from peak of P50 to trough of N95* 
Calculate P50:N95 ratio 
 
Brief flash full field ERG#+ 
Red flash duration = 300µsec 
Red flash luminance = 1.69 cd.s/m2 
Flash repetition rate = 4 Hz 
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Blue background luminance = 3.9 log scot td (206 scot cd/m2) 
 
Long duration full field ERG+ 
Red flash duration = 250msec 
Flash luminance = 55 cd/m2 
Flash repetition rate = 2Hz 
Blue background luminance = 100 scot cd/m2 
Measurement of components:  
a-wave: 
Amplitude: pre-stimulus baseline to trough of a-wave 
Time-to-peak: stimulus onset to trough of a-wave 
b-wave 
Amplitude: trough of a-wave to peak of b-wave 
Time-to-peak: stimulus onset to peak of b-wave 
PhNR-ON 
Amplitude: peak of b-wave to trough of PhNR-on 
Time-to-peak:  
d-wave 
Amplitude: time point of stimulus offset to peak of d-wave 
Time-to-peak: stimulus offset to peak of d-wave 
PhNR-OFF 
Amplitude: peak of d-wave to trough of PhNR-OFF 
Time-to-peak: stimulus offset to trough of PhNR-OFF  
 
Long duration focal ERG+ 
Red on Blue 
Red flash duration = 250msec 
Flash luminance = 55 cd/m2 
Flash repetition rate = 2Hz 
Blue background luminance = 100 scot cd/m2 
Stimulus size = 20o 
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Test area: Central, nasal, temporal macula 
Blue on Amber (focal) 
Blue flash duration = 250msec 
Flash luminance = 55 cd/m2 
Flash repetition rate = 2Hz 
Amber background = 100 scot cd/m2 
Stimulus size = 20o 
Test area: Central, nasal, temporal macula 
Measurement of components: See “3.e.” above 
 
(*: ISCEV protocol; #: Settings adopted from (Binns et al., 2011); +: Test 
requires pupil dilation with 1% Tropicamide) 
POSTERIOR SEGMENT OCULAR 
HEALTH AND FUNDUS 
EXAMINATION 
Direct ophthalmoscope (Keeler 
Professional) 
Fundus camera (Topcon 3D 1000 
OCT) 
Ophthalmoscopy: Assess 
Vitreous, Optic nerve head, Cup to disc ratio, Pallor, Disc contours, Macula 
Fundus photography:  
Peripheral retina Field angle: 45o  
Take photograph with macula centred 
Assess central retina and optic nerve head features (cup to disc ratio and 
disc pallor) 
RETINAL NERVE FIBRE LAYER 
THICKNESS 
Topcon 3D OCT 1000 Scan type:  
B-scan of Macula 
B-scan of Optic nerve 
Record average mean (360o) thickness (µm) and mean thickness of 
temporal, superior, nasal, inferior quadrants 
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APPENDIX V – SAMPLE SIZE CALCULATION FOR A 
BIVARIATE CORRELATION 
The total sample size required for a bivariate correlation, N, is given by: 
𝑁 = (
𝑍𝛼 +  𝑍𝛽
𝐶
)
2
+ 3 
 
Where Zα is the z-score for α (2-tailed) and Zβ is the z-score for β. α is the level of 
significance (p-value) and β =1 −
𝑝𝑜𝑤𝑒𝑟
100
. C =0.5× ln(
1+𝑟
1−𝑟
) , where r is the correlation 
coefficient.  
 
Based on previous studies, the correlation between the retinal nerve fibre layer and 
ERG amplitude shows a large effect (r > 0.5). To determine the required sample size 
for this study using r = 0.5, p = 0.05 and power = 80%,  
𝐶 =  0.5× ln (
1 + 0.5
1 − 0.5
) 
C = 0.549 
 
Given that Zα = 1.960 and Zβ = 0.842, then  
𝑁 = (
1.960 +  0.842
0.549
)
2
+ 3 
N = 29.05 
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APPENDIX VI – POWER SPECTRUM OF FOCAL AND 
PATTERN ELECTRORETINOGRAM 
Focal and pattern ERGs were Fourier analysed offline to remove high frequency 
signals. The Fourier analysis was based on the approach (derived from first 
principles) by Stroud (1986). A visual inspection of the power spectrum (generated 
offline) of the focal ERGs showed that most of the power was concentrated in the 
first 20 harmonics (40 Hz) (Figure II.1). In the case of the PERG, the power was 
concentrated in the first 10 harmonics (20 Hz) (Figure II.2). However, the cut-off was 
increased to 25 harmonics (50Hz) for the focal ERG and 15 harmonics (30 Hz) for 
the PERG as these were points at which the power had levelled off. 
 
 
Figure II.1. Power spectrum for grouped average focal ERG of 12 control participants. 
 
Figure II.2. Power spectrum for grouped average PERG of 12 control participants. 
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